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proteins, including histones, and participates in and influences every DNA-related process. Chromatin's
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lysine PTMs, and the non-histone chromatin lysine PTMs. First, we demonstrated that the JmjC domaincontaining protein Kdm5 demethylates methylated lysine 4 of histone H3 in vitro and in vivo, refuting the
longstanding hypothesis that lysine methylation is irreversible. Second, we confirmed and characterized
monomethylation of lysine 20 of histone H4. Its abundance is highest at heterochromatic locations
including rDNA, the silent mating type loci, and subtelomeres, lowest at euchromatic locations including
centromeres and promoter/5' regions of genes, and intermediate inside genes. We observed a correlation
between the locations of H4 K20A-mediated derepression and H4 K20me1 enrichment. Additionally, H4
K20me1 decreases globally during replicative ageing and may participate in survival during DNA damage.
Our results refute the longstanding hypothesis that this PTM is not conserved in S. cerevisiae and
potentially identify the first repressive budding yeast histone lysine methylation. Third, we investigated
NuA4's lysine acetylation of the chromatin protein Spt16, identified by a previously published in vitro
acetyltransferase screen. Mass spectrometry identified three acetylation sites in vivo and their
substitution with unacetylatable arginines, but not the acetyllysine mimics glutamine, causes moderate
heat-sensitivity. Our results suggest that Spt16 acetylation occurs in vivo and is necessary for heattolerance.
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ABSTRACT

LYSINE POST-TRANSLATIONAL MODIFICATIONS OF SACCHAROMYCES
CEREVISIAE CHROMATIN PROTEINS
Christopher R. Edwards
Shelley L. Berger, Ph.D.
DNA exists within the cell as part of a complex structure called chromatin which is
comprised of many proteins, including histones, and participates in and influences every
DNA-related process. Chromatin’s proteins are modified post-translationally and this
impacts their functions and in turn, the DNA processes in which they participate.
However, the repertoire of post-translational modifications (PTMs), the enzymes that
create and remove them, and their roles in chromosome biology are not fully
understood. We have used the budding yeast Saccharomyces cerevisiae to investigate
chromatin PTMs, specifically lysine modifications, through three avenues: the enzymes
that regulate lysine PTMs, the histone chromatin lysine PTMs, and the non-histone
chromatin lysine PTMs. First, we demonstrated that the JmjC domain-containing protein
Kdm5 demethylates methylated lysine 4 of histone H3 in vitro and in vivo, refuting the
longstanding hypothesis that lysine methylation is irreversible. Second, we confirmed
and characterized monomethylation of lysine 20 of histone H4. Its abundance is highest
at heterochromatic locations including rDNA, the silent mating type loci, and
subtelomeres, lowest at euchromatic locations including centromeres and promoter/5’
regions of genes, and intermediate inside genes. We observed a correlation between
the locations of H4 K20A-mediated derepression and H4 K20me1 enrichment.
Additionally, H4 K20me1 decreases globally during replicative ageing and may
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participate in survival during DNA damage. Our results refute the longstanding
hypothesis that this PTM is not conserved in S. cerevisiae and potentially identify the
first repressive budding yeast histone lysine methylation. Third, we investigated NuA4’s
lysine acetylation of the chromatin protein Spt16, identified by a previously published in
vitro acetyltransferase screen. Mass spectrometry identified three acetylation sites in
vivo and their substitution with unacetylatable arginines, but not the acetyllysine mimics
glutamine, causes moderate heat-sensitivity. Our results suggest that Spt16 acetylation
occurs in vivo and is necessary for heat-tolerance.
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DISSERTATION CHAPTER 1
Introduction

The nature of chromatin
DNA is a linear nucleic acid chain with regions, called genes, serving as templates for
protein synthesis by the translation machinery. This is DNA’s essential function and
most processes occurring on DNA serve to facilitate or ensure the fidelity of this function.
Transcription relays the protein-synthesis instructions to the translation machinery, DNA
repair maintains the fidelity of these templates, DNA replication duplicates the DNA
molecules to ensure that each daughter cell inherits a copy, and homologous
recombination reorganizes the combination of gene versions that are present within
each DNA molecule to promote genetic variability (Campbell, N.A., 1999).
DNA does not exist naked within the cell, but rather is part of a large and
complex proteinacious structure called chromatin. Chromatin’s components include the
DNA, transcribed RNAs, and a variety of proteins participating in the above mentioned
processes, but primarily proteins called histones. Histones exist in chromatin as
octamers containing two copies each of the core histones H2A, H2B, H3, and H4. An
additional linker histone, linker histone H1, exists in chromatin separate from the
octamers. These octamers are integrated into chromatin as structures termed
nucleosomes, each of which consists of one octamer with ~146bp of the linear DNA
molecule wrapped around twice. Nucleosomes are distributed across the entire DNA
molecule (with exceptions such as telomeric repeats) with variable length spaces inbetween them along the DNA, resulting in a structure reminiscent of beads on a string.
While “chromatin” can refer to the complex of DNA, RNA, histones, and non-histone
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proteins, we will here use “chromatin” to also refer to DNA with histones (Luger, K.,
1997; Campbell, N.A., 1999).
Each core histone has a globular domain that comprises the bulk of and
mediates histone-histone interactions within the nucleosome, and an unstructured Nterminal tail that extends into the surrounding nucleoplasm. These core histones interact
with one another via the “histone fold” within their globular domains and with the DNA
strand that is wrapped around the octamer via numerous hydrogen bonds and positive
charges derived from amino acid side chains on the nucleosome’s surface (Luger, K.,
1997).
Each DNA molecule is partially condensed by being wrapped around many
histone octamer thus allowing it to fit within the nucleus. Chromatin however can
achieve additional levels of compaction. Adjacent nucleosomes and the linker histone
H1 can interact to reduce the physical space in-between them, large stretches of
chromatin may retract to form “30nm fibers,” and during mitosis, these higher-order
chromatin structures achieve maximal compaction to form the famous chromosome
structure (Li, G., 2011).
In addition to facilitating DNA compaction, nucleosomes can also stearically
block access to DNA-interacting factors. In vitro transcription for example can occur on
naked DNA but not so well on reconstituted chromatin, presumably since the
nucleosomes block recruitment of the transcription initiation complex and translocation of
the RNA polymerase (Pavri, R., 2006). Likewise, in vivo transcription involves
nucleosome depletion at promoters and transcribed regions (Jiang, C., 2009),
modulation of nucleosome structure ahead of RNA polymerase 2 (RNApol2) to allow its
translocation, and restoration of nucleosome structure behind elongating RNApol2 to
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prevent inappropriate intragenic transcription initiation (Belotserkovskaya, R., 2003;
Fleming, A.B., 2008; Xin, H., 2009). Additionally, nucleosomes provide a surface with
which chromatin-binding proteins can interact (discussed below) (Ruthenburg, A.J.,
2007).
Nucleosomes thus participate in all chromatin-related processes and can be
altered in three ways that influence these processes. First, nucleosomes can be
incorporated into, evicted from, and translocated along chromatin, thereby altering what
regions of DNA are accessible. These changes occur via histone chaperones that
incorporate them (Burgess, R.J., 2010) and ATP-dependent histone remodelers that
reposition or evict them (Saha, A., 2006). Nucleosomes’ structures can also be
modulated by FACT to change DNA accessibility in a way that is ATP-independent
(Winkler, D.D., 2011). Second, the histone composition of nucleosomes can involve
non-canonical (variant) histones. For example, Htz1 can replace H2A and is associated
with promoters, H2AX can replace H2A and participates in DNA damage repair by being
phosphorylated, MacroH2A can replace H2A in the inactive X Barr body, and
Centromeric Protein A (CENPA) can replace H3 at centromeres and participates in
centromere and kinetochore function (Talbert, P.B., 2010). Third, histones can be
modified post-translationally (below).

The nature of post-translational modifications
Post-translational modifications (PTMs) are any change to a protein’s structure that
occurs after translation and includes proteolyses, conformational changes, and the
covalent attachment or removal of chemical groups, usually to amino acid side chains.
The effect is a diversification of the protein’s local structure, potentially affecting protein
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interactions or the protein itself, and this provides several advantages to the cell. First,
proteins can be synthesized in an inactive form that only becomes active after PTM. For
example, some Caspases cannot participate in the apoptotic program until they have
been activated by cleavage (Pop, C., 2009). Second, chemical alterations to amino acid
side chains limit the number of tRNAs that must exist. Without PTMs, codons and
tRNAs would have to exist for acetyllysines, methyllysines, phosphoserines, etc. Third,
it is more economical to modify a protein than to replace it. For example, if a protein
within a complex has to be acetylated, it is more energy-efficient and less disruptive to
the complex if the acetyl group is added post-translationaly than if the protein is removed
and replaced with an acetyl protein. Fourth, it is faster to alter a protein by PTM than to
synthesize a new one.
Many PTMs exist. Isopeptide bonds can be hydrolyzed and caspases are an
example (Pop, C., 2009). Prolyl residues can be isomerized between cis and trans
conformations (Lu, K.P., 2007). Fpr4 for example can isomerizes proline 38 of histone
H3, thereby affecting lysine 36 methylation that participates in transcription (Nelson,
C.J., 2006). Small proteins can be fused to lysines and include Ubiquitin and related
proteins like SUMO (Small Ubiquitin-related Modifier) and Nedd8 (Kerscher, O., 2006).
Most proteins can be ubiquitylated and many such as p53 can be SUMOylated and
neddylated. Small molecules can also be covalently bound to amino acid side chains
and this is a very diverse group of PTMs. Phosphate groups can be fused to the
hydroxyl oxygens of serines, threonines, and tyrosines (Ubersax, J.A., 2007). Proline’s
cyclical backbone can be hydroxylated (Gorres, K.L., 2010). Chains of ADP-ribose can
be covalently bound to glutamic or aspartic acid (Schreiber, V., 2006). Methyl groups
can be covalently attached to the guanidinium nitrogens of arginines (Di Lorenzo, A.,
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2011). Finally, acetyl, butyryl, propionyl, crotonyl, and methyl groups can be fused to the
epsilon amine nitrogen of lysines (Yang, X.J., 2008).
Each PTM has advantages and disadvantages for the cell. Isopeptide bond
hydrolyzation is the most dramatic structural change but is irreversible. The addition of
small proteins provides a relatively large structure that could have strong stearic effects
and provides the opportunity for chain formation since the attached proteins could also
be modified. Ubiquitin for example can form polyubiquitin chains that have different
functions depending on the chains’ structure and monoubiquitination of histones is
proposed to act as a wedge to force nucleosomes apart (Kerscher, O., 2006).
Phosphate attachment is a relatively small structural change but creates a negative
charge. Acetyl attachments to lysine are also a relatively small structural change but
remove a positive charge and add a carbonyl carbon to the end of the side chain (Chen,
Y., 2007; Zhang, K., 2009; Tan, M., 2011). Adjacent acetylations can also sometimes
work synergistically, allowing for a graded effect that depends on the abundance of
acetylations (Yang, X.J., 2008). Finally, methylation of arginines and lysines causes a
relatively small structural change but leaves the positive charge present. Importantly,
methylation allows for a high degree of structural diversification at a single residue.
Whereas the other small molecule modifications are either present or absent, arginines
can be un-, mono-, asymmetrically di-, or symmetrically dimethylated, and lysines can be
un-, mono-, di-, or trimethylated. In-general, we will use “post-translational modification”
to refer to the covalent attachment of molecules.
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The mechanisms by which post-translational modifications function
PTMs can generally affect their target proteins through three mechanisms. First, PTMs
can directly alter the modified protein’s structure or function. For example, the
spontaneous compaction of in vitro reconstituted chromatin can be inhibited by
acetylated histone H4 lysine 16 (H4 K16ac) and ubiquitylated H2B (Shogren-Knaak, M.,
2006; Lu, X., 2008; Fierz, B., 2011). The mammalian gluconeogenesis enzyme Pck1 is
acetylated and this promotes its enzymatic activity in vitro (Lin, Y.Y., 2009). Additionally,
some Caspases can autoproteolyze to activate their apoptotic ability (Pop, C., 2009).
Second, PTMs can interact with proteins to affect their function without affecting
their recruitment. For example, H2B ubiquitylation is necessary for H3 K79 methylation
by Dot1 and hDot1L in vivo. On in vitro reconstituted chromatin however, H2B
ubiquitylation promotes hDot1L’s H3 K79 histone methyltransferase (HMT) activity
without affecting its recruitment, implying an allosteric affect that promotes enzymatic
activity (McGinty, R.K., 2008).
Third, PTMs can promote or block the recruitment of other molecules. For
example, the side chain amine group hydrogen of H3 K56 can hydrogen bond with DNA
at the nucleosome’s DNA entry-exit site. Acetylation of this residue removes this H-bond
resulting in decreased nucleosome-DNA contact and increased accessibility of
nucleosomal DNA in vitro (Masumoto, H., 2005). The greatest effect of PTMs on protein
interactions however is on the recruitment of “readers,” proteins that bind other modified
proteins dependent on their modifications. A variety of domains mediate these
interactions by “reading” the structural changes caused by the PTMs. For example, SH2
and BCRT domains bind phosphopeptides, bromodomains bind acetyllysines, ubiquitinassociated domains bind polyubiquitins, and PH fingers and chromo, tudor, and MBT
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domains bind methyllysines (Yun, M., 2011). This may be PTMs’ most important
function and as such, a large repertoire of known interactions exists.
For example, the histone methyltransferase MMSET is recruited to MDC1 at sites
of DNA damage via interactions between MMSET’s phosphorylated serine 102 and
MDC1’s phospho-binding BRCT domain (Pei, H., 2011). Monoubiquitylated K123 of S.
cerevisiae histone H2B recruits the COMPASS complex subunit Cps35 to promote H3
K4me3 in vivo (Lee, J.S., 2007) and simultaneously blocks recruitment of the HMT Set2
to prevent H3 K36 methylation in vivo and in vitro (Wyce, A., 2007). Interactions
between K48-linked polyubiquitin chains and ubiquitin-associated domains recruits
polyubiquitylated proteins to the proteasome for degradation (Welchman, R.L., 2005).
The budding yeast SAGA histone acetyltransferase (HAT) complex is recruited to the
promoter and 5’ regions of genes via interactions with H3 K4me3 (Bian, C., 2011). Sir3
of the Sir2/3/4 complex binds chromatin via interactions with the H4 K16 and H3 K79
epitopes and is blocked by H4 K16ac and H3 K79me (Altaf, M., 2007).
Shizosaccharomyces pombe Crb2 binds H4 K20me2 and its mammalian counterpart
53BP1 binds H4 K20me2 and p53 K370me2 via tandem tudor domains during DNA
damage (Botuyan, M.V., 2006; Huang, J., 2007). Trimethylated H3 K9 of mammalian
heterochromatin can recruit HP1 to promote proper chromatin structure (Schotta, G.,
2004). H4 K20me1 recruits L3MBTL1 via an MBT domain to promote chromatin
compaction in vitro (Trojer, P., 2007). S. cerevisiae intragenic H3 K36me3 recruits the
small Rpd3 complex which then deacetylates histones to promote sufficient chromatin
compaction levels (Carrozza, M.J., 2005). Finally, H3 K27me3 participates in Polycomb
complex recruitment to promote transcription repression (Simon, J.A., 2009).
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The biological significance of post-translational modifications
PTMs are most well-studied on histones and through these three mechanisms play
important roles in almost every chromatin-related process. Almost every known
modification type participates in DNA damage repair, occurring on both histones and the
repair machinery to coordinate the many protein interactions (Lukas, J., 2011). H4 S1
phosphorylation during S. cerevisiae meiosis promotes chromatin compaction
(Krishnamoorthy, T., 2006). Chromatin compaction is directly influenced by H2B
ubiquitylation and H4 K16ac (Shogren-Knaak, M., 2006; Fierz, B., 2011), and by the
recruitment of chromatin compaction proteins like L3MBTL1 by H4 K20me1 (Trojer, P.,
2007) and heterochromatin proteins like HP1 by H3 K9me3 (Schotta, G., 2004). H3
K56ac and H4 K20me1 respectively participate in the DNA damage response and DNA
replication (Masumoto, H., 2005; Brustel, J., 2011). Finally, transcription is orchestrated
by numerous PTMs; histone acetylation occurs at promoter and 5’ regions to make DNA
accessible for transcription initiation, histone deacetylation occurs at middle and 3’
regions to make DNA inaccessible for transcription initiation, H3 K4me3 occurs at 5’
regions, H3 K36me3 occurs at middle and 3’ regions to recruit the deacetylases, H3 K79
methylation occurs intragenically perhaps to exclude the Sir proteins, H2B ubiquitylation
occurs intragenically to coordinate these three methyllysines, H2A ubiquitylation occurs
to repress transcription with the Polycomb complexes, and H3 K9 and H4 K20
monomethylation may participate in a repressive manner as well, although how is
unclear.
It is increasingly clear that PTMs are not limited to histones but rather occur on
and regulate many proteins in the cell. Histones are thus a useful model for
understanding the biochemistry and role of PTMs on non-histone proteins and,
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considering the extent to which histone are modified, are a particularly useful model for
understanding the coordination and crosstalk that could occur on heavily decorated nonhistone proteins like p53. While our current understanding of non-histone PTMs is in its
infancy, there are already many examples of their importance. Phosphorylations occurs
on many DNA damage repair proteins and are critical mediators of intracellular signaling
pathways (Lukas, J., 2011). Acetylation occurs on Hsp90 to influence its protein
chaperone functions (Kovac, J.J., 2005), p53 to influence its transcription activation
activities (Bode, A.M., 2004), Pck1 to influence its gluconeogenesis enzymatic activity
(Lin, Y.Y., 2009), and many other proteins including alpha tubulin, GDH, the hormone
receptor LXR, Foxo1 and eNOS, beta-catenin, PGC-1alpha, CPS1, and Ku70 (Close, P.,
2010; Yang, X.J., 2008). Methylation occurs on p53 to affect its gene-association and
transcriptional activity, TAF10 to affect its transcriptional activity, the chloroplast protein
Rubisco, the mitochondrial protein Cytochrome C, the ribosomal proteins Rpl23ab and
Rpl12, and the receptor tyrosine kinase VEGFR1 (Huang, J., 2008).
Considering the range of biological roles with which PTMs are associated, it is
unsurprising that they are increasingly connected to diseases. Histone deacetylase
(HDAC) inhibitors are noted for their anti-tumor properties (Bode, A.M., 2004). SIRT6
was recently shown to prevent the metabolic shift of glucose away from cellular
respiration outside of hypoxic conditions (Zhong, L., 2010). This inappropriate shift
towards anaerobic glycolysis is reminiscent of the “Warburg” effect that occurs in tumor
cells. Translocations involving the mammalian H3 K4 methyltransferase MLL are linked
to Acute Myeloid Leukemia and knockdown and pharmacological inhibition of the
acetyllysine-binding protein Brd4 recently demonstrated potent toxicity to these cancer
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cells (Zuber, J., 2011). Finally, increased H4 K16ac during S. cerevisiae replicative
ageing limits yeast replicative lifespan (Dang, W., 2009).

Enzymes that create and remove post-translational modifications
The covalent attachment and removal of these proteins and small molecules are
facilitated by many enzymes. Ubiquitin and related proteins are attached to target
lysines by a series of three enzymes (E1-3). Ubiquitin’s C-terminus is first covalently
attached to an E1 ubiquitin-activating enzyme in an ATP-dependent manner, then
transferred to an E2 ubiquitin-conjugating enzyme, then transferred to a target protein by
an E3 ubiquitin-ligase (Kerscher, O., 2006). The result is a peptide bond between a
lysine epsilon nitrogen and the ubiquitin C-terminal carboxylic acid that can be
hydrolyzed by ubiquitin proteases to create a free ubiquitin and restored lysine.
Phosphates are transferred from ATP to the hydroxyl oxygens of serine, threonine, and
tyrosine side chains by kinases resulting in a negative charge for the amino acid. A
phosphatase (phosphorylase) can then hydrolyze to remove the phosphate group
(Ubersax, J.A., 2007).
Acetyl (and presumably propionyl, butyryl, and crotonyl) groups are covalently
attached to the epsilon nitrogen of lysine side chains by acetyltransferases. This
process is proposed to involve deprotonation of the amine group’s hydrogen, resulting in
the nitrogen performing a nucleophilic attack on the carbonyl carbon of an acetyl
coenzyme-A molecule. The result is an acetyl group covalently bound to the epsilon
nitrogen by its carbonyl carbon, increasing the lysine side chain’s size, adding a polar
carbonyl group, and reducing its net charge to neutral (Berndsen, C.E., 2008). Two
classes of deacetylases remove these acetyl groups, one of which requires the cofactor
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NAD+. Up to three methyl groups can be covalently attached to lysine, resulting in
relatively small or large structural changes and maintenance of the positive charge. This
reaction is facilitated by methyltransferases that may deprotonate the lysine’s epsilon
nitrogen, after which the nitrogen attacks the methyl group of an S-adenosyl methionine.
The methyl group then transfers to the lysine leaving behind an S-adenosyl
homocysteine (Xiao, B., 2003).
While most known chemical modifications have enzymes to facilitate their
removal, lysine methylations were long considered permanent due to the absence of any
identified lysine demethylase. The closest enzyme to a demethylase was PADI4, an
arginine “demethylase” that actually changes methylarginine into citrulline rather than
unmethylated arginine (Thompson, P.R., 2006). The reversibility of methylation was
demonstrated however when in vitro lysine demethylase activity was shown for LSD1
(BHC110) via its amine oxidase domain (Shi, Y., 2004) and JHDM1 via its JmjC domain
(Tsukada, Y., 2005). Both domains function by hydroxylating the target methyl group
making a carbanolamine that then “falls off” as formaldehyde. The epsilon nitrogen
binds a proton in its place resulting in the lysine having one less methyl group. LSD1
achieves this hydroxylation by removing a hydrogen from both the target methyl group
and epsilon nitrogen, resulting in an imine (-N=C-) that is hydrated to hydroxylate the
methyl group. This mechanism cannot target trimethyllysines since their nitrogen has no
hydrogen to remove. JmjC domains however bypass this restriction by directly
hydroxylating the target methyl group. The enzyme forms a complex with iron, alphaketoglutarate, and oxygen, breaking alpha-ketoglutarate into succinate and carbon
dioxide and producing an oxoferryl species that hydroxylates the methyllysine (Shi, Y.,
2007).
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Methods to study post-translational modifications
PTM studies generally involve observing when and where in the cell (and along the
genome for a chromatin PTM) it is present. While mass spectrometry can be used in
some cases, antibodies specific to the modification and surrounding epitope are often
the preferred method. Peptide competitions can argue that these antibodies recognize
their intended targets, but only abrogation of the modification can truly rule out crossreactivity with other epitopes in vivo. While loss or decrease of the PTM can be
achieved by overexpressing, knocking down, or knocking out the responsible enzyme,
these approaches have three disadvantages. First, enzyme redundancy might minimize
changes to the modification’s levels. Second, if the enzyme modifies multiple residues
on the same protein, as sometimes occurs with histone acetylation, ruling out crossrecognition by the antibody may be difficult. Third, this experiment is impossible if the
responsible enzyme is unknown.
Another method to demonstrate antibody specificity is to mutate the modified
residue, preferably such as to mimic the unmodified state. Unlike enzyme perturbations,
this guarantees that the PTM-of-interest is eliminated, better ensures that similar marks
on the same protein are not affected, and does not require the responsible enzyme to be
known. This method however has the disadvantage of eliminating all marks on that
residue, meaning it cannot rule out that the antibody recognizes other modifications of
that amino acid.
PTM studies also involve decreasing or increasing its levels to determine what it
does. While this can be accomplished by enzyme overexpression, knockdown, or
knockout, this has several disadvantages. First, enzyme redundancy might minimize
changes to the modification’s levels. Second, if the enzyme targets multiple proteins, all
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of these PTMs may be affected. Third, the responsible enzyme must be known.
Mutating the modified residue is again a better alternative for several reasons. Unlike
enzyme perturbations, this guarantees that the PTM-of-interest is eliminated, better
ensures that other marks created by the enzyme are not affected, and does not require
the responsible enzyme to be known. Further, some substitutions can mimic the
constitutive presence of PTMs. Aspartic acid for example can be a phospho mimic while
glutamine can be an acetyllysine mimic. Therefore, while residue substitutions will
eliminate all of a residue’s modifications, PTM mimics can sometimes reveal which
residue’s modifications perform which function.
For these reasons, amino acid substitution experiments are critical for PTM
studies and add much when paired with enzyme perturbation experiments. Amino acid
substitutions can be difficult in higher eukaryotes however. To reveal a PTM’s function,
the modified protein’s endogenous genes must be removed and replaced in the genome,
or on a plasmid, by a gene containing the amino acid substitution. Such targeted
knockouts are difficult in some higher eukaryotes and if the gene to be deleted has
multiple copies, as is the case for histone genes, then a substitution experiment may be
unfeasible even in genetically tractable higher eukaryotes like mice. An alternative
approach is to knock down the endogenous mRNA and simultaneously express a gene
that is knockdown-resistant and contains the residue substitution. This method however
is only as effective as the RNAi.
Yeast are a useful alternative model organism to use for PTM studies, especially
for chromatin. Like mice, they are genetically tractable. Unlike mice however, they
possess fewer histone genes, making histone residue substitution experiments relatively
easy. Since they are unicellular, cell-cycle and molecular events can be studied without
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resorting to the in vitro conditions of mouse cell cultures or having to tease apart tissuespecific effects. Conversely, yeast do not offer the chance to study the effects of PTMs
on cell fate, development, or tissue-specific functions. Importantly, as described below,
S. cerevisiae have chromatin that lacks several well-studied PTMs and components that
are found in higher eukaryotes. Due to this “simplicity,” yeast may make it easier to
tease apart the molecular properties of chromatin and protein PTMs, but cannot guide
the research of all the higher eukaryote chromatin components.

Saccharomyces cerevisiae chromatin post-translational modifications
S. cerevisiae possess all the major types of modifications including lysine acetylation,
ubiquitylation, sumoylation, and methylation, arginine methylation, and serine, threonine,
and tyrosine phosphorylation. Many well-known histone PTMs are conserved including
the H3 and H4 tail acetylations, H4 K16ac, H2B monoubituitylation, and all three
methylation states of H3 K4, H3 K36, and H3 K79. Methylation at these three lysines
are greatly conserved in eukaryotes, with genome-wide patterns having many similarities
between budding yeast and mammals. Many PTM enzymes are also conserved
including the H3 K4 HMT COMPASS complex (the MLL complex in mammals) and the
H3 K79 HMT Dot1 (hDot1L in humans) (Martin, C., 2005).
Notably, several well-studied PTMs and enzymes in higher eukaryotes lack
corresponding PTMs and orthologs in S. cerevisiae. Methylated H3 K9, H3 K27, and H4
K20 have not been identified, although the lysines are conserved. H2A ubiquitylation
has also not been found. Obvious orthologs of the corresponding mammalian HMTs
and ubiquitin ligases are also not present. It is intriguing that the major histone
modifications considered absent in budding yeast (listed above) are generally linked to
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transcriptional repression or chromatin compaction and further, S. cerevisiae are not
known to have verified repressive histone lysine methylations. S. cerevisiae chromatin
is thus considered to be less compacted and regulated by a smaller number of histone
PTMs than higher eukaryote chromatin (Sautel, C.F., 2007).

Important questions about chromatin post-translational modifications
Chromatin PTM research can be organized into three avenues: investigating the PTM
enzymes, investigating the histone chromatin PTMs, and investigating the non-histone
chromatin PTMs. Numerous important questions remain to be answered within each
field. Enzymes, for example, are unknown for the recently identified S. cerevisiae
histone PTMs H2B K37 (Gardner, K.E., 2011) and H3 K42 (Hyland, E.M., 2011).
Histone methyllysine demethylases were also only recently discovered and many are
predicted but poorly characterized in every model organism (Klose, R.J., 2006).
Histone chromatin PTMs are not fully understood in that their full repertoire is not
known and many that are known are not sufficiently characterized. Mass spectrometry
of mammalian histones for example recently identified 67 new marks including two new
modification types, lysine crotonylation and tyrosine hydroxylation (Tan, M., 2011), and
another mass spectrometry approach a few years ago also reported new modifications
in multiple organisms including S. cerevisiae (Garcia, B., 2007). Since these
approaches identified so many previously unknown PTMs but failed to identify other
known PTMs, many marks may have been missed and await discovery. Other histone
marks such as H4 K20 methylation are already known and well-studied, but considered
rather complicated due to being linked to a large number of processes and due to
occasionally conflicting reports (Brustel, J., 2011; Yang, H., 2009).
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Similarly, non-histone chromatin PTMs are not fully understood in that the
repertoire of known PTMs is still in its infancy and many remain to be identified and
characterized. p53 for example is subject to almost every PTM type and illustrates how
extensive their regulation of non-histone chromatin-associated proteins can be (Bode,
A.M., 2004). Methylation and acetylation are increasingly reported on non-histone
proteins as well (Huang, J., 2008; Close, P., 2010). Importantly, a recent report
identified 91 in vitro targets of the S. cerevisiae HAT NuA4, including many chromatinassociated proteins, and they await individual confirmation and characterization (Lin,
Y.Y., 2009).

Our studies of Saccharomyces cerevisiae chromatin post-translational modifications
We have chosen to investigate chromatin PTMs through the three previously described
avenues of research: the PTM enzymes, the histone chromatin PTMs, and the nonhistone chromatin PTMs. We have chosen to use the budding yeast S. cerevisiae as
our model organism since it provides technological advantages including the critical
ability to generate amino acid substitutions in histones and other proteins. We have
chosen to focus on PTMs of lysine since they are the most varied. Finally, we have also
chosen to focus primarily, though not solely, on lysine methylation since this is lysine’s
most complex and functionally diverse modification and since its recently discovered
reversibility makes it an important area of investigation. Below are the three specific
aims which we intended to carry out in order to better understand lysine chromatin PTMs
in S. cerevisiae.
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1) Histone Lysine Demethylation in S. cerevisiae:
Lysine methylation, long considered permanent, was shown to be reversible by the
mammalian LSD1 amine oxidase domain (Shi, Y., 2004) and the JHDM1 JmjC domain
(Tsukada, Y., 2005) a few years ago. Since JmjC domains are predicted in almost every
model organism and five S. cerevisiae proteins (Klose, R.J., 2006), important questions
in this avenue of chromatin PTM research are which predicted JmjC domain proteins are
demethylases, which chromatin methyllysines they target, and what biological processes
they influence. We have chosen to ask whether the JHD2 protein product Kdm5 (aliases
Jhd2, Yj89, and Yjr119c) demethylates histone methyllysines in vitro and in vivo and
whether it regulates methyllysines during transcription.

2) Histone Lysine Methylation is S. cerevisiae:
We have chosen to investigate histone methyllysines in S. cerevisiae by attempting to
confirm the presence of and characterize H4 K20me1. H4 K20 is mono-, di-, and
trimethylated in many higher eukaryotes. The monomethylated state is especially
interesting since it seems to be distinct from the other states in terms of the responsible
enzymes, genomic enrichment, reader proteins, and biological functions. However, this
PTM is considered complicated, partly due to occasionally conflicting reports, but mainly
due to the large number of functions to which it is linked, although it is generally
considered associated with transcriptional repression and chromatin compaction.
Briefly, mammalian H4 K20me1 is considered associated with repressed regions, is
enriched inside genes relative to flanking regions, promotes transcription repression,
recruits chromatin compactions proteins, promotes compaction in vitro, may promote
origin licensing, is cell cycle-regulated, and may participate in DNA replication, mitosis,
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and DNA damage repair (Brustel, J., 2011; Yang, H., 2009). Further, studies involving
perturbing its methyltransferase Set8 (Pr-Set7) are complicated by the fact that this may
alter the di- and trimethylated states and the fact that Set8 targets p53 and perhaps
other proteins (Shi, X., 2007). The genetically tractable Schizosaccharomyces pombe
also possess H4 K20me1, but using it as a model to clarify H4 K20me1’s role is limited
since H4 K20me2, 3 are also present, the same enzyme may create all three states, and
functional differences between the states are unclear (Sanders, S.L., 2004).
Unlike most higher eukaryotes, S. cerevisiae was considered to lack methylation
of H4 K20, as well as H3 K9 and H3 K27. These three lysines are conserved from
budding yeast to humans and their methylation in higher eukaryotes is associated with
transcriptional repression or chromatin compaction. In contrast, lysines H3 K4, H3 K36,
and H3 K79 and their methylation are conserved from budding yeast to humans and this
methylation is associated with transcriptional activity or an open chromatin state (Martin,
C., 2005). S. cerevisiae thus possess all six conserved lysines and the three “active”
methylations but lack the three “repressive” methylations. As such, budding yeast are
considered to have chromatin that is generally more “open” than higher eukaryote
chromatin.
Since a mass spectrometry report suggested that monomethylated H4 K20 exists
in S. cerevisiae (Garcia, B.A., 2007), we chose to confirm and characterize this mark for
several reasons. First, since budding yeast are excellent for studying histone PTMs, and
since the di- and trimethylated states may be absent, unlike in S. pombe, this would be
an excellent opportunity to study the role of this particular methylation state of this lysine.
Second, if this mark were associated with repression, this would refute the longstanding
notion that repressive S. cerevisiae histone methyllysines do not exist.
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3) NuA4 Acetylation of Spt16 in S. cerevisiae:
We have chosen to investigate lysine modifications of non-histone chromatin proteins by
attempting to confirm and characterize the acetylation of Spt16. Using a budding yeast
proteome microarray, the HAT NuA4 was recently shown to in vitro acetylate 91
proteins, many of which are chromatin-related (Lin, Y.Y., 2009). One in vitro target was
Spt16, part of the yFACT complex that is essential and participates in transcription
elongation and possibly DNA replication and repair. Since this would be an opportunity
to expand the repertoire of non-histone acetylation targets in vivo, shed light on NuA4’s
function, and elucidate the regulation of a critical chromatin protein, we chose to confirm
and characterize the acetylation of S. cerevisiae Spt16.
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Section 1

Chapter Summary & Explanation of My Contributions

We sought to characterize the Saccharomyces cerevisiae JmjC domain-containing
protein Kdm5 (JHD2) in vivo and in vitro. The work resulted in the following publication:
Ingvarsdottir, K., Edwards, C., Lee, M.G., Lee, J.S., Schultz, D.C., Shilatifard, A.,
Shiekhattar, R., and Berger, S.L. Histone H3 K4 Demethylation During Activation and
Attenuation of GAL1 Transcription in Saccharomyces cerevisiae. Molecular & Cellular
Biology. Volume 27, 2007, 7856-7864.
This work and its supplementary materials are respectively presented in sections two
and three of this chapter. Kristin Ingvarsdottir, a graduate student in the lab, was first
author and performed the in vivo characterizations. My contributions were the in vitro
characterizations (Figure 1) and a protein alignment of Kdm5 and a mammalian homolog
called Jarid1d (Supp. Figure 1) and resulted in a second authorship. Section four
contains an in vivo experiment and additional discussion points that are not present in
the article and were performed and written by me.
To perform the in vitro characterization, I cloned JHD2 into pFastBac for inset cell
expression, purified FLAG-Kdm5, and used it in in vitro demethylation reactions with
core histones or histone H3 tail peptides. Demethylation was observed via western
analyses with methyl-specific antibodies. Kdm5 decreased H3 K4me2, 3 levels on core
histones, and very slightly decreased H3 K4me1 levels. Kdm5 also targeted H3
peptides with mono-, di-, or trimethylated K4, demonstrating specificity for all three
methylation states. While H3 K4me1 peptides were demethylated, reactions with H3
K4me2, 3 peptides resulted in an accumulation of H3 K4me1, 2, consistent with a
distributive mechanism in which it removes methyl groups one at a time, creating lower
methyl states as intermediates (Frederiks, F., 2008). Substitution of a predicted catalytic
residue abrogated demethylase activity. Kdm5 also did not demonstrate activity on
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methylated H3 K4 of nucleosomes (data not shown), similar to its mammalian ortholog
Jarid1d. The additional unpublished in vivo experiment consisted of overexpressing
JHD2 in vivo and observing that this produces a global decrease in H3 K4me3 levels.
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Section 2

Kdm5 Demethylates Methylated H3 K4 in Saccharomyces
cerevisiae

ABSTRACT
In mammalian cells, histone lysine demethylation is carried out by two classes of
enzymes, the LSD1/BHC110 class and the jumonji class. The enzymes of the jumonji
class in the yeast Saccharomyces cerevisiae have recently also been shown to have
lysine demethylation activity. Here we report that the protein encoded by YJR119c
(termed KDM5), coding for one of ﬁve predicted jumonji domain proteins in yeast,
speciﬁcally demethylates trimethylated histone H3 lysine 4 (H3K4me3), H3K4me2, and
H3K4me1 in vitro. We found that loss of KDM5 increased mono-, di-, and trimethylation
of lysine 4 during activation of the GAL1 gene. Interestingly, cells deleted of KDM5 also
displayed a delayed reduction of K4me3 upon reestablishment of GAL1 repression.
These results indicate that K4 demethylation has two roles at GAL1, ﬁrst to establish
appropriate levels of K4 methylation during gene activation and second to remove K4
trimethylation during the attenuation phase of transcription. Thus, analysis of lysine
demethylation in yeast provides new insight into the physiological roles of jumonji
demethylase enzymes.
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INTRODUCTION
Histone posttranslational modiﬁcations are centrally involved in genome regulation.
Histone methylation occurs at both lysine (K) and arginine residues and plays a key role
in chromatin organization and transcriptional regulation (Kouzarides, T., 2002;
Margueron, R., 2005; Martin, C., 2005). In particular, methylation at lysine residues of
histone H3 and H4 during gene regulation has been characterized extensively and linked
to either gene activation (e.g., H3K4, H3K36, and H3K79) or repression (e.g., H3K9,
H3K27, and H4K20). Histone H3 lysine methylation in the yeast Saccharomyces
cerevisiae has been reported to occur at three residues (K4, K36, and K79) (Martin, C.,
2005; Sims, R.J., 2003), and each correlates with gene activation. The methylation
reaction is catalyzed either by many lysine-speciﬁc methyltransferases within the large
SET domain family (all known sites except H3K79) or by the unrelated Dot1 (H3K79)
(Shilatifard, A., 2006).
Until recently, histone lysine methylation was speculated to be irreversible and
therefore possibly a true epigenetic modiﬁcation persisting through cell division.
However, two families of demethylation enzymes capable of targeting methylated lysine
residues have now been identiﬁed (Cloos, P.A., 2006; Cuthbert, G.L, 2004; Fodor, B.,
2006; Klose, R.J., 2006; Lee, M.G., 2005; Shi, Y., 2004; Tsukada, Y., 2006; Wang, Y.,
2004; Whetstine, J.R., 2006; Yamane, K., 2006). LSD1, a catalytic engine of
multicomponent corepressor complexes, was the ﬁrst demonstrated lysine demethylase,
reversing dimethylated histone H3 lysine 4 (H3K4me2) (Lee, M.G., 2005; Shi, Y., 2004;
Shi, Y.J., 2005). However, this enzyme is unable to remove methyl groups from
trimethylated lysine because of the inherent limitation of its enzymatic reaction
mechanism. In contrast, a second class of histone lysine demethylases, consisting of the
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JmjC domain containing proteins, are able to demethylate not only di-but also
trimethylated histone marks (Cloos, PA., 2006; Fodor, B.D., 2006; Klose, R.J., 2006;
Tsukada, Y., 2006; Yamane, K., 2006). Only recently have demethylases targeting the
trimethylated form of H3K4 been characterized. The four members of the JARID family
in mammalian cells contain a JmjC domain which is critical for their H3K4 demethylation
activity (Christensen, J., 2007; Iwase, S., 2007; Klose, R.J., 2007; Lee, M.G., 2007).
These enzymes have been shown to have in vivo effects on H3K4 methylation status,
both on a global scale and at speciﬁc genes where they also affect the transcription
levels. Studies of H3K4 demethylases in lower organisms are not as far advanced as
those of mammalian counterparts. Lid, the only homolog of the JARID family in
Drosophila melanogaster, has been shown to have H3K4 demethylation activity in vivo
on a global scale (Eissenberg, J.C., 2007; Lee, N., 2007; Secombe, J., 2007). The same
is true for JMJ2, the ﬁssion yeast homolog (Huarte, M., 2007), and YJR119c, the
budding yeast homolog (Liang, G., 2007; Seward, D.J., 2007; Tu, S., 2007) of the JARID
family. However, it remains to be established whether lysine demethylation has genespeciﬁc regulatory functions in lower eukaryotes.
Here we perform a detailed analysis of the demethylation activity of S. cerevisiae
Kdm5 both in vitro and in vivo. (Note that YJR119c has been termed Jhd2 in recent
literature, but we will refer to this protein as Kdm5 in accordance with a new
nomenclature system for histone-modifying enzymes [Tony Kouzarides, personal
communication]). We investigate whether Kdm5 is involved in regulating H3K4
methylation levels at speciﬁc genes. Our results provide evidence for a role of the
enzyme in both modulating the level of K4 methylation during the peak of transcription
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and removing the modiﬁcation during attenuation as full gene repression is
reestablished.

MATERIALS AND METHODS
Yeast strains and plasmids. Yeast strains used in this study are listed in Table S1 in the
supplemental material. Gene deletions were performed as described previously
(Longtine, M.S., 1998). Recombinant Kdm5 was created by cloning the KDM5 open
reading frame (ORF) using a TOPO TA cloning kit (Invitrogen). An Expand high-ﬁdelity
PCR system (Roche) was used to amplify and subclone the cDNA of KDM5 into a
modiﬁed pFAST Bac HTA baculovirus vector containing N-terminal FLAG and six-His
tags. The KDM5 ORF, with a 500-nucleotide upstream sequence and a 250-nucleotide
downstream sequence, was similarly cloned using a TOPO TA cloning kit (Invitrogen)
and subcloned into pRS314 using an Expand high-ﬁdelity PCR system (Roche). FLAG
tagging and amino acid substitutions were made using a QuickChange kit (Stratagene).

Afﬁnity puriﬁcation of recombinant Kdm5. Flag-His-Kdm5 was expressed in 500 ml of
baculovirus-infected Sf21 insect cells and harvested at 72 h (Wistar Institute Protein
Expression Core). Cells were lysed with 50 ml insect lysis buffer KCl250 (50 mM
HEPES, pH 8.0, 250 mM KCl, 10% glycerol, 0.1% NP-40, 1 mM EDTA, 0.5 mM
phenylmethylsulfonyl ﬂuoride [PMSF], protease inhibitors), sonicated, and incubated
overnight at 4°C with 200 fl mouse anti-Flag (a-Flag) agarose beads (Sigma). Beads
were washed ﬁve times with 20x volume insect wash buffer KCl500 (50 mM HEPES, pH
8.0, 500 mM KCl, 10% glycerol, 0.1% NP-40, 1 mM EDTA, 0.5 mM PMSF, protease
inhibitors) and once with 20x volume demethylation buffer (50 mM HEPES, pH 8.0, 5%
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glycerol). The recombinant protein was eluted with 0.5 fg/fl1x Flag peptide in
demethylation buffer.

In vitro demethylation reaction and Western analysis. Bulk calf thymus his-tones (4 fg;
Sigma) or H3 peptides (100 ng; Upstate) were incubated with the indicated amounts of
recombinant proteins in histone demethylase assay buffer [5% glycerol, 50 mM HEPES
K, pH 8.0, 2 mM ascorbate, 1 mM a-ketoglutarate, 100 fM Fe(II), 0.2 mM PMSF,
protease inhibitors] in a ﬁnal volume of 11 flat 37°C for 5 h. Incubation products were
analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and Western
blotting. Mixtures from the reactions that used histones and peptides as substrates were
electrophoresed on 4 to 20% Tris-glycine and 12% NuPAGE gels, respectively
(Gallagher, S.R., 2006; Laemmli, U.K., 1970), transferred to PVDF membranes, and
probed with methyl-speciﬁc antibodies (Gallagher, S., 2004). An anti-H3 antibody served
as a loading control. The following antibodies were used for the Western blotting:
H3K4me1 (ab8895; Abcam), H3K4me2 (ab7766; Ab-cam), H3K4me3 (07-473; Upstate),
H3 (ab1791; Abcam), H3K36me3 (ab9050; Abcam), H3K79me2 (ab3594; Abcam), and
FLAG-horseradish peroxidase (A8592; Sigma). For Western analysis on global protein
levels, whole-cell extracts were electrophoresed on 4 to 20% Tris-glycine gels,
transferred to 0.2-fm nitrocellulose membranes, and probed with the following
antibodies: anti-Set1 (from A. Shilatifard, Stowers Institute, MO), anti-FLAG–horseradish
peroxidase (M2; Sigma), and anti-H3 (ab1791; Abcam).
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ChIP and GAL1 and SUC2 inductions. Chromatin immunoprecipitation (ChIP)
experiments were carried out as described before (Burke, D., 2000; Henry, K.W., 2003).
For GAL1 inductions, cells were grown in yeast extract-peptone-dextrose (YPD)
overnight, diluted in yeast extract-peptone-rafﬁnose to mid-log phase, and grown for 2 to
3 h. Galactose was added to the media to a ﬁnal concentration of 2%, and 2 h later
glucose was added to a ﬁnal concentration of 2%. For SUC2 inductions, cells were
grown in YPD overnight, diluted to mid-log phase in the morning, and grown for 2 h.
Cells were spun down, washed in yeast extract-peptone plus 0.05% glucose, and
resuspended in the low-glucose media. Two hours later, glucose was added to the
media for a ﬁnal concentration of 2%. Cells were cross-linked with 1% formaldehyde for
5 min (histone ChIP) or 20 min (factor ChIP). Protein (1 to 2 mg) was
immunoprecipitated as described previously (Henry, K.W., 2003). Antibodies used for
ChIP were anti-H3 (ab1791; Abcam), anti-H3 monomethyl K4 (ab8895; Abcam), anti-H3
dimethyl K4 (ab7766; Abcam), anti-H3 trimethyl K4 (ab8580; Abcam), and anti-Set1
(from A. Shilatifard, Stowers Institute, MO). Inputs (1:100 dilutions) and eluates were
ampliﬁed using an ABI 7900HT fast thermal cycler (Applied Biosystems) and the primer
pairs described in Table S2 in the supplemental material. Each PCR consisted of 10 fl
SYBR green dye I (Applied Biosystems), 0.1 fl forward primer (10 fM), 0.1 fl reverse
primer (10 fM), 4.8 flH2O, and 5 fl sample. The PCRs went through a program consisting
of 50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 s and 60°C for 1 min.
Each sample was run in triplicate, and average values of eluates were normalized to
average values of inputs (relative IP) and then further normalized to the relative IP of an
untranscribed region of DNA (the IntV region).
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RNA analysis. Cells were grown to mid-log phase and 5 to 10 ml of cultures harvested
for RNA analysis. Total RNA was prepared by hot acidic phenol extraction as described
before (Collart, M.A., 1996). RNA was reverse transcribed with TaqMan reverse
transcription reagents (Applied Biosystems) by using random hexamer primers
according to the manufacturer’s instructions. The resulting cDNA was ampliﬁed in real
time using an ABI 7900HT fast thermal cycler (Applied Biosystems) with the primer pairs
described in Table S2 in the supplemental material. Each PCR consisted of 10 fl SYBR
green dye I (Applied Biosystems), 0.1 fl forward primer (10 fM), 0.1 fl reverse primer (10
fM), 4.8 flH2O, and 5 fl sample. The PCRs went through a program consisting of 50°C
for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 s and 60°C for 1 min. The data
were normalized to ampliﬁcation of 18S ribosomal cDNA.
Antibody production. The recombinant N-terminally truncated Set1 protein (rSet1) was
expressed in Escherichia coli. The pMCSG7 plasmid vector was used for protein
expression (Stols, L., 2002) to produce a fusion protein with polyhistidine tags along with
the Set1 protein coding sequence. The construction of the expression vector was carried
out by PCR using primers 5' TACTTCCAATTCAATGCTa
tgAGCACATATACTCCTACCGTCA 3' and 5' TTATCCACTTCCAATGtca
GTTCAAGAAACCTTTACAATTAGGTG 3' (lowercase letters represent the positions of
the start and stop codons). One milligram of puriﬁed rSet1 protein was injected into
rabbits and guinea pigs (Pocono Rabbit Farm & Laboratory) (protocol for antibody
production at http://www.prfal.com/protocol.php).
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RESULTS
Kdm5 has speciﬁc demethylase activity towards all methylated states of H3K4.
The ﬁve S. cerevisiae predicted ORFs bearing homology to JmjC catalytic domains were
compared to Jarid1d, a histone demethylase in mammals that targets H3K4me3 and
H3K4me2 (Lee, M.G., 2007). Within the JmjC domain and over the entire protein, Kdm5
(YJR119c) has the highest identity to Jarid1d (Fig. 1A; see also Fig. S1 in the
supplemental material). Further, Kdm5 (like Jarid1d) has JmjN, BRIGHT, and PHD
domains in colinear arrangement with Jarid1d, which is not the case for the other yeast
jumonji proteins (Fig. 1A; see also Fig. S1 in the supplemental material). These
similarities prompted us to test whether Kdm5, like Jarid1d, is a histone H3K4
demethylase.
FLAG-tagged Kdm5 was expressed via baculovirus infection of Sf21 insect cells.
After 72 h of infection, cells were lysed and recombinant protein puriﬁed on FLAG
antibody beads, followed by FLAG peptide elution, gel electrophoresis, and Colloidal
Blue staining. The results showed one band of expected size for Kdm5 (Fig. 1B), which
was conﬁrmed by Western blotting with FLAG antibody (data not shown). The protein
was tested in a demethylase assay using calf thymus histones as substrates, under
conditions that were used previously to test Jarid1d (Lee, M.G., 2007). The assay with
the yeast protein resulted in a substantial reduction in H3K4me3 and H3K4me2 levels in
a dose-dependent manner and a slight reduction in H3K4me1 levels (Fig. 1C). However,
no changes in K36me3 and K79me2 levels were observed (Fig. 1C), which is in accordance with other reports showing no activity of this enzyme towards H3 methylated on
K36 and K79 (Liang, G., 2007). This proﬁle of activity was similar to that of Jarid1d, used
as a control for these reactions (Fig. 1C).
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In order to investigate the importance of the different domains of Kdm5, we
created point mutations at conserved residues in either the PHD domain (D254A) or the
JmjC domain (H427A). Recombinant Kdm5 carrying either of these mutations was
expressed in insect cells and yielded amounts of protein equal to that of the wild-type
protein (Fig. 1B). When tested in the demethylase assay, the recombinant protein carrying a mutation in the PHD domain (D254A) yielded results similar to those for the wildtype protein (Fig. 1D). However, the JmjC domain mutant (the H427A mutant) showed
no activity towards the histone substrates methylated on H3K4 (Fig. 1D), suggesting that
the enzymatic activity of Kdm5 is indeed dependent on the conserved sequence of the
JmjC domain.
Although these assays showed only a minor reduction in H3K4me1 levels, the
full activity of the enzyme towards this substrate could be masked by the conversion of
H3K4me3 and H3K4me2 into the H3K4me1 form. Therefore, we performed the
demethylase assay with histone H3 peptides containing the three forms of methylated
K4. The reactions where the substrate was either H3K4me3 or H3K4me2 resulted in an
accumulation of H3K4me1, but the reaction with H3K4me1 as a substrate resulted in an
almost complete reduction in me1 signal (Fig. 1E). Again, the recombinant protein with
the H427A mutation did not show any activity towards the methylated peptides (Fig. 1E).

Kdm5 affects H3K4 methylation levels during active transcription of the GAL1 gene and
has modest effects on GAL1 expression.
We analyzed the function of Kdm5 in vivo. A strain bearing a deletion of the gene was
generated and tested for effects on H3K4 methylation. Histones were prepared by acid
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extraction from the parental and deletion strains and analyzed by quantitative Western
blotting using K4 methylation-specific antibodies. No clear differences in the levels of
mono-, di-, or trimethylation were detected, and an antibody for unmodified histone was
used as a comparison (data not shown).
Although global methylation levels are not altered substantially by deletion of
KDM5, methylation may be affected on specific genes. We examined the GAL1 gene
under conditions where RNA is not transcribed (raffinose) or transcribed at high
levels (galactose) (Fig. 2A). ChIP analysis using highly specific antibodies (see Fig. S2
in the supplemental material) was carried out for H3K4 methylation at the GAL1 gene
under these conditions. We examined mono-, di-, and trimethylation levels relative to the
IntV region and normalized to unmodified H3 levels. In the wild-type strain, K4
monomethylation increases twofold at the 5’ end of the ORF in galactose, whereas, as
expected (Ng, H.H., 2003), both di- and trimethylation strongly increase in galactose
(approximately 10-fold) (Fig. 2B). We examined K4 methylation levels in the KDM5
deletion relative to the wild type in galactose and found substantial increases for mono
and dimethylation (more than fourfold) and lower increases for trimethylation (less than
twofold) (Fig. 2B). We analyzed the 3’ end of the ORF and observed no increases for
mono, di-, or trimethylation in the wild-type strain in galactose but increases in all three
states in the KDM5 deletion strain relative to the wild type (see Fig. 5A).
We examined GAL1 RNA levels in the KDM5 deletion strain in galactose to
determine whether the increase in methylation is reflected in higher transcription. RNA
levels are slightly higher in the absence of Kdm5 (Fig. 2C). We speculated that there
might be an additive effect on RNA levels among the S. cerevisiae jumonji domain
proteins. To test this, we prepared a double disruption of KDM2 (JHD1) and KDM5. We
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chose KDM2 because it was shown previously to have demethylase activity towards H3
methylated on K36 (Fang, J., 2007; Tsukada, Y., 2006), a distinct activation-linked H3
methylation (Henry, K.W., 2003). We found that the double disruption showed a greater
increase in RNA levels than either single disruption (Fig. 2C), an effect that was
observed at various times of galactose induction (data not shown).

Kdm5 affects Set1 recruitment during active transcription of the GAL1 gene.
The Set1 enzyme carries out all H3K4 methylation in S. cerevisiae, including mono-, di-,
and trimethylation (Briggs, S.D., 2001; Krogan, N.J., 2002; Nagy, P.L., 2002; Roguev,
A., 2001; Santos-Rosa, H., 2002). Set1 is a component of the protein complex
COMPASS, composed of intrinsic components that regulate its relative abilities to mono, di-, and trimethylate K4 (Morillon, A., 2005; Nagy, P.L., 2002; Roguev, A., 2001;
Schneider, J., 2005). Higher levels of methylation at GAL1 in the kdm5 mutant led us to
examine the level of the Set1 enzyme at the gene. We used an antibody highly speciﬁc
for Set1 as shown by Western analysis of whole-cell yeast extracts and ChIP assay (Fig.
3A). ChIP assays showed that Set1 levels increased more than twofold in the KDM5
deletion strain compared to the wild type in galactose, both at the 5' ORF (Fig. 3B) and
the 3' ORF (see Fig. 5C, left) of GAL1. To test whether the lower Set1 recruitment in the
wild-type strain was dependent on the demethylase activity of Kdm5, we performed the
same ChIP experiments with two additional strains consisting of the KDM5 deletion
strain reconstituted with either a wild-type copy of KDM5 or a copy of KDM5 carrying a
mutant JmjC domain. Both the wild-type and the mutant copy were FLAG tagged and
were found to express at equal levels judging by FLAG Western blot analysis of wholecell extracts (Fig. 3C). The FLAG-tagged wild-type copy complemented the deletion
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strain, as it resulted in the same low levels of Set1 recruitment during galactose
induction as the wild-type parental strain (Fig. 3D). However, the deletion strain
containing the mutant JmjC domain protein showed as high levels of Set1 as the
deletion strain alone (Fig. 3D), suggesting that the demethylase activity of Kdm5 is
involved in the regulation of Set1 recruitment during GAL1 activation. This effect is not
due to global changes in Set1 protein levels as they were determined to be equal in all
strains used for these ChIP experiments (Fig. 3E).

Kdm5 affects H3K4 methylation levels during shutdown of GAL1 transcription.
Transcription of GAL1 shuts down as the cells are shifted from galactose media into
repressive glucose (Fig. 2A). We tested whether demethylation of H3K4 correlates with
this attenuation phase of gene expression. When the wild-type strain is switched from
galactose growth to glucose, trimethylation is reduced, dimethylation remains constant,
and monomethylation increases slightly at the 5' end of the gene (Fig. 4A). Interestingly,
the reduction in dimethylation and especially in trimethylation is signiﬁcantly delayed in
the absence of Kdm5 (Fig. 4A). We found that the wild-type and KDM5 deletion strains
grew at the same rates (data not shown); hence, the methylation difference detected in
the two strains during return to the repressive state is not the result of altered replication.
We examined Set1 levels in glucose conditions and found that the levels decreased in
the absence of Kdm5, just as in the wild-type strain (Fig. 4B). The 3' end of the gene
also showed an increase in methylation but no increase in Set1 levels (Fig. 5B and C,
right). Thus, persistence of high methylation without Kdm5 is not due to Set1 remaining
bound to the GAL1 gene. To determine whether the effects on methylation levels were
speciﬁcally due to Kdm5 enzymatic activity, we performed these ChIP experiments with
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the two additional strains used previously for the Set1 ChIP, containing either a wild-type
copy of KDM5 or a copy of KDM5 carrying a mutant JmjC domain. All four strains were
grown during galactose-inducing conditions followed by glucose-repressive conditions,
and ChIP analysis was carried out as described above. When focused on repressive
conditions for GAL1, where trimethylation of H3K4 is reduced in a wild-type strain, we
saw similar trimethylation levels in the KDM5 deletion strain carrying a FLAG-tagged
wild-type copy of KDM5 (Fig. 4C). However, the mutant copy of KDM5 resulted in higher
trimethylation levels, comparable to the levels seen in the deletion strain (Fig. 4C).
These results add further support to our hypothesis that Kdm5 has demethylase activity
in vivo and that this activity is involved directly in gene regulation.

Kdm5 lowers H3K4 trimethylation levels during shutdown of SUC2 transcription.
We examined H3K4 methylation levels at other genes in the KDM5 deletion strain. First,
we tested constitutive genes, such as PMA1 and ADH1, but could not detect any
differences in methylation levels between the wild-type and the deletion strains (data not
shown). Next we examined another inducible gene, SUC2. SUC2 RNA levels increased
during the induction, but there was no signiﬁcant difference in transcription between the
wild-type and the deletion strains (data not shown). ChIP analysis of H3K4 trimethylation
levels at the 5' end of the gene showed a substantial decrease in the wild-type strain
from the induced state back to the repressed state of SUC2 transcription, whereas the
KDM5 deletion strain showed only a very slight decrease (Fig. 6). These results show
that Kdm5 effects on K4 methylation levels are not restricted to the GAL1 gene.
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DISCUSSION
Here we report that the protein encoded by KDM5 is a histone demethylase and shows
substrate speciﬁcity for histone H3K4 in vitro. Kdm5 speciﬁcally reverses all methylated
states of K4 but not other H3 methylation states (K36me3 and K79me2) (Fig. 1C and D).
A mutation in the JmjC domain of Kdm5 abrogates this demethylase activity towards
methylated H3K4, whereas a mutation in the PHD domain does not (Fig. 1D).
We have observed Kdm5-dependent H3K4 demethylation in vivo within the
GAL1 and SUC2 ORFs. K4 is methylated by the Set1 component of the COMPASS
complex, and the relative levels of mono-, di-, and trimethylation are established by
regulation of COMPASS (Schneider, J., 2005). While monomethylation does not
increase during gene activation, both di-and trimethylation increase when GAL1 is
induced by growth in galactose media. The trimethylated form of H3K4 is known to be
focused speciﬁcally at the 5' end of genes (Santos-Rosa, H., 2002), and, via PHD
domain interactions, it may help to recruit complexes involved in gene activation
(Taverna, S.D., 2006).
We observed three consequences of deleting Kdm5, manifesting in altered
amounts and locations of K4 methylation within the GAL1 ORF. One normal function of
Kdm5 is to prevent high levels of Set1 recruitment during maximally active gene
transcription (Fig. 3B). The elevated levels of Set1 recruitment in the KDM5 deletion
strain result in abnormally high levels of mono-and dimethylated H3K4 (Fig. 2B). The
result is an altered balance of the methylation states, where the relative increase in
trimethylation is reduced compared to the increases in mono-and dimethylation. This
function of Kdm5 is dependent upon its enzymatic activity, as the catalytic mutant
version of Kdm5 shows the same high levels of Set1 recruitment at the GAL1 5' ORF
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region as the KDM5 deletion strain (Fig. 3D). One possible explanation for this effect
might be that the loss of Kdm5 activity results in the recruitment of a speciﬁc form of
COMPASS, one that produces primarily di-and monomethylated H3K4. For instance, it
has been shown that a strain lacking the COMPASS subunit Cps60 or Cps40 results in
normal global levels of H3K4 di-and monomethylation but almost nonexistent levels of
H3K4 trimethylation (Schneider, J., 2005).
Second, during the attenuation phase following induced transcription, the level of
trimethylated K4 is reduced, ﬁnally falling to levels characteristic of the fully repressed
gene. It appears that the loss of methylation is an active process mediated by Kdm5,
because deletion of the demethylase results in delayed reduction of the methylation (Fig.
4A). This is further supported by analysis of a strain where Kdm5 bears a mutant JmjC
domain, which shows methylation levels comparable to those for the KDM5 deletion
strain (Fig. 4C). In contrast to the events that occur during GAL1 induction, during
repression of this gene, the Set1 recruitment in the KDM5 deletion strain is not higher
than the recruitment levels in the wild-type strain. This suggests that Kdm5 is actively
demethylating H3K4 at the GAL1 5' ORF during the transcriptional repression phase.
Another inducible gene, SUC2, also shows a delayed reduction in trimethylation levels in
the deletion strain during attenuation. It may be that Kdm5 functions primarily at
inducible genes, since none of the constitutively active genes tested showed differences
in methylation levels between the KDM5 deletion and wild-type strains. In mammalian
cells, low methylation levels in repressed genes have been shown to be maintained by
JARID demethylases (Christensen, J., 2007; Klose, R.J., 2007; Lee, M.G., 2007), but it
was not known previously that there is active demethylase-dependent reduction of H3K4
trimethylation levels during shutdown of transcription. However, we cannot conclude that
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Kdm5 is directly responsible for this demethylation event since we were not able to
detect Kdm5 protein at the GAL1 ORF by ChIP. The S. cerevisiae and the
Schizosaccharomyces pombe JmjC proteins appear to be refractory to ChIP, as other
groups report similar difﬁculty (Huarte, M., 2007; Kim, T., 2007). This may be due to
transient association of the enzymes with chromatin or to the enzymes functioning on
histones as octamers while not tightly associated with DNA.
A third function of Kdm5 is observed at the 3' end of the gene. Normally, there is
no apparent increase in any methylation state or Set1 levels during gene activation,
whereas in the absence of Kdm5 there is an increase in Set1 and in all methylation
states relative to those for the wild type (Fig. 5).
Our analysis thus reveals that Kdm5 has multiple roles in regulating K4
methylation. At the 5' end of the GAL1 ORF, Kdm5 establishes relative methylation
levels, limits methylation levels during activation, and functions to reduce methylation
levels during attenuation of transcription. At the 3' end of the gene, Kdm5 prevents
methylation. It thus appears that reversible lysine methylation of histones is conserved
through evolution, and this investigation of S. cerevisiae reveals novel gene-speciﬁc
regulatory functions of demethylation.
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Figure 1. Kdm5 demethylates H3K4 mono-, di-, and trimethyl. (A) Schematic
representation of JARID1d and the five closest S. cerevisiae homologues, including
Kdm5. Sequence identities of the JmjC domains of the five proteins to the JARID1d
JmjC domain are indicated. aa, amino acids. (B) Colloidal Blue staining of recombinant
Kdm5. Flag-His-Kdm5 (wild type, H427A mutant [JmjC domain], and D254A mutant
[PHD domain]) was purified from Sf21 cells using an -Flag column and eluted in
demethylation buffer using Flag peptides. The purity of the enzymes was determined by
electrophoresis of 4µL of the protein on a 4 to 20%Tris-glycine gel, followed by staining
with Colloidal Blue. (C) Demethylation reactions were performed with 4µg of bulk calf
thymus histones and no enzyme, recombinant JARID1d (a known demethylase), or
increasing amounts of recombinant Kdm5. Reaction mixtures were electrophoresed on a
4 to 20% Tris-glycine gel, transferred to PVDF membranes, and probed with methylspecific antibodies. An anti-H3 antibody served as a loading control. Amounts of
recombinant protein added are indicated above the lanes. Antibodies used are indicated
to the left of each blot. (D) Demethylation assay comparing recombinant wild-type Kdm5
(WT) and the two mutant Kdm5 enzymes (H427A and D254A). The reaction was carried
out and analyzed as described for panel C. Approximately 3µg of recombinant protein
was used for each reaction. (E) Demethylation reactions were performed with 100ng of
histone H3 peptides containing mono-, di-, or trimethylated lysine 4 and no enzyme, 3µg
of recombinant wild-type enzyme (WT), or 3µg of recombinant mutant enzyme (H427A).
Reaction mixtures were run on 12% NuPAGE gels, transferred to PVDF membranes,
and probed with methyl-specific antibodies. Enzymes and peptides used are indicated
above the lanes. An anti-FLAG antibody indicated the relative amounts of recombinant
enzymes. Antibodies used are indicated to the left of the blots.
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Figure 2. RNA and histone H3 K4 methylation levels during activation of GAL1. (A)
GAL1 RNA levels in wild-type strain during galactose induction and return to growth in
glucose. RNA was extracted from cell pellets collected after 2 h of growth in raffinose
(RAFF)-containing media, 2 h of growth in galactose (GAL), and 15 min of growth in
glucose (GLU). Quantitative reverse transcription-PCR experiments were performed
with total RNA to assess the transcript levels of GAL1. GAL1 expression levels after
normalizing each signal to those obtained from the 18S rRNA locus are shown and
presented as levels of induction, with GAL1 levels in raffinose set to 1. Error bars show
standard deviations (SD). (B) Histone H3 K4 methyl ChIP in wild-type and KDM5
deletion strains, followed by quantitative PCR analysis at the GAL1 5’ ORF. Samples
were taken after 2 h of growth in raffinose and 2 h of growth in galactose. Each graph is
a representative of several ChIP experiments. Each data point represents an average of
two to three quantitative PCR analyses. Error bars show SD of quantitative PCR
analysis. Specificity of the antibodies used for ChIP is shown in Fig. S2 in the
supplemental material. Data are shown as percentages of input (relative IP) after being
normalized to relative IP of the IntV region and again normalized to total histone H3
ChIP signals. The normalized signal for the wild-type (WT) strain in raffinose media was
set to 1. (C) GAL1 RNA levels analyzed in samples taken after 30 min of growth in
galactose media for the indicated strains. RNA was analyzed by reverse transcription
followed by real-time amplification. GAL1 RNA levels were normalized to 18S RNA
levels and wild-type GAL1 levels set to 1. Error bars show SD of quantitative PCR
analysis.
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Figure 3. Set1 levels during activation of GAL1. (A) Specificity of -Set1 antibody. (Top)
Western blot analysis of increasing amounts of whole-cell extracts from either a wildtype (WT) strain or a SET1 deletion strain. (Bottom) Set1 ChIP with two negative
controls, a SET1 deletion strain and rabbit immunoglobulin G (NoAb). (B) Set1 ChIP in a
wild-type strain and a KDM5 deletion strain, followed by quantitative PCR analysis at the
GAL1 5’ ORF. Samples were taken after 2 h of growth in raffinose (RAFF) and 2 h of
growth in galactose (GAL) and analyzed as described in the legend for Fig. 2B. Error
bars show standard deviations of quantitative PCR analysis. Data are shown as
percentages of input (relative IP) after being normalized to relative IP of the IntV region.
The normalized signal for the wild-type strain in raffinose media was set to 1. (C)
Expression levels of FLAG-tagged wild-type and H427A E429A mutant KDM5. Western
blot analysis of whole-cell extracts from the indicated strains. The upper panel shows the
FLAG Western blot, and the lower panel shows an H3 Western blot as a loading control.
(D) Set1 ChIP in the indicated strains, followed by quantitative PCR analysis at the
GAL1 5’ ORF. Samples were taken after 2 h of growth in galactose and analyzed
as described for panel B. The normalized signal for the wild-type strain was set to 1.
kdm5+KDM5, KDM5 deletion strain with a FLAG-tagged wild-type copy of KDM5;
kdm5+kdm5 H427AE429A, KDM5 deletion strain with a FLAG-tagged H427A E429A
mutant copy of KDM5. (E) Expression levels of Set1. Western blot analysis of whole-cell
extracts from the indicated strains. The upper panel shows the Set1 Western blot,
and the lower panel shows an H3 Western blot as a loading control.
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Figure 4. Histone H3 K4 methylation and Set1 levels during repression of GAL1. (A)
Histone H3 K4 methyl ChIP in wild-type (WT) and KDM5 deletion strains, followed by
quantitative PCR analysis at the GAL1 5’ ORF. Samples were taken after 75 min and
280 min of growth in glucose (GLU) and analyzed as described in the legend for Fig. 2B.
(B) Set1 ChIP in the wild-type strain and the KDM5 deletion strain, followed by
quantitative PCR analysis at the GAL1 5’ ORF. Samples were taken after 75 min and
280 min of growth in glucose and analyzed as described in the legend for Fig. 3B. (C)
Histone H3 K4 trimethyl ChIP in the indicated strains, followed by quantitative PCR
analysis at the GAL1 5’ ORF. Samples were taken after 280 min of growth in glucose
and analyzed as described in the legend for Fig. 2B. kdm5+KDM5, KDM5 deletion
strain with a FLAG-tagged wild-type copy of KDM5; kdm5+kdm5 H427AE429A, KDM5
deletion strain with a FLAG-tagged H427A E429A mutant copy of KDM5.

Figure 5. Histone H3 K4 methylation and Set1 levels at GAL1 3’ ORF. (A) Histone H3
K4 methyl ChIP in wild-type and KDM5 deletion strains during activation of GAL1.
Samples were taken after 2 h of growth in raffinose (RAFF) and 2 h of growth in
galactose (GAL). Each graph is a representative of several ChIP experiments. Each data
point represents an average of two to three quantitative PCR analyses. Error bars show
standard deviations of quantitative PCR analysis. Data are shown as percentages of
input (relative IP) after being normalized to relative IP of the IntV region and again
normalized to total histone H3 ChIP signals. The signal for the wild-type (WT) strain in
raffinose media was set to 1. (B) Histone H3 K4 methyl ChIP in wild-type and KDM5
deletion strains during repression of GAL1. Samples were taken after 75 min and 280
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min of growth in glucose (GLU) and analyzed as described above. (C) Set1 levels during
activation and repression of GAL1. (Left) Samples were taken after 2 h of growth in
raffinose and 2 h of growth in galactose and analyzed as described in the legend for Fig.
3B. (Right) Samples were taken after 75 min and 280 min of growth in glucose and
analyzed as described in the legend for Fig. 3B.

Figure 6. Histone H3 K4 methylation levels during activation and repression of SUC2.
Histone H3 K4 trimethyl ChIP in wild-type (WT) and KDM5 deletion strains, followed by
quantitative PCR analysis at the SUC2 5_ ORF. Samples were taken after 2 h of growth
in low glucose (GLU) (0.05%) and both 15 and 30 min of growth in YPD. Each data
point represents an average of two to three quantitative PCR analyses. Error bars show
standard deviations of quantitative PCR analysis. Data are shown as percentages of
input (relative IP) after being normalized to relative IP of the IntV region and again
normalized to total histone H3 ChIP signals. The normalized signal for the wild-type
strain in low-glucose media was set to 1.
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Section 3

Supplementary Materials for Section Two

Supplementary Table 1. Yeast strains used in this study.

Supplementary Table 2. Oligonucleotides used in this study.
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Supplementary Figure 1. An alignment of the JmjN, PHD, and JmjC domains of KDM5
and JARID1d. Identical residues highlighted in red. Residues mutated in the JmjC and
the PHD domain are in blue and underlined.

Supplementary Figure 2. Specificity of histone antibodies. ChIP of wild-type strain and
a strain carrying a K4A mutation in histone H3 grown in raffinose using either the
indicated histone specific antibodies (wild-type signal set to 1) or rabbit IgG (No Ab),
followed by quantitative PCR analysis. Error bars show s.d. White bar: Wild-type strain.
Grey bar: H3K4A strain. Striped bar: ChIP samples of wild-type strain with rabbit IgG (No
Ab).
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Supplementary Figure 1. An alignment of the JmjN, PHD, and JmjC domains of KDM5
and JARID1d.
JmjC Domains
Jarid1d
VGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMKMLT
Kdm5
IGSLFSTFCWHMEDQYTLSANYQHEGDPKVWYSIPESGCTKFNDLLNDMS
Jarid1d
Kdm5

PELFDSQPDLLHQLVTLMNPN--TLMSHGVPVVRTNQCAGEFVITFPRAY
PDLFIKQPDLLHQLVTLISPYDPNFKKSGIPVYKAVQKPNEYIITFPKCY

Jarid1d
Kdm5

HSGFNQGYNFAEAVNF
HAGFNTGYNFNEAVNF

PHD Domains
Jarid1d
Kdm5

CQVCSRGDEDDKLLFCDGCDDNYHIFCLLPPLPEIPRGIWRCPKCI
CIVCRKTNDPKRTILCDSCDKPFHIYCLSPPLERVPSGDWICNTCI

JmjN Domains
Jarid1d
PPECPVFEPSWAEFQDPLGYIAKIRPIAE--KSGICKIRPPADWQPPFAV
Kdm5
MEEIPALYPTEQEFKNPIDYLSNPHIKRLGVRYGMVKVVPPNGFCPPLSI

Supplementary Figure 2. Specificity of histone antibodies.
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Section 4

Additional Results & Discussion

RESULTS & DISCUSSION
JHD2 Overexpression Reduces H3 K4me3 Globally In Vivo
To ask whether Kdm5 affects H3 K4 methylation in vivo, we engineered yeast strains in
which endogenous genes encoding JmjC domain-containing proteins (including JHD2)
were driven by a galactose-inducible GAL1 promoter, one of yeast’s strongest
promoters. Yeast with endogenous JHD2 driven by either its endogenous promoter or
the GAL1 promoter were grown in galactose to induce and whole-cell extracts were
analyzed by western analysis with methyl-specific antibodies. As expected based on our
in vitro demethylase reactions, strains in which JHD2 was driven by the inducible
promoter had lower global H3 K4me3 levels than strains in which JHD2 was driven by its
endogenous promoter (Figure 1). The effect on H3 K4me3 levels was specific since H3
K36me3 levels were not greatly reduced. As a control, total histone H3 levels were
comparable between these strains.
We note that our manuscript reported that a JHD2 deletion strain did not have
expectedly increased H3 K4 methyl levels globally. The reasons are unclear however
several explanations are possible. Demethylase activity with endogenous Kdm5 levels
may be too low for its loss to produce a detectable global effect. Redundant
demethylase activities may exist in vivo, although no other H3 K4-specific demethylases
have been reported to date. Alternatively, Kdm5 loss might be compensated for by
increased Set1 (H3 K4 methyltransferase) abundance or activity such that global H3 K4
methylation levels are unchanged.
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Kdm5 demethylation mechanism
While our in vitro demethylase reactions with Kdm5 and core histones revealed obvious
decreases in H3 K4me2, 3, they revealed only a minor decrease in H3 K4me1. This
might result from Kdm5 demethylating K4me1 and simultaneously converting K4me2, 3
to K4me1. To determine whether the monomethylated state was demethylated, we
repeated in vitro demethylase reactions with histone H3 peptides in which K4 was mono, di-, or trimethylated. Reactions with H3 K4me1 peptides resulted in a loss of the
monomethylated state. However, reactions with H3 K4me2, 3 peptides resulted in a
decrease in the di- or trimethylated states and an increase in the mono-, or mono- and
dimethylated states. This is indicative of Kdm5 demethylating H3 K4me2, 3 to the
unmethylated state but producing H3 K4me1, 2 as intermediate states.
These results are consistent with a mechanism in which Kdm5 binds its target,
removes a methyl group, and dissociates, thus removing the methyl groups one at a
time. Such a distributive mechanism has been noted in other chromatin modifiers such
as the H3 K79 HMT Dot1 (Frederiks, F., 2008). This is in contrast to a processive
mechanism in which case Kdm5 would bind and remove all the methyl groups it intends
to remove before dissociating. In this case, no intermediates would be detected.

Kdm5 in the context of others’ work
Our finding that Kdm5 targets methylated H3 K4 was confirmed by other groups. We
note that while we used western analyses of in vitro reactions, one group used in vitro
radioactive formaldehyde release assays (Liang, G., 2007), a second used mass
spectrometry of yeast-purified histones (Tu, S., 2007), a third and fourth observed that
Kdm5 depletion in vivo lengthens H3 K4me’s half-life globally via western analyses and
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at a number of genes via ChIP (Radman-Livaja, M., 2010; Seward, D.J., 2007), and a
fifth observed global loss of H3 K4me3 in vivo upon JHD2 overexpression via western
analyses (Huang, F., 2010). Kdm5’s demethylase activity is thus confirmed by multiple
groups and methods.
We note that the in vitro radioactive formaldehyde release assays detected
demethylation of H3 K4me2, 3, but not H3 K4me1 (Liang, G., 2007). The reason for this
difference is unclear. Their substrates were recombinant H3 histones with either K4me1
or both K4me2 and me3 which were created by HKMTs. We used calf thymus-purified
histones that have many endogenous PTMs and synthetically-derived histone H3
peptides. Since histone tails are unstructured, we believe our results with unstructured
peptides are valid. Reaction conditions like buffer composition or incubation time could
have inhibited the others’ demethylation reactions. In support of our results, it was
recently reported that if H3 K4me3 is eliminated in vivo via a Set1/COMPASS mutation,
Kdm5 overproduction then produces a slight H3 K4me1 decrease globally (Huang, F.,
2010).
We noted in our manuscript that while JHD2 deletion and overexpression altered
H3 K4 methyl levels at GAL1 during induction and repression, we failed to confirm Kdm5
recruitment here using ChIP. Since then, others have similarly reported that JmjC
proteins Jhd1 and Rph1, which demethylate H3 K36, can influence H3 K36me levels
inside genes but are not detectably enriched there by ChIP (Kim, T.S., 2007). This
suggests that the inability to detect JmjC protein recruitment to genes that are affected
by them may be a general property of the JmjC proteins rather than a failure by our ChIP
methods. Their structure may simply be hard to crosslink to histones, their in vivo
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histone interactions may be too transient to be detectable, or they may preferentially
demethylate chromatin modifiers, making their effects on histones indirect in vivo.
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METHODS
Yeast strain production and galactose-induction
GAL promoter insertions were performed as described previously (Longtine, M.S., 1998)
and confirmed by PCR. Yeast were grown to mid-log phase in YP+Dextrose, then were
grown in YP+Raffinose for 2 hours, then grown in YP+Galactose for 1 hour to induce
GAL1-JHD2.

Whole-cell extract (WCE) preparation
Yeast were grown in YPD (or YP+Galactose for overexpressions) to mid-log phase,
resuspended in TENG-300 buffer (50mM Tris-Cl pH 7.5, 300mM NaCl, 0.5% NP-40,
1mM EDTA, 10% glycerol, 0.5mM PMSF, protease inhibitors), beat with silica beads,
and sonicated after which lysates were cleared by centrifugation at 14krpm. Bradford
assays determined protein concentrations.

Western analyses
Samples were run on polyacrylamide gels, transferred to PVDF, and probed with
antibodies against total H4 (Millipore 05-858) or H3 K4me3 followed by incubation with
chemiluminescence reagent. Signals were visualized with a Fujifilm LAS-3000 Image
Reader.
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Figure 1. JHD2 overexpression reduces H3 K4me3 levels globally. Yeast with
endogenous JHD2 driven by its endogenous promoter or a GAL1 promoter were grown
in galactose after which whole-cell extracts were checked by western analyses. Induced
genes and antibodies used are respectively indicated above and to the left of each blot.
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Section 1

Chapter Summary

The work in this chapter resulted in a publication (below) confirming and characterizing
monomethylation of Saccharomyces cerevisiae histone H4 lysine 20.
Edwards, C.R., Dang, W., and Berger, S.L. Histone H4 Lysine 20 of Saccharomyces
cerevisiae is Monomethylated and Functions in Subtelomeric Silencing. Biochemistry.
Volume 50, 2011, 10473-10483.
The work and its supplementary materials are presented in sections two and three of this
chapter, respectively. References have been integrated into the dissertation
bibliography. Additional results are presented in section four.
Previous studies have indicated that lysine methylations correlating with
compacted or repressive chromatin, including at H3 K9, H3 K27, and H4 K20, are
absent in the budding yeast Saccharomyces cerevisiae. A mass spectrometry report in
2007 suggested however that S. cerevisiae H4 K20 may be monomethylated (H4
K20me1). This modification is conserved in higher eukaryotes where it is connected to a
very large number of processes, although it is generally associated with transcriptional
repression and chromatin compaction. However, understanding its overall role has been
challenging due to this large number of possible functions. We chose to confirm and
characterize S. cerevisiae H4 K20me1 since this might be a chance to refute the
longstanding notion that repressive methyllysines are absent in budding yeast and since
this would be an opportunity to study this interesting modification using a very genetically
tractable organism.
We find that H4 K20me1 is detectable on endogenous H4 by western analysis
using methyl-specific antibodies, and the signal is abrogated by H4 K20 substitutions
and by competition with H4 K20me1 peptides. Using chromatin immunoprecipitation we
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show that H4 K20me1 levels are highest at heterochromatic locations, including
subtelomeres, the silent mating type locus, and ribosomal DNA repeats, lowest within
euchromatin at centromeres and promoter/5’ regions of genes, and intermediate inside
genes. Further, an H4 K20A substitution strongly reduced heterochromatic reporter
silencing at subtelomeres and the silent mating type loci, and led to an increase in
subtelomeric endogenous gene expression. The correlation between the location of H4
K20me1 and the effect of the H4 K20A substitution, suggests that this modification plays
a repressive function.
H4 K20me1 levels do not show cell cycle-regulation but decrease during
replicative ageing. This modification also may negatively contribute to survival during
DNA damage. Our results indicate that H4 K20me1 is evolutionarily conserved from
simple to complex eukaryotes and suggest that it may be the first negative regulatory
histone methylation in S. cerevisiae.
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Section 2

Histone H4 Lysine 20 of Saccharomyces cerevisiae is
Monomethylated and Functions in Subtelomeric Silencing

ABSTRACT
Histones undergo posttranslational modifications that are linked to important biological
processes. Previous studies have indicated that lysine methylation correlating with
closed or repressive chromatin is absent in the budding yeast Saccharomyces
cerevisiae, including at H4 lysine 20 (K20). Here we provide functional evidence for H4
K20 monomethylation (K20me1) in budding yeast. H4 K20me1 is detectable on
endogenous H4 by western analysis using methyl-specific antibodies, and the signal is
abrogated by H4 K20 substitutions and by competition with H4 K20me1 peptides. Using
chromatin immunoprecipitation we show that H4 K20me1 levels are highest at
heterochromatic locations, including subtelomeres, the silent mating type locus, and
ribosomal DNA repeats, and lowest at centromeres within euchromatin. Further, an H4
K20A substitution strongly reduced heterochromatic reporter silencing at telomeres and
the silent mating type locus, and led to an increase in subtelomeric endogenous gene
expression. The correlation between the location of H4 K20me1 and the effect of the H4
K20A substitution, suggests that this modification plays a repressive function. Our
findings reveal the first negative regulatory histone methylation in budding yeast, and
indicate that H4 K20me1 is evolutionarily conserved from simple to complex eukaryotes.
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INTRODUCTION
DNA exists within the cell wrapped around protein octamers composed of two copies
each of histones H2A, H2B, H3, and H4. These histones participate in most DNArelated events such as transcription, replication, DNA repair, and chromatin compaction,
and undergo numerous posttranslational modifications (PTMs) that influence these
processes. Lysine methylation is one such modification and occurs on six lysines (H3
lysines 4, 9, 27, 36, and 79 and H4 lysine 20) from the fission yeast
Schizosaccharomyces pombe to humans, the only exception being H3 K27, which is not
known to be methylated in fission yeast. Lysine can be reversibly mono-, di-, or
trimethylated and this modification is associated with different biological phenomena
depending on the site and degree of methylation (Kouzarides, T., 2007).
H4 K20 is a particularly interesting residue since its methylation is linked to many
physiological processes. The K20 methylated form recruits the methyllysine-binding
protein L3MBTL1 to promote chromatin compaction (Min, J., 2007; Trojer, P., 2007;
Kalakonda, N., 2008), and also recruits the respective human and fission yeast DNA
repair proteins 53BP1 and Crb2 to sites of DNA damage (Sanders, S.L., 2004; Botuyan,
M.V., 2006). The methyltransferase Set8 (PrSet-7) localizes to replication forks in
human cells to monomethylate H4 K20; and disrupting Set8 function results in replication
defects (Huen, M.S., 2008; Jørgensen, S, 2007; Tardat, M., 2007). H4 K20me1 is
enriched at genes and linked to transcription, which may be associated with
transcriptional attenuation (Vakoc, C.R., 2006; Congdon, L.M., 2010). In addition, in
mammals, mono- and tri-methylated H4 K20 localize respectively to the transcriptionally
silent X chromosome Barr body and pericentromeric heterochromatin (Schotta, G.,
2004).
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In addition to the role of H4 K20 methylation, the residue itself may be linked to
heterochromatin function as part of a patch of basic amino acids (K16RHRK20). In
budding yeast, this patch, in particular the RHR motif, recruits or regulates several
chromatin proteins, including Isw2 ATP nucleosome remodeling complex, Sir2/3/4
deacetylase complex, and Dot1 methylase (Fazzio, T.G., 2005; Altaf, M., 2007;
Fingerman, I.M., 2007). Lysine 20, however, has been less well studied in budding
yeast, and its role and modifications have not been elucidated.
While lysine methylation associated with active transcription (H3 K4, K36, K79) is
conserved from budding yeast to humans, lysine methylation associated with gene
repression (H3 K9 and K27, and H4 K20), is generally thought to be absent in S.
cerevisiae (Fang, J., 2002; Nishioka, K., 2002; Schotta, G., 2004). However, intriguingly,
mass spectrometry suggested that H4 K20me1 exists in budding yeast in low
abundance (Garcia, B.A., 2007). Because of the important role of H4 K20 in histoneprotein interactions, and the conservation of its methylation throughout higher
organisms, we sought to confirm the presence of H4 K20 methylation in S. cerevisiae,
and to investigate possible functional roles for the modification and the K20 residue
itself.
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MATERIALS AND METHODS
Plasmids. SET4 was amplified by the Expand High Fidelity PCR System (Roche),
cloned into pBM272 (GAL promoter, CEN, ARS, URA3), and sequenced. Amino acid
substitutions were engineered into the H3/H4 plasmid pRM204 (HHT2, HHF2, CEN,
ARS, TRP1) using the QuikChange site-directed mutagenesis kit (Agilent) and confirmed
by sequencing. pBY011 (GAL promoter, CEN, ARS, URA3) overexpression plasmids
were acquired from the Yeast FLEXGene Collection (Hu, Y., 2007).

Yeast strains. Supplementary table S1 lists strains used in this study. Gene deletions
and GAL promoter insertions were performed as described previously (Longtine, M.S.,
1998). Plasmid transformations were performed using standard lithium acetate
methods. Deletions, insertions, transformations, plasmid shufflings, and histone FLAG
tags were confirmed by PCR, sequencing, and FLAG westerns as necessary.
Strains with ORFs deleted or overexpressed were created as follows.
Heterozygous Diploid Deletion Collection (Winzeler, E.A., 1999) clones were sporulated
to produce haploid methyltransferase deletion clones (YCE 002-016) after which mating
tests and PCR confirmed ploidy and deletions respectively. To acquire additional
methyltransferase deletion strains (YCE EH A2-C4), genes were deleted in the H3/H4
shuffle strain JPY12 after which JPY12 and the deletion strains were transformed with
FLAG-H4 plasmids (pRM204). Strains were then grown on synthetic complete (SC)
media lacking tryptophan to select for pRM204 and dilute out the original JPY12 histone
plasmid. RKM2 and demethylase deletion strains were created by standard gene
knockout methods. Overexpression strains were created by transforming pBM272 or
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FLEXGene Collection plasmids (pBY011) containing galactose-inducible genes into
yeast or by integrating galactose-inducible promoters into the genome.
Strains with subtelomeric URA3 and ADE2 reporters plus wild-type or mutant
histones were created as follows. pRM204 with wild-type or mutant H3/H4 genes were
transformed into UCC1369 to create YCE UA1 to UA9 after which strains were grown on
SC media lacking tryptophan to select for pRM204 and dilute out the original histone
plasmid. Plasmids were similarly transformed into UCC7262 to make YCE UC1 to UC9,
and UCC7266 to make YCE UD1 to UD9. UCC1369, UCC7262, and UCC7266 are
reported elsewhere (Leeuwen, F. van, 2002).
All other mutant histone strains were created as follows. pRM204 (or derivatives
of this) containing wild-type, FLAG-tagged, or mutant H3/H4 genes were transformed
into the H3/H4 shuffling strain FY1716 after which SC media containing 5-FOA was used
to select against the original FY1716 histone plasmid. Strains with either WT or K20
substitutions of H4 integrated into the genome were made as previously described
(Dang, W., 2009).

Whole-cell extract (WCE) preparation & FLAG-affinity purification. Yeast were grown in
YPD (or YP+Galactose for overexpressions) to mid-log phase, resuspended in TENG300 buffer (50mM Tris-Cl pH 7.5, 300mM NaCl, 0.5% NP-40, 1mM EDTA, 10% glycerol,
0.5mM PMSF, protease inhibitors), beat with silica beads, and sonicated after which
lysates were cleared by centrifugation at 14krpm. Bradford assays determined protein
concentrations. Anti-FLAG-agarose beads (Sigma) were incubated with WCEs
overnight and then washed with TENG-300. FLAG peptides (Sigma) then competed off
FLAG-tagged proteins.
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Western analyses. Samples were run on polyacrylamide gels, transferred to PVDF, and
probed with antibodies followed by incubation with chemiluminescence reagent. Signals
were visualized with a Fujifilm LAS-3000 Image Reader. Supplementary table S2 lists
antibodies used in this study. Roche supplied calf thymus histone H4.

Dot blots & peptide competitions. Peptides matching the first thirty amino acids of
budding yeast histone H4 plus a C-terminal cysteine were synthesized with no
modifications, acetylated K16, monomethylated K20, or both modifications (Baylor
College of Medicine Protein Chemistry Core Laboratory). Peptides matching the higher
eukaryote histone H4 lysine 20 epitope without modifications or with mono, di, or
trimethylated lysine 20 were purchased from ABCam (ab2622, ab14964, ab17043,
ab17567, ab21044). Ab21044 spans residues 16-25; all others span residues 17-24.
For dot blots, known amounts of peptides were spotted onto PVDF and probed with
antibodies. For peptide competitions, westerns were performed as usual except that
antibodies were first incubated with peptides at room-temperature for one hour.

Phenotype assays and determination of reporter expression. Yeast from YPD cultures
were washed and resuspended in water, serially diluted, and spotted onto media that
were then incubated at 30°C (37°C for heat sensitivity). Yeast with a URA3 reporter
were spotted onto SC media, SC media lacking uracil, or SC media with 5-FOA followed
by incubation at 30°C. Yeast with an ADE2 reporter were grown on YPD plates at 30°C
and then left at 4°C for several days to allow pigment accumulation. Images were
recorded with a scanner.
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Replicative lifespan assay. Replicative lifespan assays and data analysis were
performed as previously described (Dang, W., 2009).

Chromatin immunoprecipitation assay and determination of RNA levels. For ChIP, yeast
were crosslinked with 1% formaldehyde at room temperature for 10 min followed by
chromatin immunoprecipitation as described previously (Wyce, A., 2007). To extract
RNA, yeast were lysed via bead-beating after which RNA was purified from extracts
using the Qiagen RNeasy kit and converted to cDNA using random hexamers (IDT) and
the Applied Biosystems Taqman reverse transcriptase kit. cDNAs and ChIP DNA were
analyzed using the Applied Biosystems 7900HT Fast Real-Time PCR System.
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RESULTS
Lysine 20 of histone H4 is monomethylated in budding yeast.
To determine whether lysine 20 of histone H4 is monomethylated in S. cerevisiae, we
acquired a commercially available anti-H4 K20me1 polyclonal antibody (ABcam ab9051)
and tested it in dot blots using H41-30 peptides that were unmodified, monomethylated at
K20 (H4 K20me1), acetylated at K16 (H4 K16ac), or had both modifications. The
antibodies preferentially recognized monomethylated versus unmethylated peptides and
showed no affinity for H4 K16ac (Fig. 1A). The antibody also comparably detected H4
K20me1 in the presence or absence of H4 K16ac.
We then determined whether H4 K20me1 is detectable by western analysis of
whole-cell extracts (WCEs) from a variety of strains. An epitope was detected migrating
similarly to calf thymus H4 in all strains tested regardless of genetic background (S288C,
SK1, and W303), mating type, ploidy, or whether the H4 gene was present in the
genome or on a plasmid (Fig. 1B). Importantly, substitution of H4 K20 with the
chemically similar arginine (to mimic unmodified lysine) abrogated the signal. We also
probed WCEs with anti-H4 K20me2, 3 antibodies but failed to detect these modifications
(Fig. S2).
To confirm that the western signal was from H4 rather than a similarly-migrating
protein, we performed westerns with WCEs from strains in which all copies of H4 were
either FLAG-tagged or untagged (Fig. 1C). WCEs containing untagged H4 had an H4
K20me1 western signal co-migrating with calf thymus H4, whereas WCEs with FLAG-H4
had the H4 K20me1 signal migrating slower than calf thymus H4 (Fig. 1C, left). A FLAGH4 K20R substitution abrogated this signal confirming that the slower migrating species
was FLAG-H4. These WCEs were also subjected to FLAG-affinity purification after
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which elutions were analyzed by western analysis. The H4 K20me1 epitope was
purified from WCEs with FLAG-H4 but not from WCEs with untagged H4 or FLAG-H4
K20R (Fig. 1C, right). These results show that the epitope is present on H4, and there is
no cross-reaction with any other H3 methylation.
To further confirm the presence of the K20me1 modification, WCEs from wildtype or H4 K20R yeast were probed with anti-H4 K20me1 antibodies that had been preincubated without peptides (control) or with different concentrations of H4 peptides
having or lacking K20me1. Control competition produced a western band with the wildtype but not mutant WCEs, and this epitope was competed in a dose-dependent manner
by monomethylated but not unmodified peptides (Fig. 1D). This preferential competition
was seen with WCEs from yeast of three different genetic backgrounds (Fig. 1E).
As further evidence for the existence of H4 K20me1, a second commerciallyavailable antibody (Millipore 04-735, formerly Upstate 05-735) was tested. This antibody
showed specificity in dot blots for monomethylated rather than unmethylated,
dimethylated, or trimethylated H4 peptides, and detection remained constant for the
double modified K16ac and K20me1 peptide (Fig. 2A, B). The antibody also detected
budding yeast H4 in westerns of WCEs, co-migrating with calf thymus H4, and yeast H4
detection was abrogated by alanine, arginine, glutamine, or methionine K20 substitutions
but not by an H4 K16R substitution (Fig. 2C). Further, this western signal was
preferentially competed by peptides with monomethylated but not unmethylated,
dimethylated, or trimethylated lysine 20 (Fig. 2D). We conclude, using a wide variety of
approaches and multiple antibodies, that H4 K20me1 is present in the budding yeast S.
cerevisiae.
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Approaches to identify enzymes that modify H4 K20 in budding yeast.
To identify histone methyltransferases (HMTs) and demethylases (HDMs) for this
modification, a list of candidates was produced. Since most known histone lysine
methyltransferases have a SET domain, we selected the twelve S. cerevisiae SET
domain-containing proteins (SET1 to SET6, RKM1 to RKM4, CTM1, and EFM1). We
also selected the non-SET domain-containing HMT DOT1 and three putative arginine
methyltransferases (HMT1, RMT2, and HSL7). We selected the five S. cerevisiae
Jumonji-C (JmjC) domain-containing proteins (JHD1, JHD2, RPH1, GIS1, and ECM5),
since this domain often has histone demethylase activity, and the proposed HDM ELP3
(Chinenov, Y., 2002; Paraskevopoulou, C., 2006). These genes were individually
deleted or overexpressed and H4 K20me1 levels were checked by western analysis.
H4 K20me1 levels in deletion strains were checked by western analyses of
FLAG-purified histones from strains with FLAG-tagged H4 and WCEs from all other
strains (Fig. 3A, 3B, S3). As positive controls, deleting SET1 (Fig. 3A), SET2 (Fig. S3A),
or DOT1 (Fig. 3B, S3A, S3B) decreased H3 K4me3, H3 K36me3, or H3 K79me3 levels
respectively. However, none of the deletion strains had significantly altered H4 K20me1
levels. Individual deletions of 14 additional ORFs whose protein products share
homology with Dot1 (Supp. Table S3) also failed to abrogate the H4 K20me1 western
signal.
Since enzyme redundancy might prevent H4 K20me1 levels from changing with
individual or even double deletions, we overexpressed candidates individually and
checked WCEs by western analysis (Fig. 3C, S4). As positive controls, overexpressing
RPH1 (Fig. 3C, S4B, S4C) and JHD2 (Fig. S4B) decreased H3 K36me3 and H3 K4me3
levels respectively. However, H4 K20me1 levels did not change upon induction of any
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of the candidates. In summary, deletion or overexpression of known or potential HMTs
or HDMs did not alter H4 K20me1 levels in yeast.

Examination of crosstalk between H4 K20me1 and other modifications.
To test whether other histone modifications affect H4 K20me1, WCEs from strains with
substitutions of known modified histone H3 and H4 residues were probed with anti-H4
K20me1 antibodies. H4 K20 substitutions eliminated the H4 K20me1 signal whereas all
other substitutions (e.g. the triple substitution H4 K5R/K8R/K12R – all acetylated
residues) had no effect (Fig. 2C). Substitutions of H3 K4, H3 K36, and H3 K79 were not
tested since deleting or overexpressing SET1, SET2, or DOT1 did not affect H4 K20me1
levels (Fig. 3, S3, S4).
We then tested whether, conversely, H4 K20me1 altered H4 K16ac levels. H4
K16R and H4 K16Q mutations eliminated the K16ac signal, whereas H4 K20
substitutions showed no effect on K16ac (Fig. 2C). H4 K16ac levels were also checked
at various locations in the genome by ChIP and were not affected by H4 K20R
substitution (data not shown). We conclude that H4 K20me1 is not altered by other
abundant modifications (most of which correlate with transcription), nor does H4 K20
substitution affect H4 K16ac.

H4 K20me1 Abundance at Genomic Heterochromatin and Euchromatin
To determine the distribution of the methylation at key locations in the genome, we
performed ChIP against H4 K20me1 and total H4 followed by qPCR of various locations.
We checked heterochromatic locations and non-heterochromatic locations including
upstream of and throughout the body of several genes as well as centromeres which,
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unlike in higher eukaryotes, are not known to contain heterochromatin (Buhler, M., 2009;
Ishii, K., 2009). We found that the H4-normalized ChIP signal for H4 K20me1 was
higher than IgG-mock ChIPs for all locations tested, but not in the H4 K20R substitution
control ChIP (Fig. 4B). We found a preferential distribution of H4 K20me1 levels within
heterochromatic regions, including subtelomeres, rDNA, and the silent mating type loci
HML (Fig. 4A, 4B, 4C lower panel). The lowest level of H4 K20me1 was found at
centromeres (Fig. 4A, 4B, 4C lower panel). In general, genes showed an intermediate
level between heterochromatin (highest levels) and centromeres (lowest levels) (Fig. 4A,
4B, 4C lower panel). In addition, transcribed regions/open reading frames (ORFs) of
genes were higher in K20me1 compared to the upstream promoter regions and at 5’ and
3’ ends of genes (Fig. 4A, 4C, and 4D).
As a further control for these results, we examined ChIP signals for H3 K4me3
normalized to total histone H4. As expected, and in contrast to the distribution of H4
K20me1, H3 K4me3 levels were lower at heterochromatic locations and higher at some
euchromatic locations, particularly several centromeres and the 5’ region of an ORF
(Fig. 4C, compare upper panel with H3 K4me3 to lower panel with H4 K20me1).

Phenotypic assays of H4 K20 substitution mutants in heterochromatic gene silencing,
stress pathways, and during replicative aging.
As discussed above, H4 K20 is part of a patch of basic residues (K16RHRK20) that is
linked to heterochromatin. Since we detected preferential localization of H4 K20me1 at
heterochromatin, and since K20me1 in higher eukaryotes is linked to heterochromatin,
chromatin compaction, and gene silencing, we investigated whether budding yeast H4
K20 and its methylation are linked to heterochromatic silencing in yeast. We used classic
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heterochromatic silencing reporters at telomeres and HML, and also assayed
subtelomeric endogenous gene expression.
Expression of a URA3 reporter integrated at heterochromatic regions
subtelomere VIIL (Fig. S5A), HMR (Fig. S5B), or HML (Fig. 5A) in yeast that have either
wild-type or mutant histones was determined by comparing growth on nonselective SC
plates to selective SC-URA plates (increased expression causes increased growth) or
SC+5FOA plates (increased expression causes decreased growth). As positive
controls, H4 K16R, H4 K16Q, and H3 K79R mutants caused silencing defects of
subtelomeric URA3, and H4 K16R and H4 K16Q mutants caused silencing defects of
URA3 at HMR and HML loci (Fig. 5A, S5). We found that H4 K20A showed dramatic
silencing defects at subtelomere VIIL, HMR, and HML, whereas H4 K20R did not
change reporter expression at these tested locations. Strains with an ADE2 reporter at
subtelomere VR were also analyzed by observing yeast coloration (red and white
respectively indicate silencing and expression). While H4 K16R, H4 K16Q, and H4
K20A mutations caused ADE2 silencing defects, an H4 K20R substitution did not (Fig.
5A, S5). Importantly, H4 K20A substitution did not globally increase H4 K16ac levels in
the cell (Fig. 2C) indicating that the reduction of silencing was not due to an indirect
effect on acetylation.
To determine if similar derepression occurs at endogenous genes, we checked
expression levels of genes proximal and distal to the telomere of chromosome VIIL. The
most telomere-proximal gene is COS12 and its location is similar to that of the
subtelomeric URA3 reporter used above (Takahasi, Y., 2011) (Fig. S5). While wild-type
and H4 K20R strains had little or no detectable COS12 expression, H4 K20A strains
showed strong derepression of this gene (Fig. 5B, lower panels). Interestingly, while
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these effects were seen at the telomere-proximal COS12, the distal MNT2 and ADH4
showed no such derepression with any H4 K20 substitutions, whereas numerous
intermediate genes showed de-repression with the H4 K20A substitution that became
less intense as the distance from the telomere increased. Similar results were seen
whether mRNA levels were normalized to ACT1 mRNA (Fig. 5B, lower panels) or 18S
rRNA (data not shown). Genes PAU11 and YGL260w were not included due to qPCR
difficulties resulting from their homologies to other genes in the genome.
To determine whether these K20A-mediated silencing defects correlate with
levels of H4 K20me1, we performed ChIP for this mark across the chromosome VIIL
subtelomeric region. Interestingly, the telomere-proximal locations contained higher H4
K20me1 relative to the telomere-distal locations, and the level graded at the genes inbetween (Fig. 5B, upper panel). We noted that the four most telomere-proximal genes
we tested (COS12, YGL262w, YPS5, and YGL258w-a) had H4 K20A-mediated derepression that was greater than two-fold whereas the three most telomere-distal genes
we tested (VEL1, MNT2, and ADH4) had H4 K20A-mediated de-repression that was less
than two-fold or non-existent. While the H4 K20me1 levels decreased as distance from
the telomere increased, we noted that H4 K20me1 levels amongst the telomere-distal
group of genes were significantly lower than amongst the telomere-proximal group of
genes (Fig. 5B, upper panel). The observations that H4 K20A, but not K20R, reduced
heterochromatic silencing and increased subtelomeric transcription are discussed in
detail below.
We assayed H4 K20 substitution mutants under a wide variety of growth
conditions to test many different gene signaling pathways. Wild-type, H4 K20A, and H4
K20R yeast grew similarly on rich and synthetic media plates at 30°C (Fig. S6), and wild-
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type, H4 K20R, and H4 K20M yeast showed similar growth kinetics in liquid YPD media
at 30°C (data not shown). H4 K20A and H4 K20R mutants displayed no obvious growth
advantages or disadvantages compared to wild-type yeast under a variety of stress
conditions (Fig. S6 and summarized in Table 1). Thus, any effects of H4 K20A do not
appear to be the result of general defects in chromatin structure, stress response, or cell
viability.
Acetylation of H4 K16, a residue proximal to H4 K20, increases at
heterochromatin during replicative aging in budding yeast (Dang, W., 2009). Since we
observed heterochromatic localization of H4 K20me1, we investigated whether H4
K20me1 levels change during replicative aging. In two yeast strains, older cells had
higher H4 K16ac levels by western analysis of histones, as expected (Dang, W., 2009).
Interestingly, H4 K20me1 levels were dramatically reduced during aging compared to
young cells, opposite to K16ac (Fig. 5C).

DISCUSSION
While previous analyses indicated that H4 K20 is not methylated in S. cerevisiae (Fang,
J., 2002; Nishioka, K., 2002; Schotta, G., 2004), mass spectrometry data suggested that
H4 K20me1 exists in low abundance (Garcia, B.A., 2007). Using multiple methods, we
demonstrate that S. cerevisiae H4 K20 is, indeed, monomethylated. Anti-H4 K20me1
antibodies detected an H4 epitope in western blots of WCEs from various strains and
purified H4. These western signals from endogenous histones were abrogated by a
K20R substitution and were preferentially competed by H4 K20me1 peptides (Fig. 1 &
2). In contrast, we detected neither di- (consistent with previous reports (Fang, J., 2002;
Nishioka, K., 2002)) nor tri-methylated H4 K20 in budding yeast (Fig. S2). Since
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antibodies are central to modification studies, we note that there was significant lot-to-lot
variation in the efficacy of H4 K20me1 antibodies, typical of many modification
antibodies (Egelhofer, T.A., 2011).
Our evidence supporting the existence of budding yeast H4 K20me1 is not
entirely surprising. First, studies reporting its absence according to western analysis
actually used antibodies raised against H4 K20me2 peptides, and not K20me1 (Fang, J.,
2002; Nishioka, K., 2002). Second, although budding yeast lack orthologues to higher
eukaryote H4 K20 methylase enzymes, chromatin modifying enzymes sometimes lack
expected protein sequence homologies or domains. For example, most HMTs have a
SET domain and yet the H3 K79 HMT Dot1 has a different catalytic domain (Nguyen,
A.T., 2011). Third, although the amino acid sequence surrounding budding yeast H4
K20 is not totally conserved in higher eukaryotes, it is fully conserved in fission yeast
(Supp. Fig. S1), which has K20 methylation (Sanders, S.L., 2004).

Functions of H4 K20 monomethylation.
H4 K20me1 is reported in higher eukaryotes to be associated with transcriptional
silencing, chromatin compaction, and heterochromatin. We therefore hypothesized that
this modification would preferentially associate with heterochromatic regions of the
budding yeast genome. Levels of H4 K20me1 were significantly higher at
heterochromatic locations and lower at euchromatic locations, including centromeres
which, unlike in higher eukaryotes, are not heterochromatic (Fig. 4A, 4C lower panel)
(Buhler, M., 2009; Ishii, K., 2009). We also found H4 K20me1 to be higher in the middle
of genes relative to upstream regions and 5’ or 3’ ends (Fig. 4A, 4D), consistent with
findings from mammalian studies showing enrichment of H4 K20me1 inside of genes
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(Vakoc, C.R., 2006; Congdon, L.M., 2010). H4 K20me1 may have a compaction
function within genes, similar to H3 K36me3, which localizes to the 3’ half of genes and
recruits HDACs to promote chromatin compaction (Carrozza, M.J., 2005).
The previous relationship of H4 K20 methylation to heterochromatin, DNA
replication, DNA repair, and chromatin compaction in higher eukaryotes, prompted
testing of these pathways in budding yeast. It is intriguing that H4 K20A substitution
produced dramatic silencing defects at subtelomeres, including the most telomereproximal gene COS12 and multiple adjacent subtelomeric genes (Fig. 5B lower panel),
and at the silent mating type loci HMR and HML (Fig. S5B, 5A). Interestingly, H4
K20me1 levels showed a striking correlation with K20A-mediated silencing defects along
regions proximal and distal to telomere VIIL (Fig. 5B, compare lower and upper panels).
The silencing defects are not an indirect effect of increasing acetylation at H4 K16,
because global H4 K16ac levels were comparable in strains bearing wild type H4
relative to K20A (Fig. 2C), and was not due to general disruption of chromatin structure
since the H4 K20A mutant did not show increased transcription at all genes examined
(Fig. 5B lower panels). Previous studies of the K16RHRK20 patch in vitro and in vivo
have not identified a role for K20 in recruitment or regulation of heterochromatic or other
complexes, such as Sir2/3/4, Isw2, or Dot1 (Fazzio, T.G., 2005; Altaf, M., 2007;
Fingerman, I.M., 2007). It will be interesting in future studies to determine the role of
K20me1 in promoting repression at subtelomeres and at the silent mating type loci.
In contrast to K20A, the H4 K20R substitution did not show silencing defects at
subtelomeres and silent mating type loci, nor did K20R exhibit phenotypes associated
with DNA replication inhibitors, DNA damaging agents, or other stress conditions (Fig.
5A, S5, S6 and Table 1). Nonetheless we favor the view that there is a function for H4
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K20me1, based on the strong correlation between the location of the modification at
heterochromatic regions, and the highly specific defect of H4 K20A in telomere-proximal
regulation. One possible explanation for the absence of an effect of K20R in silencing,
or other processes, is that effector proteins may interact with this basic patch through
binding to both the residues and K20me1, such that interactions are compromised by
loss of either, but only sufficiently to produce a detectable phenotype with loss of the
residues. In this view, K20A may alter the structure sufficiently to disrupt binding, but
loss of methylation alone via K20R, would not disrupt binding.
An alternative possibility is that the methylation is redundant with other
pathways. Such a scenario is not uncommon in budding yeast chromatin. Indeed, it is
remarkable that certain well-known modifications, such as H2B K123 ubiquitylation,
which is present on more than half the histone H2B proteins in the cell, has only a
modest phenotype when abrogated by a K123R substitution. Yet, when K123R is
combined with deletion of GCN5, the major H3 acetyltransferase (whose deletion also
results in only minor reduction of transcription), there is a strong synthetic effect, causing
very low transcription (Kao, C.F., 2004).
Since acetylation of the adjacent H4 K16 participates in replicative aging (Dang,
W., 2009), we examined whether H4 K20me1 is also linked to aging. Interestingly, H4
K20me1 levels were reduced in older compared to younger yeast (Fig. 5C). This
lowered detection is not due to H4 K16ac obscuring the K20me1 signal, because
substituting K16 to arginine or glutamine does not globally alter K20me1 levels (Fig. 2C),
nor does K16ac prevent K20me1 recognition in peptide dot blots (Fig. 1A, 2A). This
result is consistent with association of H4 K20me1 and H4 K16ac with opposing
chromatin states, i.e. the former with condensed and silent chromatin, whereas the latter
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with open and active chromatin. It is possible that the decrease in K20me1 in old cells
might affect protein recruitment or chromatin structure. We note that we have not
observed a change in lifespan in an H4 K20R substitution (data not shown), thus a role
of H4 K20me1 during aging is unclear. However, we do not believe that such a function
would occur by altering H4 K16ac levels, since levels of this adjacent modification are
not altered by H4 K20R substitutions (Fig. 2C).

Unexpected histone modifications and unidentified enzymes in budding yeast.
Budding yeast histones have additional lysines methylations, some of which are
conserved in higher eukaryotes. Recently H2B K37 methylation was identified at low
levels in S. cerevisiae, and this residue and methylation are both conserved in complex
eukaryotes; substitution mutations here (K37R and K37A) have no detectable phenotype
however (Gardner, K.E., 2011). Similarly, H3 K42 methylation was recently identified in
budding yeast and may be linked to transcription; lysine to arginine substitution mutation
here however also has no detectable phenotype (Hyland, E.M., 2012). These findings,
along with our data on H4 K20 and its methylation, indicate that histone lysine
methylation, including low abundance marks, may be more common than previously
appreciated, and may have pathway-specific functions that are difficult to reveal.
Furthermore, similar to H4 K20me1, individual deletions of DOT1 and all known
SET domain-containing genes do not abrogate H2B K37 or H3 K42 methylation
(Gardner, K.E., 2011; Hyland, E.M., 2012) and combinatorial deletions of three known
arginine methyltransferases do not abrogate H3 R2 methylation (Kirmizis, A., YEAR).
While enzyme redundancies may be the reason in some cases, unidentified
methyltransferases may instead be responsible for these previously unknown budding
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yeast modifications. Genome-wide deletion and overexpression screens and
biochemical methods may help to discover the responsible enzymes.
While H4 K20 and H2B K37 are conserved and methylated from S. cerevisiae to
higher eukaryotes, H3 K9 and H3 K27 are also conserved and methylated in higher
organisms, but reportedly unmethylated in S. cerevisiae. Our western analyses have not
revealed H3 K9me in budding yeast (data not shown), however our search for this mark
has not been extensive; we note that recent mass spectrometry data detected low levels
of this modification (Garcia, B.A., 2007), and the S. cerevisiae HDM Rph1 targets H3
K9me in vitro (Klose, R.J., 2007). Whether any other “absent” marks are actually
conserved in this model organism remains to be determined.
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Table 1. Stress conditions tested.1
Conditions tested with H4 K20R

Conditions tested with H4 K20A

YPD or SC at 37°C (Heat sensitivity)

YPD or SC at 37°C (Heat sensitivity)

YP + Galactose (Galactose utilization)

YP + Galactose (Galactose utilization)

YP + Acetate (Acetate utilization)

YP + Acetate (Acetate utilization)

YP + Ethanol & glycerol (Ethanol &

YP + Ethanol & glycerol (Ethanol &

glycerol utilization)

glycerol utilization)

YP + Raffinose (Raffinose utilization)

YP + Sucrose (Sucrose utilization)

YPD + 100-125mM Hydroxyurea (DNA

YPD + 100-125mM Hydroxyurea (DNA

replication stress)

replication stress)

YPD + 10-15µg/mL Camptothecin

YPD + 10-15µg/mL Camptothecin

(Topoisomerase inhibition stress)

(Topoisomerase inhibition stress)

YPD + 1M NaCl (Osmolarity stress)

YPD + 1M NaCl (Osmolarity stress)

SC + UV light (DNA damage)

SC + UV light (DNA damage)

YPD + 0.01-0.05% MMS (DNA damage)
YPD + 0.02% H2O2 (Oxidative stress)
SC Lacking inositol (Inositol utilization)
YP + Low glucose (respiration)

1

Stress conditions used in phenotype assays. Growth of wild-type and H4 K20 substitution yeast were
compared between stress and non-stress conditions.
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Figure 1. H4 K20me1 detectable in budding yeast. (A) Peptides matching the first 30
amino acids of H4 with or without acetylated lysine 16 or monomethylated lysine 20 were
spotted onto PVDF and probed with antibodies. Peptides, peptide amounts, and
antibodies are respectively indicated to the left, top, and bottom of the blots. (B) H4
K20me1 is detectable in whole-cell extracts (WCEs) from strains of different genetic
backgrounds, mating types, and ploidies, is detectable whether H4 genes are present in
the genome or on a plasmid, and is abrogated by an H4 K20R substitution. WCEs were
analyzed on polyacrylamide gels, transferred to PVDF, and probed with antibodies. H4
levels are a loading control. Calf thymus H4 is a positive antibody control. Antibodies
are indicated to the left of each blot. Strains, genetic backgrounds, and mating types are
indicated above each lane. Strains FY1716, YKI071, and YWD193 have H3/H4 genes
present only on a plasmid. (C) To confirm that the H4 K20me1 signal is H4 and not a
similarly migrating protein, WCEs with untagged H4, FLAG-H4, or FLAG-H4 K20R were
subjected to FLAG-affinity purification. WCEs and elutions were analyzed by western
analyses. Antibodies are indicated to the left of each blot. The FLAG tag and K20R
substitution are indicated above each lane. An asterisk indicates a non-specific band
that obscures FLAG-H4 in WCEs. Arrows indicate untagged H4 in WCEs and FLAG-H4
in eluates. (D & E) H4 K20me1 western signals preferentially competed by
monomethylated rather than unmethylated H4 peptides. WCEs were analyzed on
polyacrylamide gels, transferred to PVDF, and probed with anti-H4 K20me1 antibodies
(1mg/mL) that were pre-incubated with no peptides or H4 peptides (100ng/mL or 1ng/mL
in D, 100ng/mL in E) that were or were not monomethylated at lysine 20. H4 levels are
a loading control. Antibodies are indicated to the left of each blot. Strains, peptides, and
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peptide concentrations are indicated above each blot. Arrow indicates H4 K20me1.
Asterisk indicates a non-specific band.

Figure 2. H4 K20me1 detectable with Millipore antibody 04-735. (A, B) Peptide dot
blots as in figure 1A. (C) Substitutions of modifiable histone residues do not affect H4
K20me1 levels and H4 K20 substitutions do not affect H4 K16ac levels. WCEs from
yeast with wild-type or mutant histones were analyzed by western analyses. Antibodies
and histone mutations are respectively indicated to the left of and above each blot.
Asterisk indicates a non-specific band present on blot probed for H4 K16ac. (D) Western
blots with peptide competitions as in 1D, E.

Figure 3. Deleting and overexpressing candidate genes does not change H4 K20me1
levels. (A, B) FLAG-H4 was purified by FLAG-affinity purification from strains with
candidate HMTs deleted. WCEs and FLAG elutions were analyzed by western analysis.
Antibodies and strains are respectively indicated to the left of and above each blot.
FLAG levels are a loading control. (C) WCEs from strains with candidate HMTs
overexpressed from a plasmid were analyzed by western analysis. Antibodies and
strains are respectively indicated to the left of and above each blot. H4 levels are a
loading control. An H4 K20R strain serves as a negative antibody control.

Figure 4. ChIP-qPCR analysis of H4 K20me1. Sonicated chromatin from yeast with
WT or K20R histone H4 were immunoprecipitated by antibodies against H4 K20me1 or
total H4 and co-purified DNA was analyzed by qPCR. Bars indicate H4 K20me1 levels
normalized to total H4 levels (A) or no antibody or H4 K20me1 levels normalized to input
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levels (B). Genomic locations are indicated below each pair of bars. (C) Comparison of
H3 K4me3 versus H4 K20me1 levels relative to H4 levels at several loci. (D) H4
K20me1 levels relative to H4 levels across several regions: ACT1 ORF, RCK2-YEF3
region, and YLR454w region. Horizontal bars and arrows underneath graph represent
genome and genes respectively. Position of bar graph bars above genes indicates
locations of checked regions. A, B, and D represent means and standard error of the
mean (S.E.M.) of three experiments.

Figure 5. Phenotype analysis of H4 K20me1. (A) Dilutions of hml::URA3 ADE2-TEL-VR
yeast with wild-type or mutant histones were grown on synthetic complete (SC), SCURA, or SC+5FOA media. Media and strains are indicated above and to the right of
each plate respectively. Increased growth on SC-URA media and decreased growth on
SC+5FOA media compared to SC media indicate increased URA3 expression. White
and red yeast coloration respectively indicates ADE2 expression and silencing. (B) H4
K20me1 levels at and expression of genes proximal and distal to telomere 7L were
determined by ChIP of H4 K20me1 and total H4 and by qPCR of harvested RNAs. (top)
ChIP was as in Figure 4. H4 K20me1 levels per total H4 levels are shown with means
and standard errors of the mean. ChIP locations residing along chromosome 7L are
indicated in the map by black triangles while above numbers indicate which locations
correspond to which bars in the above graph. Locations 2-5 were compared to locations
6-8 using a Wilcoxon rank sum test and generated the indicated P-value. (bottom) RNA
was extracted from yeast with WT, K20R, or K20A histone H4. mRNA levels of genes
proximal and distal to telomere 7L were determined by qPCR and normalized to ACT1
mRNA. Means and standard error of the means are shown. WT and H4 K20A samples
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were compared using a T-test and generated the indicated P-values. (C) H4 K20me1
levels are lower in replicatively older than younger yeast. WCEs from replicatively young
or old yeast were analyzed by western analyses. Antibodies are indicated to the left of
each blot. Samples and strains are indicated above each lane. Average numbers of
bud scars (cell divisions) for each yeast sample are indicated in parentheses. H3 levels
are a loading control.
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Section 3

Supplementary Materials for Section Two

Supplementary Table S1. Yeast strains used in this study.
Figure 1

Genotype

Source

W303-1A

Mata ade2-1 can1-100 ura3-1 leu2-3,112 trp1-1 his3-11,15

Thomas,
B.J., 1989

IPY36 (Isogenic
to SB301)

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG

Sterner,
D.E., 2002

BY4741

Mata his3Δ1 leu2Δ0 ura3Δ0 met15Δ0

Brachmann,
C.B., 1998

BY4742

Mata his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0

Brachmann,
C.B., 1998

FY406

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hta1htb1)::LEU2 (hta2-htb2)::TRP1 pSAB6(HTA1, HTB1,
CEN, URA3)

Hirschhorn,
J.N., 1995

FY1716

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pDM1(HHT2, HHF2,
CEN, URA3)

Nathan, D.,
2006

YKI071

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pRM204(HHT2, HHF2,
CEN, TRP1)

This study

YWD193

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pWD93(pRM204 HHT2,
hhf2 K20R, TRP1, CEN)

This study

LNY150

Mata/Mata leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG
lys2-SK1/lys2-SK1 his4-N/his4-G ura3-SK1/ura3-SK1
ho::LYS2/ho::LYS2

L.
Neigeborn

MWY1038

Mata leu2::hisG trp1::hisG lys2-SK1 his4-N/G ura3-SK1
ho::LYS2

Edward
Winter

MWY1039

Mata leu2::hisG trp1::hisG lys2-SK1 his4-N/G ura3-SK1
ho::LYS2

Edward
Winter

YKI156

Mata his3D200 leu2D1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pRM204(HHT2, FLAGHHF2, CEN, TRP1)

This study
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YCE017

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE003(pRM204 HHT2,
FLAG-hhf2 K20R, CEN, TRP1)

This study

YKI071

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pRM204(HHT2, HHF2,
CEN, TRP1)

This study

YWD193

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pWD93(pRM204 HHT2,
hhf2 K20R, TRP1, CEN)

This study

Figure 2

Genotype

Source

YWD 1000

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2

Dang, W.,
2009

YWD 1120

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 hhf2 K20R

This study

YWD 1121

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 hht2 A15V-hhf2 K20M

This study

YCE074

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1)

This study

YCE075

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE007(pRM204 HHT2,
hhf2 K20R, CEN, TRP1)

This study

YCE129

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE028(pRM204 HHT2,
hhf2-K20Q, CEN, TRP1)

This study

YCE126

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE005(pRM204 HHT2,
hhf2-K20A, CEN, TRP1)

This study

YWD123

Mata his3D200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pWD23(pRM204 HHT2,
hhf2 K16R, CEN, TRP1)

Dang, W.,
2009

YWD125

Mata his3D200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pWD25(pRM204 HHT2,
hhf2 K16Q, CEN, TRP1)

Dang, W.,
2009

YKI076

Mata his3D200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pRM204(HHT2, hhf2
K5A K8A K12A, CEN, TRP1)

This study
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TY99

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pTK59(pRM204 HHT2,
hhf2 S1A R3A, CEN, TRP)

This study

T7

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pRM204(hht2 K9A S10A
K14A, HHF2, CEN, TRP1)

This study

TY102

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pTK57(pRM204 HHT2,
hhf2 S1E, CEN, TRP)

Cheung,
W.L., 2005

Figure 3, S3, S4

Genotype

Source

IPY36 (Isogenic
to SB301)

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG

Sterner,
D.E., 2002

YKI112

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG rph1::KanMX

This study

YKI113

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG jhd1::KanMX

Ingvarsdottir,
K., 2007

YKI114

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG ecm5::KanMX

This study

YKI115

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG gis1::KanMX

This study

YKI127

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG jhd2::HIS3

Ingvarsdottir,
K., 2007

YKI188

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG elp3::HIS3

This study

BY4742

Mata his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0

Brachmann,
C.B., 1998

YCE 002

Mat alpha set2::KanMX his3Δ1 leu2Δ0 ura3Δ0 [met15Δ0
and/or lys2Δ0]

This study

YCE 004

Mat alpha set3::KanMX his3Δ1 leu2Δ0 ura3Δ0 [met15Δ0
and/or lys2Δ0]

This study

YCE 006

Mat alpha set4::KanMX his3Δ1 leu2Δ0 ura3Δ0 [met15Δ0
and/or lys2Δ0]

This study

YCE 008

Mat alpha set5::KanMX his3Δ1 leu2Δ0 ura3Δ0 [met15Δ0
and/or lys2Δ0]

This study

YCE 010

Mat alpha ctm1::KanMX his3Δ1 leu2Δ0 ura3Δ0 [met15Δ0
and/or lys2Δ0]

This study
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YCE 012

Mat alpha rkm1::KanMX his3Δ1 leu2Δ0 ura3Δ0
[met15Δ0 and/or lys2Δ0]

This study

YCE 014

Mat alpha rkm3::KanMX his3Δ1 leu2Δ0 ura3Δ0
[met15Δ0 and/or lys2Δ0]

This study

YCE 016

Mat alpha dot1::KanMX his3Δ1 leu2Δ0 ura3Δ0 [met15Δ0
and/or lys2Δ0]

This study

YCE EH A2

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
pRM204(HHT2, FLAG-HHF2, CEN, TRP1)

This study

YCE EH A4

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
set1::KanMX pRM204(HHT2, FLAG-HHF2, CEN, TRP1) This study

YCE EH A6

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
set2::KanMX pRM204(HHT2, FLAG-HHF2, CEN, TRP1) This study

YCE EH A8

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
set3::KanMX pRM204(HHT2, FLAG-HHF2, CEN, TRP1) This study

YCE EH A10

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
set4::KanMX pRM204(HHT2, FLAG-HHF2, CEN, TRP1) This study

YCE EH A12

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
set5::KanMX pRM204(HHT2, FLAG-HHF2, CEN, TRP1) This study

YCE EH B2

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
set6::KanMX pRM204(HHT2, FLAG-HHF2, CEN, TRP1) This study

YCE EH B4

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
rkm4::KanMX pRM204(HHT2, FLAG-HHF2, CEN,
TRP1)

This study

101 | P a g e

YCE EH B6

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
efm1::KanMX pRM204(HHT2, FLAG-HHF2, CEN,
TRP1)

This study

YCE EH B8

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
rkm3::KanMX pRM204(HHT2, FLAG-HHF2, CEN,
TRP1)

This study

YCE EH B10

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
dot1::KanMX pRM204(HHT2, FLAG-HHF2, CEN,
TRP1)

This study

YCE EH B12

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
hmt1::KanMX pRM204(HHT2, FLAG-HHF2, CEN,
TRP1)

This study

YCE EH C2

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
rmt2::KanMX pRM204(HHT2, FLAG-HHF2, CEN,
TRP1)

This study

YCE EH C4

Mata his3Δ200 leu2Δ1 lys2Δ0 met15Δ0 ura3-167 trp1Δ63
ade2::his (hht1-hhf1)::natMX (hht2-hhf2)::hygMX
RDN1::mURA3/HIS3 RDN1::Ty1-MET15 TELV::ADE2
hsl7::KanMX pRM204(HHT2, FLAG-HHF2, CEN,
TRP1)

This study

YKI071

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pRM204(HHT2, HHF2,
CEN, TRP1)

This study

YWD193

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pWD93(pRM204 HHT2,
hhf2 K20R, CEN, TRP1)

This study

YCE019

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) rkm2::KanMX

This study

YCE082

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE007(pRM204 HHT2,

This study
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hhf2 K20R, CEN, TRP1) pBY011(GALprom, Gateway,
CEN, URA3)

YCE083

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, Gateway, CEN,
URA3)

This study

YCE084

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, SET1, CEN,
URA3)

This study

YCE085

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, SET5, CEN,
URA3)

This study

YCE086

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, SET6, CEN,
URA3)

This study

YCE087

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, RKM4, CEN,
URA3)

This study

YCE088

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, CTM1, CEN,
URA3)

This study

YCE089

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, RKM1, CEN,
URA3)

This study

YCE090

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, RKM2, CEN,
URA3)

This study

YCE091

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, RKM3, CEN,
URA3)

This study

YCE092

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,

This study
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HHF2, CEN, TRP1) pBY011(GALprom, EFM1, CEN,
URA3)

YCE093

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, HMT1, CEN,
URA3)

This study

YCE094

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, RMT2, CEN,
URA3)

This study

YCE095

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, HSL7, CEN,
URA3)

This study

YCE096

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, JHD1, CEN,
URA3)

This study

YCE097

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, RPH1, CEN,
URA3)

This study

YCE098

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, GIS1, CEN,
URA3)

This study

YCE099

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBY011(GALprom, ELP3, CEN,
URA3)

This study

YCE074

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1)

This study

YCE075

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE007(pRM204 HHT2,
hhf2 K20R, CEN, TRP1)

This study

YCE102

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 KanMX6:pGAL-SET2
pCE001(pRM204 HHT2, HHF2, CEN, TRP1)

This study
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YCE103

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 KanMX6:pGAL-DOT1
pCE001(pRM204 HHT2, HHF2, CEN, TRP1)

This study

YCE104

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 KanMX6:pGAL-SET3
pCE001(pRM204 HHT2, HHF2, CEN, TRP1)

This study

YKI161

Mata his3D200 leu2D1 ura3-52 trp1DhisG
KanMX:pGAL-RPH1

This study

YKI163

Mata his3D200 leu2D1 ura3-52 trp1DhisG
KanMX:pGAL-JHD1

This study

YKI165

Mata his3D200 leu2D1 ura3-52 trp1DhisG
KanMX:pGAL-JHD2

This study

YKI167

Mata his3D200 leu2D1 ura3-52 trp1DhisG
KanMX:pGAL-ECM5

This study

YKI169

Mata his3D200 leu2D1 ura3-52 trp1DhisG
KanMX:pGAL-GIS1

This study

YCE123

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pBM272-Empty

This study

YCE124

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pCE029(pBM272 pGAL, SET4,
CEN, URA3)

This study

YCE125

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1) pCE030(pBM272 pGAL, SET4,
CEN, URA3)

This study

Fig. 4

Genotype

Source

YWD 1000

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2

Dang, W.,
2009

YWD 1120

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 hhf2 K20R

This study

Figure 5A, S5

Genotype

Source

YCE UD1

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE001(pRM204 HHT2, HHF2, CEN, TRP1)

This study
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YCE UD2

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE005(pRM204 HHT2, hhf2 K20A, CEN,
TRP1)

This study

YCE UD3

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE007(pRM204 HHT2, hhf2 K20R, CEN,
TRP1)

This study

YCE UD4

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE014(pRM204 hht2 K79R, HHF2, CEN,
TRP1)

This study

YCE UD5

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE016(pRM204 hht2 K79R, hhf2 K20R,
CEN, TRP1)

This study

YCE UD6

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE018(pRM204 HHT2, hhf2 K16R, CEN,
TRP1)

This study

YCE UD7

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE019(pRM204 HHT2, hhf2 K16R K20R,
CEN, TRP1)

This study

YCE UD8

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE020(pRM204 HHT2, hhf2 K16Q, CEN,
TRP1)

This study

YCE UD9

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hml::URA3 pCE021(pRM204 HHT2, hhf2 K16Q K20R,
CEN, TRP1)

This study

YCE UA1

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE001(pRM204
HHT2, HHF2, CEN, TRP1)

This study

YCE UA2

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE005(pRM204
HHT2, hhf2 K20A, CEN, TRP1)

This study
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YCE UA3

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE007(pRM204
HHT2, hhf2 K20R, CEN, TRP1)

This study

YCE UA4

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE014(pRM204
hht2 K79R, HHF2, CEN, TRP1)

This study

YCE UA5

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE016(pRM204
hht2 K79R, hhf2 K20R, CEN, TRP1)

This study

YCE UA6

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE018(pRM204
HHT2, hhf2 K16R, CEN, TRP1)

This study

YCE UA7

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE019(pRM204
HHT2, hhf2 K16R K20R, CEN, TRP1)

This study

YCE UA8

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE020(pRM204
HHT2, hhf2 K16Q, CEN, TRP1)

This study

YCE UA9

MATa ade2::hisG his3Δ200 leu2Δ0 lys2Δ0 met15Δ0
trp1Δ63 ura3Δ0 adh4::URA3-TEL-VIIL ADE2-TEL-VR
hhf2-hht2::MET15 hhf1-hht1::LEU2 pCE021(pRM204
HHT2, hhf2 K16Q K20R, CEN, TRP1)

This study

YCE UC1

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE001(pRM204 HHT2, HHF2, CEN, TRP1)

This study

YCE UC2

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE005(pRM204 HHT2, hhf2 K20A, CEN,
TRP1)

This study

YCE UC3

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE007(pRM204 HHT2, hhf2 K20R, CEN,
TRP1)

This study
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YCE UC4

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE014(pRM204 hht2 K79R, HHF2, CEN,
TRP1)

This study

YCE UC5

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE016(pRM204 hht2 K79R, hhf2 K20R,
CEN, TRP1)

This study

YCE UC6

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE018(pRM204 HHT2, hhf2 K16R, CEN,
TRP1)

This study

YCE UC7

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE019(pRM204 HHT2, hhf2 K16R K20R,
CEN, TRP1)

This study

YCE UC8

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE020(pRM204 HHT2, hhf2 K16Q, CEN,
TRP1)

This study

YCE UC9

MATa ade2 his3 trp1 leu2 lys2 ura3 met15 hhf1hht1::LEU2 hhf2-hht2::MET15 ADE2-TEL-VR
hmr::URA3 pCE021(pRM204 HHT2, hhf2 K16Q K20R,
CEN, TRP1)

This study

Figure 5B

Genotype

Source

YWD 1000

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2

Dang, W.,
2009

YWD 1120

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 hhf2 K20R

This study

YWD 1119

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 hhf2 K20A

This study

Figure 5C

Genotype

Source

BY4741

Mata his3Δ1 leu2Δ0 ura3Δ0 met15Δ0

Brachmann,
C.B., 1998

W1588-4C

Mata RAD5 leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15

Thomas,
B.J., 1989

Figure S2

Genotype

Source
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FY1716

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pDM1(HHT2, HHF2,
CEN, URA3)

Nathan, D.,
2006

YWD193

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pWD93(pRM204 HHT2,
hhf2 K20R, TRP1, CEN)

This study

YWD 1000

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2

Dang, W.,
2009

YWD 1120

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 hhf2 K20R

This study

Figure S6

Genotype

Source

YWD 1000

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2

Dang, W.,
2009

YWD 1120

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 hhf2 K20R

This study

YWD 1119

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 hhf2 K20A

This study

IPY36 (Isogenic
to SB301)

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG

Sterner,
D.E., 2002

TY44

Mata his3Δ200 leu2Δ1 ura3-52 trp1ΔhisG snf2::TRP1

Lo, W.S.,
2001

YCE074

Mata his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pCE001(pRM204 HHT2,
HHF2, CEN, TRP1)

This study

YWD 156

Mata his3D200 leu2Δ1 ura3-52 trp1Δ63 lys2-128d (hht1hhf1)::LEU2 (hht2-hhf2)::HIS3 pRM204(hht2 K56R,
HHF2, CEN, TRP1)

Dang, W.,
2009

YCE 365

Mata his3D200 leu2D1 ura3-52 trp1D63 lys2-128d (hht1hhf1)::LEU2 rad9::KanMX6

This study
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Supplementary Table S2. Antibodies used in this study. Millipore 04-735 was formerly
Upstate 05-735.
Catalog
Specificity

Company

No.

Notes

H4 K20me1

ABCAM

ab9051

Rabbit polyclonal

H4 K20me1

Millipore

04-735

Rabbit monoclonal

H4 K20me2

ABCAM

ab9052

Rabbit polyclonal

H4 K20me2

Millipore

07-747

Rabbit polyclonal

H4 K20me3

ABCAM

ab9053

Rabbit polyclonal

H4

ABCAM

ab31827

Mouse monoclonal

H4

Upstate / Millipore

05-858

Rabbit monoclonal

H3

ABCAM

ab1791

Rabbit polyclonal

FLAG

Sigma

A8592

HRP-conjugated mouse monoclonal

H3 K4me3

ABCAM

ab8580

Rabbit polyclonal

H3 K4me3

Upstate / Millipore

05-473

Rabbit polyclonal - No longer available

H3 K4me3

Active Motif

39159

Rabbit polyclonal

H3 K36me3

ABCAM

ab9051

Rabbit polyclonal

H3 K79me3

ABCAM

ab2621

Rabbit polyclonal

H4 K16 acetyl

Active Motif

39167

Rabbit polyclonal

Rabbit IgG

Bio-Rad

170-6515

HRP-conjugated goat monoclonal

Mouse IgG

Bio-Rad

170-6516

HRP-conjugated goat monoclonal
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Supplementary Table S3. Additional genes whose deletions do not abrogate H4
K20me1.
Systematic

Standard

Name

Name

YBR141c

-

YBR225w

-

YBR261c

TAE1

YOR239w

ABP140

YMR053c

STB2

YMR209c

-

YNL022c

-

YNL092w

-

YBR271w

-

YDR083w

RRP8

YHR209w

CRG1

YIL064w

SEE1

YJR129c

-

YLR455w

-
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Supplementary Figure S1. Alignment of histone H4 N-terminal sequences (residues 129) from several model organisms. Lysine 20 is present in boldface.

Supplementary Figure S2. H4 K20me2, 3 not detected by western analysis. Wholecell extracts (WCEs) from yeast with WT or K20R histone H4 were analyzed by
polyacrylamide gels, transferred to PVDF, and probed with antibodies. Calf thymus
histone H4 serves as a positive control. Strains and antibodies used are indicated
above and to the right of each blot.

Supplementary Figure S3. Deleting candidate genes individually does not change H4
K20me1 levels. (A, C, D) WCEs were analyzed by western analysis. (B) FLAG-H4 was
purified by FLAG-affinity purification after which WCEs and elutions were analyzed by
western analysis. Antibodies and strains are respectively indicated to the left of and
above each blot. FLAG or H4 levels are a loading control.

Supplementary Figure S4. Overexpressing candidate genes individually does not
change H4 K20me1 levels. (A) Candidate enzymes on plasmid pBY011 were
overexpressed using a galactose-inducible promoter. (B) Candidate enzymes were
overexpressed by driving the endogenous genes with a galactose-inducible promoter.
(C) Candidate SET4 on plasmid pBM272 was overexpressed using a galactoseinducible promoter. Endogenous RPH1 or JHD2 were overexpressed as a positive
control using a galactose-inducible promoter. WCEs were analyzed by western
analysis. Antibodies and strains are respectively indicated to the left of and above each
blot. H4 levels are a loading control.
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Supplementary Figure S5. Analysis of reporter expression in yeast with URA3-TELVIIL ADE2-TEL-VR (A) or URA3::hmr ADE2-TEL-VR (B). Dilutions of yeast with wildtype or mutant histones were grown on synthetic complete (SC), SC-URA, or SC+5FOA
media. Media and strains are indicated above and to the right of each plate respectively.
Increased growth on SC-URA media and decreased growth on SC+5FOA media
compared to SC media indicate increased URA3 expression. White and red yeast
coloration respectively indicates ADE2 expression and silencing.

Supplementary Figure S6. Dilutions of WT or mutant yeast were grown under nonstress or various stress-inducing conditions. Conditions and strains are indicated above
and to the left of each plate respectively. H3 K56R, snf2, and rad9 strains are
positive controls for phenotypes.
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Section 4

Additional Results

H4 K20ME1 AND THE CELL CYCLE
H4 K20me1 abundance is cell cycle-regulated in mammals
Mammalian H4 K20me1 and its HMT Set8 are thought to participate in the cell cycle;
their abundance is lowest in S phase, becomes highest in G2-M phases, and decreases
upon return to G1 phase. We note that some reports failed to observe any cell cycle
pattern (Tardat, M., 2010; Karachentsev, D., 2007) and low abundance during S phase
is counterintuitive considering reports of Set8 interactions with PCNA during replication
(Huen, M.S., 2008; Jørgensen, S., 2007; Tardat, M., 2007). Many reports however
using mass spectrometry, western analyses, and fluorescently-labelled overexpressed
Set8, agree on the cell cycle abundance pattern (Oda, H., 2010; Wu, S., 2010; Abbas,
T., 2010; Pesavento, J.J., 2008; Brustel, J., 2011). This pattern results from Set8
degradation and H4 K20me1 demethylation during S phase by the CLR4(ctd2) ubiquitin
ligase and PHF8 demethylase, and by Set8 degradation during late M phase by the
APC/C ubiquitin ligase (Centore, R.C., 2010; Abbas, T., 2010; Liu, W., 2010; Wu, S.,
2010). A recent model proposes that this pattern restricts its different functions to the
right times (Brustel, J., 2011). For example, H4 K20me1 reportedly promotes replication
origin licensing (Tardat, M., 2010). Low levels at S phase and high levels at G2-M
phases would thus restrict licensing to after replication. Likewise H4 K20me1 reportedly
represses some replication-related genes (Abbas, T., 2010; Liu, W., 2010). Low levels
at S phase would thus derepress these genes during DNA replication. Set8 and H4
K20me1 thus play important roles in the mammalian cell cycle. However, many details
remain to be discovered and whether Set8’s methylation of histones is the actual
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mechanism is difficult to know. We thus asked whether S. cerevisiae H4 K20me1 is
similarly cell cycle-regulated.

No evidence for H4 K20me1 variation during the S. cerevisiae cell cycle
To determine whether S. cerevisiae H4 K20me1 levels change during the cell cycle, we
blocked yeast in G1 phase with Alpha Factor, G2-M phases with Nocodazole, and S
phase with Hydroxyurea and checked modification levels by western analysis (Fig. 1).
Cdc28 was similarly abundant in the different phases as expected whereas Clb2, a G2M marker, was most abundant with Nocodazole treatment and undetectable with Alpha
Factor treatment. WCEs were then loaded into protein gels to achieve similar total H4
levels and H4 K20me1 levels were checked relative to this. Unexpectedly, H4 K20me1
levels normalized to total H4 levels did not reproducibly show convincing cell cycle
patterns. Similar results were seen with an Alpha Factor block and release (data not
shown) in which cells were released from a G1 block and H4 K20me1 levels were
checked periodically for at least one cell cycle. H4 K20me1’s cell cycle regulation thus
may not be conserved in S. cerevisiae. Finding the responsible enzyme will be helpful in
confirming this by observing its cell cycle pattern. To ask whether H4 K20me1 regulates
cell cycle progression, we will determine whether H4 K20R substitutions cause cell cycle
progression delays.

H4 K20ME1 AND DNA DAMAGE
Mammalian H4 K20me1 and the DNA damage response
There is evidence that mammalian H4 K20me1 may function in the DNA damage
response, although this role has not been extensively studied. Mouse embryonic stem
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cells in culture lacking Set8 have increased DNA damage. While this may result from
replication defects, it may also occur independently of this (H2AXphos foci do not
generally colocalize with EdU foci and do occur in both EdU-positive and negative cells)
(Oda, H., 2009). Further, Set8, H4 K20me1, and 53BP1 (a DNA damage reponse
protein) foci colocalize at laser-induced DNA damage sites. Set8 and H4 K20me1 are
necessary for and precede 53BP1 recruitment and importantly, SILAC experiments
reported that 53BP1 in mammalian cells preferentially bound H4 K20me1 rather than H4
K20me2 peptides (Oda, H., 2010). While H4 K20me2 is generally considered the
preferential in vitro target of 53BP1’s tandem tudor domains (Botuyan, M.V., 2006), H4
K20me1 thus may also directly recruit 53BP1 in vivo. H4 K20me1’s role in the DNA
damage response is not well-studied however and whether H4 is Set8’s main or only
target in this process is unknown. We note that S. pombe H4 K20R substitutions and
deletions of its HMT SET9 abrogate H4 K20me1-3 and Crb2 recruitment (53BP1
ortholog) and cause DNA damage sensitivity, but the in vivo roles of each methyl state
are unknown (Sanders, S.L., 2004). We therefore asked whether S. cerevisiae H4
K20me1 is linked to the DNA damage response.

Synthetic effects with H4 K20R substitutions
We asked whether S. cerevisiae H4 K20me1 loss affects survival during DNA damage.
Wild-type and H4 K20 substitution strains grew similarly with DNA damage-inducing
agents (Fig. 2A, B, and the manuscript). Since functional redundancies can prevent
individual mutations from revealing phenotypes, we checked whether H4 K20R
substitutions combined with substitutions of histone residues linked to the DNA damage
response would reveal phenotypes. H3 K79 methylation is implicated in the DNA
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damage response (Nguyen, A.T., 2011) however, neither UV light, Camptothecin, nor
Hydroxyurea caused growth differences between H3 K79R and H4 K20R double
substitution strains relative to wild-type or single substitution strains (Fig. 2B).
Rtt109 acetylates newly synthesized H3 on K56 during S phase and this is
needed for survival during DNA damage (Masumoto, H., 2005; Han, J., 2007). We
therefore asked whether an H3 K56R and H4 K20R double substitution would reveal a
DNA damage phenotype. As reported, H3 K56R yeast grew poorly compared to wildtype yeast with Camptothecin treatment but not with vehicle alone (Fig. 2A). H4 K20R
substitutions caused no growth changes compared to wild-type yeast with either
Camptothecin or vehicle alone (Fig. 2A-C). Interestingly, while the combinatorial
substitution and H3 K56R strains grew similarly with vehicle alone, the combinatorial
strains grew moderately (~5-fold) better than the H3 K56R strains with Camptothecin
treatment (Fig. 2C). The H4 K20R substitution thus moderately rescues the H3 K56Rmediated Camptothecin-sensitivity.

A Possible Role in Survival During DNA Damage
It is intriguing that the H4 K20R and H3 K56R substitutions demonstrated a synthetic
effect (Fig. 2C) since this argues that H4 K20me1 may participate in the DNA damage
response in S. cerevisiae. It is more intriguing however that the synthetic effect was a
moderate rescue of the H3 K56R-mediated DNA damage sensitivity. Since H3 K56ac
promotes survival upon DNA damage, these results suggest that H4 K20me1 negatively
contributes to this process, opposing H3 K56ac’s function. That a synthetic effect was
not revealed with H3 K79R and H4 K20R combinatorial substitutions (Fig. 2B) argues
that this was not simply due to having multiple mutations present.

121 | P a g e
The combinatorial H3 K56R and H4 K20R substitutions have only been tested
extensively with Camptothecin. Camptothecin is a topoisomerase poison that binds to
type 1 topoisomerases such that they cleave a single DNA strand but fail to ligate it.
These single-stranded nicks may be converted to double-stranded DNA breaks during
replication by translocating replication forks (Li, T.K., 2001). The H4 K20R substitution
thus moderately rescues H3 K56R-mediated sensitivity to, most likely, double-stranded
DNA breaks that occur during S phase. Whether H4 K20me1 also participates in repair
of bases damage by UV light or alkylating agents, or double-stranded breaks that are
detected outside of S phase, remains to be seen. In addition, since topoisomerases
could affect other processes that are dependent on DNA topology, we cannot rule out
that the H4 K20R and H3 K56R synthetic effects with Camptothecin treatment are linked
to these other pathways. We are inclined to think however that DNA repair during S
phase is the relevant pathway since H3 K56ac is closely linked to this process.

Future studies of H4 K20me1 during DNA damage induction
To further examine H4 K20me1’s link to DNA damage, we will ask if a combinatorial H4
K20R and rtt109 deletion strain has a similar synthetic effect and if synthetic effects also
occur with other DNA damaging agents. This will indicate what types of damage repair
H4 K20me1 is linked to and whether topoisomerases’ role in double-stranded DNA
break creation is the mechanism. To investigate the mechanism of H4 K20me1’s
contribution, we will ask whether H4 K20me1 levels change globally or locally upon DNA
damage induction and whether H4 K20R substitutions cause defective H2AX
phosphorylation and recruitment of DNA damage repair proteins.
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METHODS
Cell cycle blocking experiments
Yeast grown in YPD were treated with cell cycle-blocking reagents after which they were
washed in PBS and frozen dry. Yeast treated with 15µg/mL Nocodazole (Sigma M1404)
were harvested after 75 minutes; G2/M-characteristic yeast budding was checked by
light microscopy. Yeast treated with 10µg/mL Alpha Factor Mating Pheromone (Sigma
T-6901) were harvested after at least 2 hours; Shmoo morphology was checked by light
microscopy. Yeast treated with 200mM Hydroxyurea were harvested after 1 hour, 2
hours, and 3 hours. Western blots for Cdc28 (Santa Cruz sc-6709; does not vary during
the cell cycle) and Clb2 (Santa Cruz sc-9071; highest at G2/M and lowest at G1)
confirmed cell cycle blocks. Westerns to check H4 K20me1 levels were run such that
similar total H4 amounts were loaded into each lane. Other westerns were run
normalized to total WCEs.
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Figure 1. H4 K20me1 levels do not vary during the cell cycle. Yeast were treated with
10µg/mL Alpha Factor Mating Pheromone (blocks in G1), 15µg/mL Nocodazole (blocks
in G2/M), 200mM Hydroxyurea (blocks in S phase), or not treated (mixed population).
Whole-cell extracts (WCEs) were analyzed by Western blot and probed for total H4, H4
K20me1, B-Actin, Cdc28 (does not vary during cell cycle), and Clb2 (highest during
G2/M and lowest during G1). WT versus H4 K20R yeast are an antibody control. Total
H4 and H4 K20me1 are probed on blots containing 1x or 2x amounts of WCEs.
Samples and antibodies are respectively indicated above and to the left of each blot.

Figure 2. Assays for yeast growth during stress conditions. Dilutions of wild-type or
mutant yeast were spotted onto plates conferring various stresses. (A) H4 K20R and H4
K20A substitutions did not affect growth during various stress conditions. (B) H3 K79R
and H4 K20R did not demonstrate synthetic effects with DNA damage stress. (C) H4
K20R moderately rescued H3 K56R-mediated Camptothecin-sensitivity.
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DISSERTATION CHAPTER 4
NuA4 Acetylation of Spt16 in Saccharomyces cerevisiae

ABSTRACT
Lysine acetylation occurs on histones and participates in most chromatin-related
processes. It is increasingly clear however that this modification occurs on non-histone
proteins, influences their functions, and is sometimes regulated by the same
acetyltransferases and deacetylases that control histone acetylation. To gain insight into
the repertoire and role of S. cerevisiae non-histone chromatin lysine acetylations, we
investigated Spt16 acetylation by the NuA4 acetyltranferase complex. Spt16
heterodimerizes with Pob3 to function as the yFACT complex. yFACT is essential and
interacts with histones in multiple processes, the most well-studied of which is
modulating nucleosome structure during transcription elongation. We find that NuA4
acetylates Spt16 in vitro and mass spectrometry determined that Spt16 overexpressed
in S. cerevisiae was acetylated at lysines 483, 583, and 607. Loss of these acetylations
by KR substitutions was not lethal and did not demonstrate defects in intragenic
transcription initiation suppression or growth defects in stress conditions. Importantly,
KR substitutions caused moderate heat-sensitivity at 39 oC whereas KQ
substitutions did not, arguing that this phenotype results from loss of acetylations rather
than loss of the lysines or other modifications. The mechanism of Spt16 acetylationmediated heat-tolerance is under investigation.
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INTRODUCTION
Lysine can be acetylated on the epsilon nitrogen of its side chains. This process is
proposed to involve deprotonation of the amine group’s hydrogen, resulting in the
nitrogen attacking the carbonyl carbon of an acetyl coenzyme-A molecule. The result is
an acetyl group covalently bound to the epsilon nitrogen by its carbonyl carbon,
increasing the lysine side chain’s size, adding a polar carbonyl group, and reducing its
net charge from positive to neutral. This modification thus extensively alters the
residue’s chemistry and in turn, its ability to bind other proteins, its interactions with DNA
(if in a nucleosome), and the structure of the protein of which it is a part (Berndsen, C.E.,
2008).
Lysine acetylation is most well-studied on histones in chromatin. This
modification occurs on numerous residues of all four core histones within chromatin and
on several residues on free histones. (Millar, C.B., 2006) This is connected to histone
deposition, DNA-binding, reader recruitment, and chromatin structure (Shogren-Knaak,
M., 2006). Depending on when it is created, where in the genome it is enriched, and on
which residue and histone it is located, this modification can impact virtually every
chromatin-related process.
Considering its ability to diversify the structure and modulate the function of
histones, it is no surprise that lysine acetylation is increasingly indentified on non-histone
proteins. For example, the mammalian chaperone Hsp90 works to adjust the folding of
client proteins as a dynamic complex with other heat-shock proteins and its acetylation
influences this. (Yu, X., 2002; Kovacs, J.J., 2005) The tumor suppressor p53 is
acetylated at multiple residues and this affects its transcription upregulation activity
(Bode, A.M., 2004). Numerous metabolic enzymes in the human liver are acetylated
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(Zhao, S., 2010). Acetylation also occurs on Ku70, alpha-tubulin, Cortactin, CPS1, betacatenin, GDH, LXR, Foxo1, and eNOS, impacting many biological processes. (Close,
P., 2010; Yang, X.J., 2008) This is however a small fraction of the proteome and many
more acetylations likely exist. A better understanding of them is necessary to fully
understand the regulatory mechanisms that govern the cell’s many pathways.
Importantly, knowledge of the acetylome may allow biological or pharmacological
modulators of acetylation to be used for combating diseases involving these pathways
(Wanczyk, M., et. al. 2011).
The transfer of an acetyl group to histone lysines is catalyzed by histone
acetyltransferases (HATs). These enzymes operate as components of multi-subunit
complexes whose subunits can influence their enzymatic activity, promote enrichment
within parts of the cell and along regions of the genome, allow recruitment to target
proteins, allow binding to nucleosomes (in the case of histone acetylation), and confer
residue specificity. These HATs and the complexes in which they reside are often
conserved from yeast to humans (Lee, K.K., 2007).
One S. cerevisiae HAT is Essential Sas-family Acetyltransferase 1 (Esa1). One
of three MYST-family acetyltransferases, Esa1 resides within the Nucleosome
Acetyltransferase of Histone H4 (NuA4) complex along with twelve other subunits (Lee,
K.K., 2007; Doyon, Y., 2004). NuA4 acetylates histones H4 (K5, 8, 12, and 16), H2A,
and Htz1 within nucleosomes (Allard, S., 1999; Clarke, A.S., 1999; Keogh, M.C., 2006).
Esa1 also exists within the less studied Piccolo NuA4 complex, consisting of Esa1 and
two of the twelve NuA4 subunits (Lee, K.K., 2007). These two Esa1 complexes are
thought to differently target Esa1 along the genome, with NuA4 enriched at specific
locations such as active genes where it creates peaks of acetylation, and with Piccolo
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NuA4 spread out along the genome, creating untargeted basal acetylation (Friis, R.M.,
2009).
Esa1 is linked to many important processes. NuA4 and its H4 acetylation are
associated with gene expression and thought to be enriched at promoter regions of
transcribed genes (Doyon, Y., 2004), although it is recently been proposed that NuA4
also localizes to and acetylates H4 inside ORFs (Ginsburg, D.S., 2009). NuA4’s HAT
activity promotes in vitro transcription of nucleosomal DNA (Allard, S., 1999) and
acetylates Htz1 K14 to promote proper kinetochore function and mitotic chromosome
segregation (Keogh, M.C., 2006). NuA4 is linked to DNA damage repair; NuA4 mutants
are hypersensitive to DNA damage and NuA4 acetylation is needed for DNA damage
repair (Doyon, Y., 2004). Importantly, Esa1 is essential since its loss halts the cell cycle
within a few cell divisions (Clarke, A.S., 1999). Although this is its most prominent
phenotype, it is unknown what Esa1 must acetylate to prevent this.
While Esa1 has been studied in a mostly histone-oriented manner, it is becoming
clear that its acetylation is not limited to nucleosomes. An example of this was NuA4’s
acetylation of one of its own components, Yng2 (Lin, Y.Y., 2008). The possible extent of
its substrate repertoire was recently revealed using a proteome microarray in which S.
cerevisiae-purified NuA4 targeted 91 out of 5,800 budding yeast recombinant proteins in
vitro (Lin, Y.Y., 2009). One target, the gluconeogenesis enzyme Pck1, is acetylated by
NuA4 in vivo to regulate its enzymatic activity and in-turn, yeast chronological lifespan.
Another important target revealed by this screen is the histone-interacting protein
Suppressor of Ty 16 (Spt16). The gene encoding it was simultaneously and
independently identified as CDC68 (Cell Division Cycle 68), since mutant alleles confer
cell cycle defects, and SPT16, since mutant alleles suppress LYS2 and HIS4
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transcription inhibition caused by insertion of a Ty transposable element within the
promoter and 5’ region (Rowley, A., 1991; Malone, E.A., 1991). This suppression occurs
due to transcription initiation being relocated from the region disrupted by the Ty element
to a downstream location within the ORF, resulting in a 5’-truncated, but functional,
protein product (Malone, E.A., 1991).
Spt16 exists as a heterodimer with Pol1-Binder 3 (Pob3) and together they
constitute the yeast Facilitates Chromatin Transcription (yFACT) complex or Cdc68Pob3 (CP) complex (Wittmeyer, J., 1997; Wittmeyer, J., 1999). The DNA-binding, HMG
domain-containing protein Non-Histone Protein 6 (Nhp6) weakly interacts with Spt16 and
Pob3 to recruit them to chromatin and together, this heterotrimer is the Spt16-Pob3Nhp6 (SPN) complex (Formosa, T., 2001; Stillman, D.J., 2010). Like Esa1, yFACT is
essential (both components) and hypomorphic mutations cause slow-growth, a
decreased maximum permissive temperature (heat-sensitivity), and transcription and
DNA replication defects (Formosa, T., 2001), in addition to the suppressor of Ty (Spt)
phenotype described above. It is unknown however which Spt16 function is the
essential function that, when disrupted, results in inviability.
Studies of yFACT and its mammalian counterpart argue for a role in modulating
nucleosomes during transcription elongation. Nucleosomes are a physical obstacle to
translocating RNA polymerase 2; in vitro transcription by RNA polymerase 2 occurs on
naked DNA but not reconstituted chromatin (Pavri, R., 2006). However, they
simultaneously limit transcription initiation to places lacking nucleosomes.
Inappropriately open chromatin inside some yeast genes allows RNApol2 and
transcription factor recruitment to intragenic sequences that are favorable for
transcription initiation but normally obscured by histones, resulting in unintended
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transcripts (cryptic intragenic transcription initiation) (Carrozza, M.J., 2005; Keogh, M.C.
2005; Joshi, A.A., 2005; Li, B., 2007). Budding yeast and mammalian FACT resolve
these two issues by modulating nucleosome structure during transcription elongation
(independent of ATP, unlike remodellors), “loosening” their structure in-front of RNApol2
to allow translocation, and “tightening” their structure behind RNApol2 to maintain
appropriate levels of DNA accessibility (Belotserkovskaya, R., 2003; Fleming, A.B.,
2008; Xin, H., 2009). While this was thought to occur via the dissociation and
reassociation of an H2A-H2B dimer (Belotserkovskaya, R., 2003), recent work in S.
cerevisiae argues for a general structural reorganization of the nucleosome (Xin, H.,
2009).
Although this is FACT’s most well-known function, Spt16 is linked to other
processes as well. Early studies of yFACT identified association with a DNA polymerase
(Wittmeyer, J., 1997; Wittmeyer, J., 1999) and recent work argued that ubiquitylation of
Spt16 directs it towards interacting with replication factors (Han, J., 2010). Since
replication of chromatin DNA requires polymerase passage through nucleosomes, it
would not be surprising if Spt16 participates here similarly to as in transcription
elongation. Hypomorphic Spt16 mutants are heat-sensitive (Formosa, T., 2001), likely
due to altered structure or protein interactions such that an essential function is
compromised. Alternatively, Spt16 might function in induction of the heat-tolerance
genes. Finally, phosphorylation of H2AX and ADP-ribosylation of Spt16 in mammals
may respectively promote and inhibit H2AX-H2A exchange during DNA damage (Heo,
K., 2008).
Since Spt16 is essential and linked to important processes, its acetylation by
NuA4 is interesting for several reasons. First, its many functions imply that PTMs of
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Spt16 might be needed to coordinate its different roles and protein-interactions. This is
not surprising since ubiquitylation and ADP-ribosylation are proposed to respectively
affect its roles in DNA replication and DNA damage repair (Han, J., 2010; Heo, K.,
2008). Second, since NuA4 is linked to transcription, acetylation of Spt16 would imply a
mechanism for this function. Third, since ESA1’s essential function is unknown, and
since SPT16 is also essential, it may be that Esa1’s essential role in the cell is mediated
through Spt16. With these implications and the in vitro Spt16 acetylation by NuA4 in
mind, we sought to examine this acetylation in vivo and determine what role, if any, it
has.
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MATERIALS & METHODS
Generation of mutant spt16 plasmids and yeast strains
Plasmids containing wild-type or mutant SPT16 were created as follows. The Expand
High Fidelity PCR System (Roche) amplified a sequence from yeast genomic DNA
spanning 1kb upstream and 500bp downstream of SPT16+ that was then ligated into
pRS313 (CEN, ARS, TRP1) or pRS316 (CEN, ARS, URA3). QuikChange site-directed
mutagenesis (Agilent) sequentially created lysine substitutions (K493R K583R K607R
K608R or K493Q K583Q K607Q K608Q) in the pRS313-SPT16 vector after which
sequencing confirmed fidelity.
SPT16+, spt16 KR, and spt16 KQ strains were created using the Delitto
Perfetto two-step gene replacement system (Storici, F., 2006). Briefly, yeast with a Cterminal 3xFLAG:KanMX cassette integrated at endogenous SPT16 were made diploid
using a plasmid expressing the HO endonuclease after which an HPH-GAL1prom-p53
V122A Delitto Perfetto cassette was inserted within one of the SPT16 ORFs,
inactivating, it, but not knocking it out. pRS316 (CEN, ARS, URA3) containing SPT16+
with flanking regions described above was transformed into these yeast and spores
were isolated that contained plasmid-based SPT16+ and genomic SPT163xFLAG:KanMX that was inactivated by the inserted Delitto Perfetto cassette. PCR
products spanning the SPT16 region containing the insert and having wild-type, KR, or
KQ sequences were amplified from the pRS313 plasmids and transformed into these
yeast. Yeast were grown on YP+Galactose plates to induce the p53 V122A
counterselectable marker (selects for yeast that lost the Delitto Perfetto cassette that
was inserted into the genomic SPT16), then SC+5FOA plates (selects for yeast that lost
the SPT16+-bearing plasmid). Yeast were further grown on YPD plates containing
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Hygromycin (indicates whether the HPH marker within the Delitto Perfetto cassette is
present), SC-URA plates (indicates whether the SPT16+-bearing plasmid is present),
and YPD plates containing G418 (indicates whether the C-terminal 3xFLAG:KanMX
cassette that was at the genomic SPT16 is present) and sequencing confirmed that the
genomic SPT16 sequence was wild-type, KR, or KQ, and contained the C-terminal
3xFLAG tag. The resulting strains contained the endogenous SPT16 with a C-terminal
3xFLAG:KanMX cassette and either wild-type, K493R K583R K607R K608R, or K493Q
K583Q K607Q K608Q sequences. Yeast with SPT16+, spt16 KR, or spt16 KQ with
his4-912 and lys2-128 were created similarly as above but starting with endogenous
SPT16+ without a C-terminal tag.

Identification of acetyllysines by mass spectrometry
Spt16 was purified from yeast and acetyllysines were identified by mass spectrometry by
Heng Zhu’s laboratory as previously described (Lin, Y.Y., 2009).

In vitro acetyltransferase reactions
In vitro acetyltransferase reactions were performed using yeast-purified NuA4,
bacterially-purified substrates, and C14 acetyl coenzyme-A. Reactions were fractionaited
on a protein gel and radiation was detected by X-ray film. All work was performed by
Wendy Walter.

Yeast phenotype analyses
Assays were performed as in chapter three. Sensitivity to 39 oC was performed by either
putting plates into 30 oC incubators and then slowly raising the temperature to 39 oC or
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putting plates into 39 oC incubators with the plates arranged in stacks with unused plates
on the top and bottom of the stacks. The was to make the temperature increase gradual
rather than quick. Yeast’s response to increased temperature depends on many factors
including the magnitude of the change and whether the yeast were switched directly to
the higher temperature or given time to adapt to a medium temperature first (Yamamoto,
N., 2008). For these reasons, we found it necessary to expose the yeast to 39 oC
gradually as described above rather than sharply and doing otherwise often resulted in
all the yeast growing too poorly to see convincing growth phenotypes.

Detection of cryptic intragenic transcription initiation
SPT16+, spt16 KR, and spt16-197 yeast were grown at 30 oC or one hour at 39 oC
after which total RNA was harvested and converted to cDNAs as described in chapter
three. Random hexamers were from the Taqman Reverse Transcriptase kit. cDNAs
were analyzed as described in chapter three. mRNA levels were checked with primers
specific for the 3’ or 5’ end and 3’:5’ ratios were determined. Increased cryptic intragenic
transcription initiation in one sample versus another would produce more mRNAs along
the 3’ than 5’ end of the gene resulting in a larger 3’:5’ ratio.
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RESULTS
In vitro & In vivo Evidence for Spt16 Acetylation
The proteome microarray is constructed with yeast-derived proteins (acetyltransferase
activity may have co-purified with them) and the acetyltransferase reactions in the
screen thus occur on an array (the surface may affect the enzyme’s or substrates’
conformation and reactivity) (Lin, Y.Y., 2009). Post-doctoral researchers in Shelley
Berger’s laboratory therefore followed-up traditional (in solution) in vitro acetylation
reactions with C14 acetyl-coenzyme A, yeast-purified NuA4, and bacterially-purified
recombinant proteins identified from the proteome microarray. Reactions were
fractionaited with a protein gel after which X-ray film detected radioactivity (Figure 1A).
All reactions containing substrates, including r. Spt16, had radioactive bands that were
absent in NuA4-only reactions and corresponded to their substrates’ expected sizes.
To determine which Spt16 lysines are acetylated, researchers in Heng Zhu’s lab
purified overexpressed Spt16 from S. cerevisiae and used mass spectrometry to identify
acetyllysines as previously described (Lin, Y.Y., 2009). Lysines 493, 583, and 607 were
identified as being acetylated (Figure 1B). Since these three sites are clustered around
the middle of Spt16, we wondered what significance this regions holds. Despite this
protein’s importance, there is limited understanding of what regions contribute to what
function. Hypomorphic mutations created by random mutagenesis are not confined to
distinct regions of Spt16 and these mutations’ phenotypes generally do not correlate with
their locations (Formosa, T., 2001). Spt16 can be organized into N-terminal, middle, and
C-terminal folding domains, a region within the middle of the protein is necessary and
sufficient for heterodimerization with Pob3 (O’Donnell, A.F., 2004; VanDenmark, A.P.,
2006), and the N-terminal region contains a histone tail-binding, catalytically inactive,
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aminopeptidase domain that is dispensable for nucleosome binding and cell viability
(VanDenmark, A.P., 2008). Interestingly, all three acetyllysines reside within or adjacent
to the Pob3-heterodimerization domain (Figure 1B) and thus might affect Pob3interactions and in turn, Spt16’s functions.

Functional Analyses of spt16 KR Substitution Strains
To determine if these acetyllysines influence Spt16’s functions, we generated yeast
strains in which the genomic SPT16 was mutated to convert the three lysines to
unacetylatable arginines. Since acetyllysines can sometimes exert their effects in a
synergistic fashion (Yang, X.J., 2008), we chose to examine simultaneous substitutions
of all three lysines (spt16 K493R K583R K607R K608R; spt16 KR). K608 was
mutated in-case it gets targeted in the absence of K607. The spt16 KR mutant strain
was viable and grew similarly to the SPT16+ strain at 30 oC (Figure 2A, B) and similar
results were seen with a SPT16 plasmid shuffle strain (data not shown). To test whether
acetylation participates in Spt16’s known functions, we compared growth of SPT16+ and
spt16 KR strains under stress conditions. We checked growth with galactose as the
carbon source or without arginine since Spt16 participates in transcription of GAL1
(Fleming, A.B., 2008) and arginine synthesis genes (Ginsburg, D.S., 2009), growth with
Hydroxyurea since Spt16 is linked to DNA replication (Wittmeyer, J., 1997; Wittmeyer,
J., 1999; Han, J., 2010), and growth with UV light. Wild-type and mutant yeast grew
similarly in all these conditions (Figure 2A, B).
Since yFACT participates in transcription elongation, in-part to maintain sufficient
intragenic compaction (Fleming, A.B., 2008), we checked whether spt16 KR yeast
haveincreased intragenic cryptic transcription initiation. The temperature-sensitive yeast

138 | P a g e
strain spt16-197 (G132D) had increased intragenic transcription initiation at four genes
at 39 oC, indicated by increased 3’ versus 5’ qPCR signals at those mRNAs (Figure 3).
The spt16 KR allele however did not produce detectable intragenic transcripts at these
genes. Since Spt16 mutations confer the spt phenotype (suppression of LYS2 and HIS4
transcription defects resulting from Ty element insertions at their promoters) (Malone,
E.A., 1991), we asked whether the spt16 KR allele confers such an effect. The spt
phenotype can be assessed using yeast where a Ty element insertion in the LYS2 and
HIS4 5’ regions inhibits their transcription, causing dependence on lysine and histidinesupplemented media. While the spt16-197 allele in this strain rescued lysine and
histidine auxotrophy, the spt16 KR allele caused no such effect (data not shown).

Analyses of spt16 KR Substitution Strain Heat-Sensitivity
Since many SPT16 mutations are sensitive to elevated temperatures (Formosa, T.,
2001), we checked whether loss of these acetylatable lysines conferred heat sensitivity.
Compared to SPT16+ yeast, spt16 KR yeast grew similarly well at 37 oC (Figure 2A)
but less well at 39 oC (Figure 2B, C). Importantly, yeast with these lysines changed to
the acetyllysine-mimic glutamine (spt16 K493Q K583Q K607Q K608Q; spt16 KQ) did
not demonstrate a growth defect relative to SPT16+ yeast at 39 oC (Figure 2B, C),
arguing that the spt16 KR heat-sensitivity resulted from loss of acetylation rather than
loss of the lysines or unidentified non-acetyl modifications at these sites.
There are several ways that Spt16 acetylation loss at these sites could cause
temperature-sensitivity. Since yFACT participates in transcription, loss of Spt16
acetylation could compromise the induction of heat-shock response genes, leading to
defective heat-tolerance. Alternatively, since yFACT is thought to participate in
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transcription initiation and elongation of many genes and DNA replication, specific
interactions involving Spt16 that are necessary for these processes but sensitive to high
temperatures might be compromised at 39 oC if not for stabilizing effects by the
acetylation. Similarly, Spt16’s general structure might be compromised at 39 oC, leading
to general loss-of-function, if not for stabilization by the acetylation. Considering that
Spt16 functions as a heterodimer with Pob3 and that all three acetyllysines reside at or
adjacent to the Pob3-interaction region, it is possible that this critical interaction is
dependent on these acetylations to maintain integrity at 39 oC.
We first asked whether the spt16 KR allele confers defective upregulation of
heat-response genes during growth at 39 oC. Yeast respond to elevated temperatures
by several mechanism, one of which is the induction of genes whose products help the
cell resist the detrimental effects of excess heat (Yamamoto, N., 2008). mRNA levels
were checked from SPT16+ or spt16 KR yeast that were grown at 30 oC or for 15, 30,
or 60 minutes at 39 oC. In wild-type yeast, SSA3, BTN2, FES1, and HSP78, Heat-Shock
Factor 1-targets that are upregulated in response to high temperatures, were induced by
15 minutes at 39 oC, whereas ACT1 and SWI6, genes not related to the heat-shock
response, showed no major changes in their mRNA levels (Figure 4). No differences
were observed however between these yeast and spt16 KR yeast in the levels of
these mRNAs.
To check whether the KR substitutions cause defects in particular Spt16
functions at elevated temperatures, we checked whether this mutant strain had
increased cryptic transcription initiation at elevated temperatures. While the spt16-197
strain had increased cryptic transcripts at 39 oC compared to at 30 oC or to wild-type
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strains at 39 oC, the spt16 KR strains had unchanged levels of intragenic transcription
initiation at four genes checked at 39 oC (Figure 3).

DISCUSSION
Spt16 Functional Regulation by Acetylation
To determine if loss of these acetylations compromises particular Spt16 functions, we
will ask if additional Spt16-regulated processes are defective with the KR substitutions
at 39 oC compared to wild-type strains. Although we have checked for spt16 KR’s
functionality at 39 oC in intragenic transcription initiation suppression, we have only
looked at a small number of genes. Numerous other cryptic transcripts exist (Li, B.,
2007) and an unbiased examination of intragenic transcription initiation would better
reveal the KR substitutions’ impact on yFACT’s regulation of intragenic DNA
accessibility genome-wide. Were Spt16 acetylation needed to maintain yFACT’s cryptic
transcription initiation suppression at high temperatures, the numerous inappropriate
transcriptions initiated at 39 oC due to the lack of acetylation might titrate out the
transcription machinery, or create a bottleneck in mRNA processing pathways,
compromising cell viability.
Another possibility is that the acetylation is needed at 39 oC for yFACT’s
nucleosome modulation activity that facilitates RNA polymerase passage. To examine
this, we will use ChIP to ask whether the decrease in intragenic histones that occurs
upon gene induction (Fleming, A.B., 2008) is compromised in KR versus wild-type
SPT16 yeast at 39 oC. As an alternative to checking histone levels by ChIP, we could
use MNase assays to observe changes in the chromatin compaction. Since yFACT is
linked to DNA replication and may have other roles, it is possible that the acetylation is
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needed for these functions at 39 oC. We also note that the decreased viability at 39 oC
with the KR substitutions may result from the combination of many impaired Spt16
functions. For example, defects in intragenic transcription suppression combined with
defects in RNA polymerase passage, DNA replication, and other Spt16 functions, might
lower viability.
Since all three acetyllysines reside in or around Spt16’s Pob3-heterodimerization
region (Figure 1B), these marks may influence this interaction, although whether these
residues lie at the Spt16-Pob3 interface is unclear due to a lack of yFACT structural
data. They might for example stabilize the Pob3 interaction in a way that is most
important during elevated temperatures. Were this true, yFACT would have decreased
integrity at 39 oC with the KR substitutions relative to wild-type Spt16, resulting in all its
functions being compromised. Another possibility is that the acetylations directly affect
Spt16’s structural stability, counteracting the destabilizing effects of heat.

Observing Acetylation of Endogenous Spt16
A critical remaining experiment is to observe these acetylations in vivo with endogenous
Spt16 levels (the mass spectrometry identified in vivo acetylation with overexpressed
SPT16). Three methods exist for identifying acetylations in vivo: mass spectrometry,
pan-acetyl antibodies, and site-specific acetyl antibodies. Mass spectrometry can
identify unknown sites but may require large amounts of protein. Pan-acetyl antibodies
can also detect unknown sites, but identifying the residues requires making potentially
many lysine substitution mutations and the binding can never be completely sequenceindependent meaning some acetylations might be missed. Site-specific antibodies have
sequence-specificity but take the longest time to acquire and must be generated for
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each acetylation. Our studies identified the sites via mass spectrometry analysis of
overexpressed yeast-purified proteins. We then attempted to confirm these acetylations
in vivo on endogenous Spt16 using pan-acetyl antibodies and the KR substitutions.
We purified total Spt16 by FLAG-affinity purification (genomic location with C-terminal
FLAG tag) and then did westerns with multiple pan-acetyl antibodies. Unfortunately,
these methods did not confirm the marks’ presence in vivo (data not shown). As
described above, site-specific acetyl antibodies may be necessary to confirm these
marks using endogenously expressed SPT16. Alternatively, since custom antibodies do
not always work, and since three such antibodies would need to be generated, mass
spectrometry could be utilized to confirm these marks if sufficient non-overexpressed
Spt16 were purified. We believe our work argues for the acetylations’ existence on
Spt16 at endogenous levels since the heat sensitivity with the KR substitutions was
not seen with the KQ substitutions.

Immediate Future Directions
Future studies of Spt16 acetylation will focus on confirmation of in vivo acetylation of
endogenous levels of Spt16 using mass spectrometry or site-specific anti-acetyllysine
antibodies. We note that if the cell requires these acetyllysines at 39 oC, then detection
may be necessary at elevated temperatures. To determine the mechanism of KRmediated heat-sensitivity, we will purify Spt16 and observe what in vivo interactions at
39 oC are altered by loss of acetylation. We will also check cryptic intragenic
transcription initiation in an unbiased fashion (expression microarrays), chromatin
structure at genes (MNase assays), and nucleosome modulation at genes (ChIPs for
total histones) between wild-type and Spt16 KR yeast at 39 oC to elucidate the
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mechanism. We believe that these continuing studies will increase the repertoire of
known non-histone chromatin acetylation targets, elucidate a role of NuA4, and reveal a
mechanism of regulation of an important chromatin protein.
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FIGURE LEGENDS
Figure 1. Spt16 acetylation
(A) Acetylation reactions were performed with yeast-purified NuA4, bacterially-purified
recombinant substrates, and radioactive acetyl-coenzyme A. Reactions were
fractionaited on a polyacrylamide gel and radioactivity was assessed by
autoradiography. Protein sizes and reactions are indicated to the left of and above each
gel. Red arrow indicates r. Spt16. (B) Map of Spt16 (1,035aa). Grey bar represents
Spt16. White boxes represent folding and Pob3-interaction domains as reported in
VanDenmark, A.P., 2008. Black boxes represent selected domains reported at
yeastgenome.org. Amino acids are indicated in parentheses. Arrows indicate
acetyllsyines.

Figure 2. Spt16 mutant growth assays
Serial dilutions of SPT16+, spt16 KR, or spt16 KQ yeast were spotted onto plates
with different growth conditions. KR indicates K493R K583R K607R K608R. KQ
indicates K493Q K583Q K607Q K608Q. (3) indicates K583, K607, and K608 mutated.
H3 versus H3 K56R, SPT16+ versus spt16 G132D, and ESA1+ versus esa1 L254P are
positive controls for stress conditions.

Figure 3. spt16 KR substitutions do not cause cryptic transcription initiation
Yeast with SPT16+ or spt16 K493R K583R K607R K608R were grown at 30 oC or 39 oC
after which total RNA was extracted. Ratios of levels of 3’ versus 5’ ends of mRNAs
indicate cryptic transcription initiation. Spt16 G132D strains have increased intragenic
transcription initiation at 39 oC.
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Figure 4. spt16 KR substitutions do not prevent heat-shock gene induction
Yeast with SPT16+ or spt16 K493R K583R K607R K608R were grown at 30 oC or 39 oC
after which total RNA was extracted.
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Table 1. Yeast strains used in this study.
Figure 2A

Genotype

Source

YCE345

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52
SPT16-3xFlag:KanMX

This study

YCE346

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K493, 583, 607, 608R-3xFlag:KanMX

This study

YCE348

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K493, 583, 607, 608Q-3xFlag:KanMX

This study

YCE349

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K583, 607, 608Q-3xFlag:KanMX

This study

YCE074

MATa his3200 leu21 ura3-52 trp163
lys(hht1-hhf1)::LEU2 (hht2-hhf2)::HIS3 with
pRM204 [HHT2, HHF2, CEN, TRP1]

This study

YCE127

MATa his3200 leu21 ura3-52 trp163
lys(hht1-hhf1)::LEU2 (hht2-hhf2)::HIS3
pCE024 [pRM204 hht2-K56R, HHF2 CEN, TRP1]

This study

FY56

Mat alpha his4-912 lys2-128 ura3-52

Malone,
E.A., 1991

L577

Mat alpha his4-912 lys2-128 ura3-52 spt16-197

Malone,
E.A., 1991

LPY3498

MATa his3200 leu2-3,112 trp11 ura3-52 ESA1

Clarke, A.S.,
1999

LPY3500

MATa his3200 leu2-3,112 trp11 ura3-52
esa1::HIS3 esa1-L254P:URA3

Clarke, A.S.,
1999

Figure 2B

Genotype

Source

YCE345

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52
SPT16-3xFlag:KanMX

This study

YCE346

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K493, 583, 607, 608R-3xFlag:KanMX

This study

YCE348

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K493, 583, 607, 608Q-3xFlag:KanMX

This study
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YCE349

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K583, 607, 608Q-3xFlag:KanMX

This study

Figure 2C

Genotype

Source

YCE345

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52
SPT16-3xFlag:KanMX

This study

YCE346

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K493, 583, 607, 608R-3xFlag:KanMX

This study

YCE348

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K493, 583, 607, 608Q-3xFlag:KanMX

This study

Figure 3

Genotype

Source

FY56

Mat alpha his4-912 lys2-128 ura3-52

Malone,
E.A., 1991

L577

Mat alpha his4-912 lys2-128 ura3-52 spt16-197

Malone,
E.A., 1991

YCE345

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52
SPT16-3xFlag:KanMX

This study

YCE346

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K493, 583, 607, 608R-3xFlag:KanMX

This study

Figure 4

Genotype

Source

YCE345

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52
SPT16-3xFlag:KanMX

This study

YCE346

MATa HIS3-200 LEU2-3,112 trp1-1 URA3-52 spt16
K493, 583, 607, 608R-3xFlag:KanMX

This study
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Section 1

Summary of our goals

We chose to use S. cerevisiae to study chromatin PTMs since it provides technological
advantages over higher eukaryotic model organisms including the critical ability to
generate amino acid substitutions in histones and other proteins. We chose to focus on
lysine’s PTMs since they are the most varied. We also chose to focus primarily, though
not solely, on lysine methylation since this is its most complex and functionally diverse
modification and since its previously discovered reversibility made it an important area of
investigation. Finally, we chose to investigate chromatin lysine modifications through
three avenues of research: the lysine PTM enzymes, the histone chromatin lysine PTMs,
and the non-histone chromatin lysine PTMs.

Our studies of Saccharomyces cerevisiae chromatin post-translational modifications
1) Histone Lysine Demethylation in S. cerevisiae:
Histone lysine methylation was long considered permanent due to the lack of an
identified demethylase. Reversibility was demonstrated however when mammalian
LSD1 and JHDM1 were shown to demethylate histone methyllysines in vitro and in vivo
via an amine oxidase and JmjC domain respectively. Since JmjC domains were
predicted in most model organisms and expected to be an important aspect of chromatin
regulation (Klose, R.J., 2006), we chose to characterize the JmjC protein Kdm5,
encoded by S. cerevisiae JHD2.
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2) Histone Lysine Methylation in S. cerevisiae:
H4 K20 is mono-, di-, and trimethylated in many higher eukaryotes. The
monomethylated state is especially interesting since it seems to be distinct from the
other states in terms of the responsible enzymes, genomic enrichment, reader proteins,
and biological functions. However, occasionally conflicting reports and the large number
of functions make its overall role not fully clear (Brustel, J., 2011; Yang, H., 2009).
Further, studies involving perturbing its methyltransferase Set8 (Pr-Set7) are
complicated by the fact that this may alter the di- and trimethylated states and the fact
that Set8 targets p53 and perhaps other proteins (Shi, X., 2007). The genetically
tractable Schizosaccharomyces pombe also possess H4 K20me1, but using it as a
model to clarify H4 K20me1’s role is limited since H4 K20me2, 3 are also present, the
same enzyme may create all three states, and functional differences between the states
are unclear (Sanders, S.L., 2004).
Unlike most higher eukaryotes, S. cerevisiae was considered to lack methylation
of H4 K20, as well as H3 K9 and H3 K27. These three lysines are conserved from
budding yeast to humans and their methylation in higher eukaryotes is associated with
transcriptional repression or chromatin compaction. In contrast, lysines H3 K4, H3 K36,
and H3 K79 and their methylation are conserved from budding yeast to humans and this
methylation is associated with transcriptional activity or an open chromatin state (Martin,
C., 2005). S. cerevisiae thus possess all six conserved lysines and the three “active”
methylations but lack the three “repressive” methylations. As such, budding yeast are
considered to have chromatin that is generally more “open” than higher eukaryote
chromatin.
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Since a mass spectrometry report suggested that monomethylated H4 K20 exists
in S. cerevisiae (Garcia, B.A., 2007), we chose to confirm and characterize this mark for
several reasons. First, since budding yeast are excellent for studying histone PTMs, and
since the di- and trimethylated states may be absent, unlike in S. pombe, this would be
an opportunity to clarify the role of this particular methylation state of this lysine.
Second, if this mark were associated with repression, this would be the first repressive
S. cerevisiae histone methyllysine.

3) NuA4 Acetylation of Spt16 in S. cerevisiae:
It is increasingly clear that PTMs are employed by the cell to regulate proteins ingeneral. Since chromatin is comprised of many non-histone proteins and is replete with
protein-modifying enzymes, it is expectable that modifications occur on and regulate
these non-histone proteins. The scope of this for acetylation was demonstrated recently
using a budding yeast proteome microarray. The HAT NuA4 in vitro acetylated 91
proteins, many of which were chromatin-related (Lin, Y.Y., 2009). One in vitro target
was Spt16, part of the yFACT complex that is essential and participates in transcription
elongation and possibly DNA replication and repair (Doyon, Y., 2004). Since this would
be an opportunity to expand the repertoire of non-histone acetylation targets in vivo,
shed light on NuA4’s function, and elucidate the regulation of a critical chromatin protein,
we chose to confirm and characterize the acetylation of S. cerevisiae Spt16.
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Section 2

Histone Lysine Demethylation in Saccharomyces cerevisiae

S. cerevisiae Kdm5 demethylates mono-, di-, and trimethylated H3 K4 in vitro
The JmjC domain-containing proteins from major model organisms can be organized
into groups based on phylogenetic analysis and domain architecture (Klose, R.J., 2006).
Kdm5 (Yjr119c in the review) is a member of the JARID group. Noting that another
JARID group member, mammalian Jarid1d, demethylates methylated H3 K4 (Lee, M.G.,
2007) and is orthologous to Kdm5 especially in terms of the predicted catalytically
essential residues, we hypothesized that Kdm5 also demethylates methylated H3 K4.
Using in vitro demethylase assays with core histones and peptides and in vivo
overexpressions of JHD2 combined with western analyses, we demonstrated the
following about Kdm5’s activity. First, Kdm5 can demethylate the mono-, di-, and
trimethylated states of H3 K4 in vitro. Second, Kdm5’s activity is site-specific since we
did not detect H3 K36 or H3 K79 demethylation in vitro and since overexpressing JHD2
did not change H3 K36me3 levels in vivo. Third, Kdm5 can target peptides and core
histones in vitro, but may not be able to target nucleosomes effectively in vitro. Fourth,
Kdm5 demethylates H3 K4me2, 3 in vitro such that the mono- and dimethylated states
can accumulate, presumably as intermediates.

S. cerevisiae Kdm5 negatively regulates Set1 and H3 K4 methyl levels at GAL1 during
induction & repression
While I contributed the previously described in vitro work, another graduate student,
Kristin Ingvarsdottir, characterized Kdm5 in vivo by using ChIP to observe H3 K4me1-3
and Set1 levels at the GAL1 5’ and 3’ regions during its induction and subsequent
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repression. Set1, as part of the COMPASS complex, is the HMT responsible for H3
K4me1-3 (Shilatifard, A., 2008) and any analysis should consider that changes in H3 K4
methylation could result from changes in Set1/COMPASS recruitment. Kdm5 loss by
JHD2 deletion did not cause noticeable changes to Set1 or H3 K4me1-3 levels globally.
Changes however were noticeable at GAL1 during its induction and subsequent
repression and can be summarized in the following three points.
First, during induction in wild-type yeast, Set1 levels increase at the GAL1 5’ but
not 3’ region. Without Kdm5 however, Set1 is now recruited to both the 5’ and 3’ regions
during induction and the increase at the 5’ region is of greater magnitude. This suggests
that Kdm5 inhibits Set1 recruitment to GAL1 during induction, partially limiting 5’
recruitment and completely preventing 3’ recruitment.
Second, during induction in wild-type yeast, H3 K4me1-3 increases at the 5’ but
not at the 3’ regions, consistent with Set1 recruitment patterns. Further, at the 5’ region,
while all three methyl states increase upon GAL1 expression, the increase is largest for
K4me3 and smallest for K4me1. Without Kdm5 however, GAL1 induction is
accompanied by an increase of all three methyl states at both the 5’ and 3’ regions.
Further, at the 5’ region during GAL1 induction, the increase in K4me3 is only slightly
larger than in wild-type yeast, but the increase in K4me1, 2 is much larger than in wildtype yeast. This suggests that Kdm5 opposes H3 K4 methylation at GAL1 during
induction, but just like with Set1 recruitment, it is a little different at the 5’ and 3’ regions.
At the 5’ region during induction, all three H3 K4 methyl states try to increase greatly but
Kdm5 suppresses the lower methyl states moreso than the higher methyl states such
that K4me1 increases the least and K4me3 increases the most. At the 3’ region during
induction, Kdm5 suppresses H3 K4me1-3.
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Third, upon repression of active GAL1 in wild-type yeast, H3 K4me1-3 are
present at the 5’ region and K4me3 in particular shows a decrease over time. Without
Kdm5 however, K4me3 levels are a little higher (as mentioned above) and decrease
slower.

Model of Kdm5 function at GAL1
Upon GAL1 induction, Set1 is recruited to the gene to increase levels of H3 K4me1-3,
which then function in transcription. Kdm5 simultaneously inhibits this methyllysine
increase, both directly by demethylating the histones, and indirectly by limiting Set1’s
recruitment or activity. Since lysine methylation regulates some non-histone proteins,
and since Set1 exists within and is regulated by the COMPASS complex (Shilatifard, A.,
2008), Kdm5 might limit Set1’s recruitment by demethylating a methyllysine on Set1 or
any other COMPASS component. Likewise, upon gene repression, Kdm5 promotes a
decrease in the 5’ region H3 K4me3 levels, likely directly by removing the methyl groups
and perhaps indirectly by promoting the dissociation of Set1/COMPASS.
An interesting question is the regulation of Kdm5’s activity at GAL1 during gene
expression and repression. Kdm5 is presumably recruited to or away from GAL1 to
regulate H3 K4 methyl levels. ChIP however failed to detect Kdm5 enrichment or
depletion at GAL1 during any change in gene expression (our unpublished results). This
might be an artifact of our ChIP methods or due to poor Kdm5 crosslinking ability or
transient interactions. It might however be a general property of JmjC proteins since
others have reported failure to observe enrichment of two budding yeast H3 K36mespecific JmjC proteins at specific genes despite those proteins affecting H3 K36me
levels at those genes. Alternatively, Kdm5 may be broadly distributed along chromatin
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and its functioning at specific places and times might be regulated by its own PTM or the
recruit of cofactors. Another possibility, if Kdm5 regulates H3 K4me levels at GAL1 only
indirectly through demethylating Set1/COMPASS recruitment, is that Kdm5 interacts with
Set1/COMPASS without binding chromatin.

Kdm5 protein interactions
Little is known about Kdm5’s in vivo protein interactions and we and others failed to
observe proteins copurifying with yeast-purified Kdm5 (Liang, G., 2007; our unpublished
results). There are however several reason to suspect that many interesting Kdm5protein interactions exist in vivo. First, the E3 ubiquitin ligase Not4 ubiquitylates Kdm5 in
vivo to regulate its stability (Mersman, D.P., 2009; Huang, F., 2010). That this
interaction was missed by us and others demonstrates that failure to observe proteins
copurifying from yeast with Kdm5 does not mean that in vivo interactions do not occur.
We note that these copurification experiments were performed under “normal” growth
conditions and some Kdm5-protein interactions may only occur during stress conditions.
Second, Kdm5 by itself may not be capable of targeting nucleosomes in vitro; we
failed to see such activity with insect cell-purified Kdm5 (data not shown), others only
reported using histone substrates (Liang, G., 2007), and notably, the mammalian
ortholog Jarid1d cannot target nucleosomes in vitro (Lee, M.G., 2007), arguing that this
may be a general property of JARID family members. Kdm5 may thus rely on adaptor
proteins to facilitate interactions with nucleosomes and as an example, mammalian
LSD1 demethylates histones by itself but requires CoREST to demethylate nucleosomes
(Lee, M.G., 2005). We note a recent report that Myc-tagged Kdm5 bound nucleosomes
in vitro. These nucleosomes were yeast-purified however and additional binding factors
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may have been present (Huang, F., 2010). Third, ChIP has not revealed Kdm5
enrichment at GAL1 (our unpublished results) despite regulating its methylation and
similar observations are reported for the JmjC proteins Jhd1 and Rph1 at other genes
(Kim, T., 2007). It thus may be that Kdm5 interacts with adaptor proteins that facilitate
its nucleosome-binding in vivo and prevent efficient ChIP crosslinking to histones.
It would be interesting to identify additional Kdm5-interacting proteins since this
would give insights into its regulation and possibly reveal additional biological roles.
Since standard Kdm5-purifications from yeast under optimal growth conditions have
revealed little, purifications under various stress or nutritional conditions may be more
informative. Noting that a budding yeast proteome microarray was created a few years
ago and successfully used in an in vitro acetyltransferase screen (Lin, Y.Y., 2009), it is
tempting to speculate that such technology could be used to identify proteins that Kdm5
directly binds (Not4 or H3 could be a positive control). Previous attempts to find Kdm5
interactors used epitope tags that may have interfered with interactions (Liang, G., 2007;
our unpublished results). Purifications of physiological Kdm5 with anti-Kdm5 antibodies
would thus be useful for future experiments.
The JmjC protein Gis1, which has no reported demethylase activity in vitro, has
JmjC and JmjN domains capable of protein interactions according to a two-hybrid
experiment (Tronnersjo, S., 2007), and the other JmjC proteins would thus be expected
to interact with many proteins as well. We note however that purifications of two other S.
cerevisiae JmjC proteins, the H3 K36 demethylases Jhd1 and Rph1, also did not
copurify other proteins (Klose, R.J., 2007; Fang, J., 2007). Like Kdm5, these
purifications used epitope tags and standard growth conditions. Budding yeast JmjC
domain proteins in-general may thus use a regulatory mechanism in which they have
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limited stable interactions under normal conditions but then stably interact with proteins
under stress conditions. We note also that Rph1 and Jhd1 purify from yeast as
oligomers while Kdm5 purifies as a monomer under normal growth conditions (Klose,
R.J., 2007; Fang, J., 2007; Liang, G., 2007) (oligomerization is undetermined for the
JmjC proteins Gis1 and Ecm5). While the biochemical implications of this are unknown,
they would certainly impact the recruitment of interacting proteins. It would not be
surprising if Kdm5 also had latent oligomerization properties that are only revealed under
non-normal growth conditions.

The state of S. cerevisiae histone lysine demethylation
S. cerevisiae has five JmjC domain-containing proteins and no obvious LDS1 orthologs.
To date, only three of them are verified demethylases; Kdm5 demethylates H3 K4 in
vitro (Seward, D.J., 2007; Liang, G., 2007; Ingvarsdottir, K., 2007) and Jhd1 and Rph1
demethylate H3 K36 in vitro (Fang, J., 2007; Klose, R.J., 2007). Gis1 and Ecm5 remain
unconfirmed as demethylases, although Gis1 perturbation reportedly affects H3 K36
methyl levels in vivo according to mass spectrometry (Tu, S., 2007). No activity however
has been reported in vitro or in vivo for Ecm5. We note that Gis1 and Ecm5 are difficult
to purify (our unpublished results) and such limitations must be overcome before
enzymatic activity can be confirmed. Since Kdm5 and Ecm5 are in the JARID family
which is known for H3 K4-specific activity (Klose, R.J., 2006), Kdm5 and Ecm5 might
work together such that Ecm5’s in vivo activity is masked by redundant Kdm5 functions.
It thus would be interesting to see what phenotypes resulted from Ecm5 and Kdm5
double deletions.
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It is noteworthy that S. cerevisiae possess more methylated histone lysines than
JmjC proteins. Methylated H3 K4 and K36 are demethylated (Liang, G., 2007; Fang, J.,
2007; Klose, R.J., 2007) as previously mentioned. Methylated H3 K79 however has no
known demethylase in any organism and is very abundant in budding yeast and thus
may not be subject to active demethylation (van Leeuwen, F., 2002). Since this
manuscript was published, we have confirmed the existence of H4 K20me1 (Edwards,
C.R., 2011) and others have confirmed the existence of methylated H2B K37 and H3
K42 (Gardner, K.E., 2011; Hyland, E.M., 2011). Whether any of the five JmjC proteins
target them is unknown. While mammalian H4 K20me1 is targeted by PHF8 (Liu, W.,
2010), our in vivo data argue that the five budding yeast JmjC proteins might not target
this mark (Edwards, C.R., 2011).

How do HKMTs and HKDMs together regulate methyllysine levels?
At least three mechanisms can regulate methyllysine levels: increases by methylation,
decreases by demethylation, and decreases by dilution during DNA replication, the first
and second of which are highly regulatable. HKMTs and HKDMs can utilize two general
strategies to maintain appropriate methyllysine levels. Their localization and activity
along chromatin can be unregulated, resulting in basal genome-wide methylation or
demethylation. Alternatively, they can be recruited to specific locations during specific
conditions.
The three known S. cerevisiae HKMTs utilize the latter strategy; Set1, Set2, and
Dot1 respectively create H3 K4, H3 K36, and H3 K79 methylation which is enriched at
genes, and Set1 and Set2 do so proportionately to transcription levels (Pokholok, D.K.,
2005). Since we and others have encountered difficulty observing enrichment of Kdm5,
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Rph1, and Jhd1 at checked locations via ChIP, and since these three demethylases
have few known interacting proteins, the JmjC proteins may utilize the former strategy.
In such a scenario, histone methyllysine patterns are maintained by location and
condition-specific HKMT activity and continuous genome-wide turnover by HKDM
activity and dilution during DNA replication. Alternatively, since another group reported
that Kdm5 loss causes delays in H3 K4me3 demethylation at many active genes upon
their repression (Radman-Livaja, M., 2010), similar to our results at GAL1, the JmjC
proteins may utilize the location-specific strategy. Continued efforts to map these
proteins’ genome-wide distributions will be needed to answer this question.

The future of lysine demethylase studies
While Kdm5, Jhd1, and Rph1 can demethylate histones, it will be interesting to ask what
non-histone proteins they also target. The ability of histone modifiers to modify other
proteins is increasingly documented in screens and studies of individual proteins. LSD1
for example was shown to demethylate methylated p53 and an in vitro acetyltransferase
screen identified 91 targets of the HAT complex NuA4 (Huang, J., 2007; Lin, Y.Y., 2009).
The failure to show enrichment of Kdm5, Jhd1, or Rph1 at any checked locations leaves
open the possibility that they exert their effects on chromatin indirectly by demethylating
non-histone proteins. Since Kdm5 loss results in increased Set1/COMPASS recruitment
to GAL1, whether this complex is demethylated (or methylated) is an obvious starting
point.
Unbiased approaches will be advantageous. While the previously mentioned S.
cerevisiae proteome microarray is an excellent tool for studying the addition of small
molecules, it has less applicability for studying the removal of small molecules. An
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alternative approach could be to identify Kdm5 interactors, check the interactors for
methylation in vivo, and then check whether Kdm5 reverses those methylation in vitro.
This method would be advantageous since it would, at the least, identify Kdm5
regulators. Another possibility would be to construct a proteome microarray using
proteins purified from yeast that were grown with radioactive S-adenosyl methionine.
Kdm5 would then be incubated with the microarray and loss of radioactivity at specific
coordinates would indicate loss of methyl groups. The disadvantage of this strategy
would be that radioactive microarrays would have to be constructed and methylations
might be missed if they are unabundant in vivo.
Another innovative possibility would be to construct a peptide library in which
mono-, di-, or trimethylated lysines were surrounded by every possible amino acid
sequence. The library would be used as the substrate in in vitro demethylase reactions.
Demethylation loss could be detected by pooling the peptides and performing mass
spectrometry to determine which methylated species had decreased abundance.
Alternatively, the peptide library could be constructed on an array that was then
incubated with the demethylase, after which demethylation would be detected using panmethyl-specific antibodies. A disadvantage of this method would be that since enzymes
interact with target proteins at multiple contact points, the interactions with peptides may
not fully represent the interactions that occur in vivo. Ultimately however, identification
of non-histone demethylase targets will depend on the prior identification of non-histone
methyl sites.
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Section 3

Histone Lysine Methylation in Saccharomyces cerevisiae

S. cerevisiae Histone H4 Lysine 20 is Monomethylated
Noting that H4 K20me1 is an interesting but complicated PTM in higher eukaryotes and
noting that S. cerevisiae lack all the “repressive” histone lysine methylations despite
having the corresponding lysines (Martin, C., 2005), we took interest in a mass
spectrometry report several years ago suggesting that K20 of budding yeast H4 is
monomethylated (Garcia, B.A., 2007). Were this mark present in S. cerevisiae, it might
be budding yeast’s first repressive histone methyllysine and could serve as a model for
studying higher eukaryote H4 K20me1. To confirm S. cerevisiae H4 K20me1 we
performed western analyses with a commercially-available H4 K20me1-specific antibody
that showed specificity for the monomethylated state in dot blots of H4 peptides. The
antibody detected an epitope in yeast whole-cell extracts that co-migrated with calf
thymus H4, had a slower migration if the H4 was FLAG-tagged, was abrogated by an H4
K20R substitution, and was competed by monomethylated but not unmodified H4
peptides. Further, a second commercially-available anti-H4 K20me1 antibody showed
similar results and showed no preferential binding of H4 K20me2, 3 peptides in dot blots
or peptide competitions of western analyses. These data acquired using two
independent antibodies argue strongly that S. cerevisiae H4 K20 is monomethylated.

In vivo characterization of H4 K20me1
We performed a variety of assays to characterize H4 K20me1 in vivo and determined
the following. First, global H4 K20me1 levels do not vary greatly during the cell cycle.
Second, H4 K20me1 levels per total H4 levels are most abundant at heterochromatic
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regions (rDNA, subtelomeres, and silent mating type loci), least abundant at
centromeres and promoter/5’ regions of genes, and have intermediate abundance inside
genes. At the genes we checked, H4 K20me1 levels per total H4 levels are slightly
higher at the middle regions than the 5’ and 3’ regions. Third, H4 K20R and K20A
substitutions by themselves do not noticeably affect growth with altered nutrient
conditions, elevated temperatures, or stresses with DNA replication or damage. Fourth,
H4 K20A, but not H4 K20R, causes silencing defects of reporters integrated at
heterochromatic regions (rDNA, subtelomeres, and silent mating type loci) and
endogenous genes at subtelomere 7L. Importantly, endogenous subtelomere 7L genes
had higher H4 K20me1 levels and larger H4 K20A-mediated derepression if they were
telomere-proximal than if they were telomere-distal. Fifth, global H4 K20me1 levels
decrease during replicative ageing. Sixth, H4 K20R substitutions moderately rescue H3
K56R-mediated Camptothecin-sensitivity, suggesting that H4 K20me1 negatively
contributes to survival during DNA damage. (Fig. 1-3)
Figure 1

H4 K20me1 / Total H4 Levels are Higher at Heterochromatic Regions

H4 K20me1 normalized to total H4 is highest at heterochromatic locations including
subtelomeres, the silent mating type locus, and rDNA, and lowest at euchromatic
locations including centromeres and the promoter/5’ regions of some genes.
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Figure 2

H4 K20me1 Decreases During Yeast Replicative Ageing

H4 K20me1 normalized to total H4 is globally less abundant in replicatively older than
younger yeast, in contrast to H4 K16ac. Green “Ac” ovals are H4 K16ac. Red “Me1”
ovals are H4 K20me1. Yellow circles are yeast.
S. cerevisiae H4 K20me1 and Survival During DNA Damage
Noting reports that mammalian H4 K20me1 may recruit DNA damage proteins and may
be needed for the DNA damage response (Oda, H., 2010; Oda, H., 2009), we asked
whether H4 K20me1 loss in S. cerevisiae causes similar defects. While an H4 K20R
substitution produced no DNA damage sensitivity, combination with an H3 K56R, but not
H3 K79R, substitution resulted in a synthetic effect with Camptothecin, but not vehicleonly, treatment. Unexpectedly, the K20R caused a moderate (~5-fold) rescue of the
K56R-mediated sensitivity. Camptothecin (CPT) interferes with topoisomerases such
that double-stranded DNA breaks are produced during DNA replication (Li, T.K., 2001).
H4 K20R thus moderately rescues the H3 K56R-mediated survival during DNA damage
(Figure 3). Rtt109 acetylates newly synthesized H3 K56 to promote recovery from DNA
damage during S phase (Masumoto, H., 2005; Han, J., 2007). How H3 K56ac does this
is not clear, but it can “loosen” chromatin and promotes nucleosome reassembly at sites
of DNA damage after repair. Noting this, several models to explain the K20R rescue can
be proposed.
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Figure 3

H3 K56R and H4 K20R synthetic effects with CPT

Camptothecin (CPT) compromises topoisomerases, promoting double-stranded DNA
breaks during DNA replication. This activates the DNA damage response during which
survival is promoted by H3 K56ac and inhibited by H4 K20me1.
First, DNA damage response efficiency is thought to depend on the level of chromatin
compaction, with increased compaction being associated with decreased DNA repair
efficiency. Presumably, tighter chromatin inhibits access to the DNA by the repair
machinery (Lukas, J., 2011). Likewise, acetylated H3 K56, which promotes survival
during DNA damage, is thought to “loosen” chromatin by abrogating hydrogen bonding
that would normally occur between the DNA backbone and the epsilon nitrogen of lysine
56’s side chain (Masumoto, H., 2005). If H4 K20me1 promotes chromatin compaction in
S. cerevisiae, similar to in higher eukaryotes, and H3 K56ac promotes chromatin
decompaction, then loss of H3 K56ac would leave chromatin more compacted and less
accessible to the DNA repair machinery whereas simultaneous loss of H4 K20me1
would decrease the compaction and thus slightly uninhibit the repair process. That H4
K20R alone did not promote survival during DNA damage implies that DNA repair and
cell growth during Camptothecin treatment are already proceeding at the maximum rate
when H3 K56ac is intact.
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Second, H3 K56ac is proposed to promote nucleosome reassembly at a DNA
damage site after repair completes (Chen, C.C., 2008), presumably by facilitating
association with histone chaperones. H3 K56ac-deficient yeast have decreased
nucleosome redeposition after repair and this is thought to prevent release from the
checkpoint, resulting in decreased growth (Chen, C.C., 2008). If H4 K20me1 inhibits
histone deposition, H4 K20me1 loss might compensate for H3 K56ac loss by moderately
uninhibiting nucleosome incorporation. Alternatively, since H4 K20me1 may function in
mammals by recruiting effectors like 53BP1 (Oda, H., 2010), it may recruit S. cerevisiae
effectors as well. If it recruits effectors that promote the DNA damage checkpoint, then
H4 K20me1 loss might compensate for H3 K56ac loss by inappropriately releasing cells
from the damage-induced checkpoint. H4 K20me1 thus might participate in the DNA
damage response by affecting chromatin or recruiting PTM readers.
We note that in our studies, H4 K20me1 was detectable at many places
throughout the genome and was not enriched during S phase, curious for a mark that
may play a role during replication at specific sites of DNA damage. H3 K56ac however
is also considered to be spread out along the genome during S phase and it is posited
that this allows it to participate in DNA repair without the cell having to target it to specific
locations (Masumoto, H., 2005). A similar reason may hold true for H4 K20me1’s
distribution throughout the genome, and if it functions to balance out H3 K56ac’s
chromatin “loosening” effects, then H3 K56ac’s ubiquitousness may be a reason for H4
K20me1’s presence across much of the genome.
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S. cerevisiae H4 K20me1 as a Potentially “Repressive” Histone Methyllysine
“Repressive” histone PTMs can have properties including association with
transcriptionally repressed genes or compacted regions of the genome, the ability to
recruit reader proteins associated with repression or compaction, or the ability to directly
promote transcriptional repression of chromatin compaction. The idea that H4 K20me1
is a “repressive” histone PTM is consistent with our results.
First, our ChIP results indicate that H4 K20me1 normalized to total H4 is higher
at all known types of S. cerevisiae heterochromatin (subtelomeres, rDNA, and the silent
mating type locus) than all checked non-heterochromatin locations. Second, our ChIP
and gene expression results show a correlation between the locations with highest H4
K20me1 levels and the genes with greatest derepression upon H4 K20A substitution.
Third, since acetylation of H3 K56 “loosens” nucleosome structure by disrupting an H3DNA contact (Masumoto, H., 2005), and since loss of H3 K56ac and H4 K20me1 may
have opposing contributions to survival during Camptothecin-mediated DNA damage, it
may be that the chromatin decompaction by H3 K56ac, which might promote repair of or
survival during the DNA damage response, is moderately counteracted by a compaction
effect by H4 K20me1. Fourth, H4 K20me1 decreases globally during yeast replicative
ageing whereas H4 K16ac, which is associated with transcriptional activity and open
chromatin states, increases globally and at specific subtelomeric locations (Dang, W.,
2009). It is thought that increased H4 K16ac at silent subtelomeres causes defective
chromatin compaction and silencing. Since H4 K20me1, in contrast, has higher
abundance at heterochromatin including subtelomeres and may promote silencing at
some subtelomeric genes, and since it has dynamic abundance during ageing that anticorrelates with H4 K16ac, H4 K20me1 may be part of a repressive chromatin state that
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is disrupted at heterochromatin by H4 K16ac during replicative ageing. While an H4
K20R substitution did not reproducibly affect replicative lifespan, an H4 K20A
substitution has not been checked and whether H4 K20me1’s decrease during ageing
occurs at heterochromatin has not been checked by ChIP.
While additional work must be done to investigate H4 K20me1’s role in the DNA
damage response and yeast replicative ageing, there are several particular experiments
that would greatly contribute to determining whether it is a “repressive” PTM. First, work
must be done to ask whether it recruits compaction or repression-associated proteins
(discussed below). Second, experiments asking whether it in vitro affects compaction of
reconstituted chromatin would be of great value. H4 K20me2, 3 reportedly promote in
vitro compaction of reconstituted chromatin with Xenopus laevis histones (Lu, X., 2008)
but H4 K20me1 was not reported and whether it has any such effect on S. cerevisiae
chromatin is unknown.

H4 K20me1 Conservation from S. cerevisiae to Higher Eukaryotes
While H4 K20me1 is conserved between S. cerevisiae and higher eukaryotes, our
studies indicate that not all of its properties are conserved. Below is a comparison of its
properties in S. cerevisiae and higher eukaryotes in terms of genomic localization,
responsible HMT, and connections to gene expression, chromatin compaction, effector
protein recruitment (or blocking), replicative ageing, the DNA damage response, and
DNA replication and the cell cycle.
First, mammalian H4 K20me1 may be associated with silenced regions and
indeed is enriched at the inactive X Barr body while Set8 reportedly copurifies with
heterochromatin (Wutz A., 2011; Wu, S., 2010). Similarly, budding yeast H4 K20me1
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was more abundant at all heterochromatin types than all checked euchromatin regions.
Second, mammalian H4 K20me1 exists within genes and tends to be most enriched at 5’
or middle regions relative to upstream and downstream regions (Congdon, L.M., 2010;
Vakoc, C.R., 2006), similar to S. cerevisiae H4 K20me1. Third, mammalian H4 K20me1
promotes or participates in silencing and examples include plasmid reporters,
endogenous genes, DNA replication-related genes, and the inactive X Barr body
(Congdon, L.M., 2010; Kalakonda, N., 2008; Abbas, T., 2010; Wutz A., 2011). Likewise,
budding yeast H4 K20me1 abundance at heterochromatic locations correlates with H4
K20A-mediated derepression of genomic reporters and endogenous genes.
Fourth, mammalian H4 K20me1 promotes chromatin compaction in vitro and
recruits compaction proteins like L3MBTL1 in vitro and in vivo (Trojer, P., 2007;
Kalakonda, N., 2008). Our studies however have not investigated H4 K20me1’s readers
or its in vitro effects on chromatin structure. Whether this function is conserved is an
open question. Fifth, H4 K20me1 levels per total H4 levels globally decrease during S.
cerevisiae replicative ageing. A connection to replicative potential in higher eukaryotes
however is not well-known so this may be a budding yeast-specific phenomenon or may
be conserved but unknown in higher eukaryotes. Sixth, mammalian H4 K20me1 may
participate in DNA repair by promoting 53BP1 recruitment (Oda, H., 2010; Botuyan,
M.V., 2006). Further, H4 K20 methylation loss in S. pombe results in DNA damagesensitivity (Sanders, S.L., 2004). Similarly, S. cerevisiae H4 K20me1 may influence cell
survival during DNA damage, although the contribution may be negative.
Seventh, mammalian H4 K20me1 is linked to DNA replication and origin
licensing and has a characteristic abundance pattern across the cell cycle (Huen, M.S.,
2008; Jørgensen, S., 2007; Tardat, M., 2007; Oda, H., 2010; Wu, S., 2010; Abbas, T.,
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2010; Pesavento, J.J., 2008; Brustel, J., 2011), whereas our studies of budding yeast H4
K20me1 did not investigate origin licensing and demonstrated neither a link to DNA
replication nor a cell cycle-dependent global abundance. Mammalian H4 K20me1’s
participation in DNA replication thus may not be conserved in S. cerevisiae and its cell
cycle abundance is definitely not conserved. We note that Hs Set8’s cell cycle
regulation is partly produced by APC/C-mediated ubiquitylation of its D-box motif during
late M phase to trigger degradation (Wu, S., 2010). This D-box motif is conserved in
Homo sapiens, Mus musculus, and Xenopus laevis Set8, but not in Danio rerio,
Drosophila melanogaster, and Caenorhabditis elegans Set8 (Brustel, J., 2011). H4
K20me1’s functions that require its downregulation during parts of the mammalian cell
cycle thus may be absent in lower eukaryotes and it would be unsurprising if S.
cerevisiae H4 K20me1 lacked such cell cycle-related roles.
Eighth, whether mammals and budding yeast are conserved in terms of the
responsible HMT is unclear. Mammals (Fang, J., 2002; Nishioka, K., 2002) possess a
dedicated H4 K20 monomethyltransferase whereas S. pombe (Sanders, S.L., 2004) and
Toxoplasma gondii (Sautel, C.F., 2007) may possess an HMT that mediates all three
methylation states, arguing that K20me1 is more functionally distinct from K20me2, 3 in
higher than lower eukaryotes. It is intriguing then that S. cerevisiae seem to only
possess the monomethylated state of H4 K20. While budding yeast would be expected
to utilize a multi-methylation state-creating enzyme like other lower eukaryotes, it likely
instead utilizes a dedicated monomethylase like higher eukaryotes.
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H4 K20me1 & the Nature of Lower Eukaryote Chromatin
It should be noted that since S. cerevisiae was long thought to lack methylation of H3
K9, H3 K27, and H4 K20, all of which are considered “repressive” methylations, S.
cerevisiae was considered to have chromatin that is more “open” or decompacted than
in higher eukaryotes. Like S. cerevisiae, Toxoplasma gondii was also thought to
possess the “open” chromatin lysine methylations (H3 K4, H3 K36, and H3 K79) but not
the “repressive” ones and thus was considered to have “open chromatin” similar to
budding yeast. It was reported a few years ago however that T. gondii chromatin has H4
K20me1-3 created by Tg Set8 (Sautel, C.F., 2007). That H4 K20 methylation exists in T.
gondii and S. cerevisiae argues that the view of the general decompaction of these lower
eukaryote genomes based on their lack of “repressive” methylations may not be entirely
accurate. We note that a mass spectrometry report detected low levels of H3 K9
methylation in S. cerevisiae (Garcia, B.A., 2007) and budding yeast Rph1 can
demethylate H3 K9 in vitro (Klose, R.J., 2007), suggesting that methylated H3 K9 may
exist here. Considering these findings, it may thus be that these lower eukaryotes
possess silencing pathways that are simply underappreciated.

The future of S. cerevisiae H4 K20me1 studies
The future of H4 K20me1 studies in S. cerevisiae should be focused on determining its
phenotypes, methyltransferase, and readers. Considering the number of molecular and
biological functions to which mammalian H4 K20me1 is linked, it is likely that S.
cerevisiae H4 K20me1 is linked to many processes as well. H4 K20 substitutions
however have revealed a very limited number of roles in standard phenotypic analyses,
perhaps due to redundant mechanisms or the phenotypes being too subtle.
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Combinatorial mutations combined with careful analyses may identify more in vivo roles
and our discovery of a synthetic effect with a topoisomerase poison demonstrates the
usefulness of this approach. Our decision to combine an H4 K20R mutation with an H3
K56R mutation during Camptothecin treatment was fortuitous, but it will be more efficient
to utilize unbiased approaches like a synthetic genetic array, which would combine H4
K20R with every possible gene deletion. This should however also involve combinations
with substitutions of modified histone residues or a histone alanine scan. This is
warranted since crosstalk between histone PTMs is well documented but importantly,
since proteins interacting with histones likely do so through multiple contact points.
To identify the responsible methyltransferase, our candidate gene
overexpression approach could be repeated with epitope-tagged versions of the proteins
to verify that the candidate enzymes are expressed. The recent identification however of
two other S. cerevisiae histone methyllysines with unidentified methyltransferases
suggests that the enzyme may not be on our or the other authors’ candidate list
(Gardner, K.E., 2011; Hyland, E.M., 2011). An unbiased approach such as a genomewide deletion or overexpression screen will be useful. The overexpression strategy will
be more difficult since some proteins might not overexpress well but redundancy and
essential genes will not be problematic like they will be for the deletion strategy.
Alternatively, an unbiased biochemical approach could be employed in which S.
cerevisiae whole-cell or nuclear fractions would be tested for in vitro H4 K20
methyltransferase activity on histones or nucleosomes.
To identify proteins that bind to or are blocked by this PTM, several options exist.
We purified epitope-tagged wild-type or K20R H4 from S. cerevisiae and observed
copurified proteins with Colloidal Blue and silver protein stains, but too many proteins
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were present to notice anything interesting (our unpublished results). Alternatively, wildtype and H4 K20R yeast could be grown with light or heavy amino acid supplements
after which material that copurified with H4 could be analyzed by mass spectrometry
(SILAC), a method that could better make sense of the purified material. Alternatively, in
vitro approaches could be used. For example, wild-type or H4 K20me1 peptides
immobilized on beads could be incubated with yeast extracts to determine what proteins
bind to or are blocked by H4 K20me1. We attempted this but our work was not
extensive. An interesting approach could utilize protein microarray technology which
has recently been successfully used to identify in vitro targets of a HAT (Lin, Y.Y., 2009).
Radioactive, epitope, or fluorescently labeled H4 K20me1 peptides could be incubated
with an array that contains all known S. cerevisiae proteins, only chromatin proteins, or
only PTM readers, after which interactions would be followed-up by standard in vitro
binding assays and in vivo coimmunoprecipitation experiments.
Several proteins interact with the patch of basic residues that occupies this part
of H4, including the Sir2/3/4 complex, Isw2, and Dot1 (Fazzio, T.G., 2005; Altaf, M.,
2007; Fingerman, I.M., 2007), and they might perhaps be blocked by this PTM.
However, H4 K16ac and H3 K79me3 levels, which are respectively regulated by Sir2/3/4
and Dot1, are not globally affected by an H4 K20R substitution (our results). Further, H4
K20 substitutions are not known to affect binding or activity of these three proteins and
monomethylation may not have any blocking effect on them. A possible binder however
might be Rad9, which participates in the DNA damage response. Mammalian 53BP1
and its S. pombe ortholog Crb2 bind methylated H4 K20 (binds K20me2 and likely
K20me1 to some extent also) as part of the DNA damage response. While they have no
overall ortholog in S. cerevisiae, budding yeast Rad9 has a tandem tudor domain that is
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similar to their tandem tudor domains. The budding yeast Rad9 tandem tudor domain
has structural differences that prevent H4 K20me2 binding in vitro but whether it binds
H4 K20me1 is unreported (Lancelot, N., 2007).
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Section 4

NuA4 Acetylation of Spt16 in Saccharomyces cerevisiae

NuA4 Acetylates Spt16 In Vitro and Acetylation May Confers Heat-Tolerance In Vivo
A budding yeast proteome microarray recently identified numerous in vitro acetyation
targets of the NuA4 HAT complex (Esa1 is the HAT) (Lin, Y.Y., 2009). We chose to
follow-up the hit Spt16 since it is an important chromatin protein. Spt16 heterodimerizes
with Pob3 to form yFACT and it and this complex are conserved in mammals. Although
also connected to DNA replication and repair, yFACT’s most well-known role is in
transcription elongation where it modulates nucleosomes in-front of and behind
elongating RNApol2 to respectively allow polymerase passage and maintain sufficient
chromatin compaction (Winkler, D.D., 2011). We note that other PTMs reportedly occur
on Spt16 and coordinate its various functions (Han, J., 2010). Acetylation may serve a
similar regulatory role.
Mass spectrometry of in vivo overexpressed Spt16 identified three sites (K493,
583, and 607) but confirmation on in vivo Spt16 under normal expression conditions has
been unsuccessful using pan-acetyl antibodies both in western analyses and IPs.
Interestingly, KR substitutions (mimics unacetylation) cause moderately decreased
heat tolerance at 39 oC whereas KQ substitutions (acetyllysine mimics) do not, arguing
that this heat-sensitivity results from loss of acetylation rather than loss of the residues
or other modifications. How these KR substitutions cause heat-sensitivity is unknown.
They do not impair suppression of cryptic intragenic transcription initiation at checked
genes or upregulation of checked heat-response genes. They may cause defects in
other yFACT pathways, or they may impair yFACT integrity or Spt16 stability resulting in
general loss-of-functions.
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Unanswered and new questions about Spt16 acetylation
Many additional questions exist regarding Spt16 acetylation. It is unknown whether any
deacetylases remove these marks. If they do, their disruption might increase
endogenous acetylation abundance to more detectable levels. It is unknown whether
Spt16 is acetylated before or after heterodimerizing with Pob3, in the nucleoplasm or on
chromatin, or at some or all of yFACT’s target genes. The answers to these questions
might reveal roles in yFACT’s biogenesis, nuclear localization, and genome-wide
recruitment. We note that yFACT’s genome-wide localization is not well-studied and
examinations of the genome-wide distribution of acetylated Spt16 may have to be paired
with this. It is not yet confirmed that NuA4 is the responsible HAT in vivo or whether it is
the only responsible HAT. Budding yeast acetyltransferases and deacetylases are
known for redundancy at histone lysines (Millar, C.B., 2006) and it would be unsurprising
if additional enzymes targeted Spt16. Ubiquitylation of budding yeast Spt16 may
participate in its DNA replication activities although the residues are unknown (Han, J.,
2010). If crosstalk exists between Spt16 ubiquitylation and acetylation, they may work
together to coordinate yFACT’s different important functions.

The future of acetylation studies
Our work contributes to the growing body of evidence arguing that acetylation is a
functional modification not confined to histones but rather widely used by the cell. While
acetylation lacks the intrinsic complexity of other modifications like methylation, which
can exist in three states on each lysine, its tendency to act synergistically amongst many
lysines allows the possibility of a gradient of functionality (Yang, X.J., 2008) or
alternatively, redundancy that could ensure continued functionality if some acetylations
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are lost. Considering acetylation’s utility and how widely used other PTMs like
phosphorylation and ubiquitylation are, it should be no surprise that many possible
targets exist for NuA4 (Lin, Y.Y., 2009).
Since histone studies have made the importance of acetyllysines clear, and since
so many remain to be confirmed and characterized on non-histone proteins, the future of
the acetylation field will likely be focused on these non-histone protein acetylations. The
number of in vitro NuA4 targets and the difficulty that can be encountered when studying
each one ensures that much work will remain for some time. We note however that this
in vitro acetylation screen is only the beginning. This method has revealed its
applicability and other S. cerevisiae HATs, and HATs from other organisms, should next
be subjected to similar experiments to illuminate the full repertoire of non-histone protein
acetylation.
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